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The QT interval, as measured on the electrocardiogram, is a reflection of the duration
of cardiac electrical depolarisation and repolarisatio. Prolongation of this interval has
long been recognised to be associated with an increased risk of cardiac arrhythmias.
This thesis discusses the history ofmeasurement of cardiac repolarisation (the QT
interval), and subsequently the various methods to correct QT for heart rate. After
highlighting the limitations of traditional QT correction formulae, I go on to describe
a novel method for continuous automated measurement the relationship between QT
and heart rate from ambulatory ECG recordings. This method's reproducibility and
the effect of lead selection is then established in healthy volunteers.
As cardiac repolarisation and the QT interval is known to be abnormally prolonged in
certain cardiac diseases, and that QT prolongation can precipitate malignant
arrhythmias, the second section of the thesis assesses the repolarisation characteristics
of patient groups with heart failure and hypertrophic cardiomyopathy. The
repolarisation properties are then compared to measures of disease severity, and
traditional markers for sudden death in these patients.
The third section of the thesis presents data gathered from patients with implantable
cardiac defibrillators (ICDs), with three main goals: firstly to establish whether there
is a particular time of day that these patients are prone to arrhythmias; secondly to
establish whether there are particular abnormalities of the repolarisation
characteristics in these patients at that time of day; and thirdly to establish whether
overall 24h repolarisation properties convey any prognostic information with regards
to the risk of further malignant ventricular arrhythmias.
The results demonstrate that the method employed throughout the thesis is
reproducible in healthy volunteers. In addition, I show that in patients with heart
failure and hypertrophic cardiomyopathy, there are marked abnormalities in several
parameters of cardiac repolarisation, and that these abnormalities are progressive with
the severity of the disease. These abnormalities might be expected to confer an
increased risk of sudden arrhythmic death. I also show that sustained ventricular
arrhythmias are far more common in the early hours of the morning in patients with a
history ofmalignant ventricular arrhythmias, and that an increase in sympathetic
activity at that time of day appears to be responsible for this. There are simulatneous
changes in cardiac repolarisation, which are less marked in subjects on beta blockade.
Previous authors have suggested that an abnormally increased 'rate corrected QT'
may be important in the early morning 'high risk' period, but from describing the
overall QT/heart rate characteristic in more detail with the method employed, I have
demonstrated that the repolarisation characteristic during the high risk period is that
of a shortened QT.
In conclusion, this thesis has exposed new information about the complexities of
cardiac repolarisation and its measurement in both health and disease. Some doubt is
cast over existing methodologies for QT 'correction' and some of the conclusions
based on these methods.
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"I don't want to achieve immortality through my work. I
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Foreword
My interest in the QT interval originates from my elective period of study at Medical
School, which I was fortunate enough to spend in the 'Ospedale Maggiore di Milano,
Dipartimento di Fisiologia Clinica e Ipertensione' under the supervision of Professor
Peter Schwartz, Dr Silvia Priori and Dr Carlo Napolitano. These researchers have
been at the forefront of research into the congenital long QT syndromes for many
years. While there, I studied the effects of the pure class III anti-arrhythmic agent d-
sotalol and its effects on action potential duration in isolated guinea pig myocytes. I
was fascinated by the phenomenon of early after-depolarisations which are seen when
the action potential becomes excessively prolonged. This is thought to be the trigger
for the development of Torsades des Pointes in patients with prolonged QT. Since
then I have always taken an interest in arrhythmias, particularly those that are related
to the QT interval.
In 1998 I contacted Dr James Neilson in the department ofmedical physics at the
Royal Infirmary of Edinburgh. He had been developing a novel method to analyse the
QT-heart rate relationship from Holter recordings. After discussion with him about
the method and seeing a demonstration of it in action, I realised that it was something
that held great promise as it used a new and ingenious approach to the analysis of
dynamic QT interval analysis. Following this Dr Neilson and I wrote a grant
application with Dr Flapan to the British Heart Foundation to evaluate the method in
clinical settings. I was successful in receiving a 2 year fellowship grant.
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The first section of the thesis concentrates on the history of the QT interval, factors
that influence it, and methods currently employed to assess rate independent changes
in QT. I go on to examine the ability of the method to monitor short and long term
changes in the QT/RR relationship in health and disease. The latter part of the thesis
is concerned with a study of patients with prior history of malignant arrhythmias who
have received implantable defibrillators, the goal being to establish whether QT/RR
parameters can yield further insights into the initiation and maintenance ofmalignant
ventricular arrhythmias.
The scope ofmy research was involved principally with the temporal relationship
between the QT interval and heart rate. As the recordings obtained for this research
were from 2 channel Holter recorders, little comment can be made about the spatial
dispersion of repolarisation. Interest in the measurement ofQT dispersion was
rekindled by the late Professor Campbell as a potentially useful tool in the risk
stratification of patients at risk from malignant arrhythmias. Since the early papers on
this subject, numerous articles have been published in a broad range ofpatient
populations. As with every test, there always exist backers and sceptics. One of the
issues with QT dispersion (QTd) is the potentially large errors in measurement. These
errors have been reduced somewhat by the introduction of automated measurement of
QTd. Nonetheless, the controversy and debate continues, with some authors referring
to it as "the greatest fallacy in electrocardiography in the '90s" (Rautaharju 1999).
While there is no doubt that spatial dispersion in repolarisation can provide a
substrate for the development of re-entrant circuits, it has been said that QT
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dispersion from 12 lead ECGs should not be thought of as the gold standard.
Recently, some researchers have shown that the measured QT dispersion seems to be
a reflection of the geometrical projection of the T wave on the surface ECG, and have
questioned its significance in disease states (Kors, van Herpen and Van Bemmel
1999). While useful information about arrhythmic risk may well come from QTd, we
will not discuss it further in the context of this thesis.
16
Glossary of Terms
a - Alpha is used to refer to the proportion of total QT adaptation to a given change
in heart rate that occurs rapidly (within one to two beats). Generally this is in the
region of 20-30% of total adaptation. The remainder (1-a) occurs gradually, and
requires several minutes to reach a steady state.
Bazett's QT correction Formula - QTc = QT/vRR, which can also be written as
QT/RR0 5, with time intervals in seconds.
Correlation coefficient (r) - During QT analysis of Holter recordings, the analysed
will continuously 'best-fit' the lag compensated QT and RR' data against an
exponential curve with variables QTo and J. To ensure that the lag compensation is
correctly adjusted, the correlation coefficient is continuously calculated. If the
correlation between QT and RR' data and an exponential curve falls below 0.8, this
section of data is excluded from calculation of the 24h mean values ofQTo and J.
CL - Cycle length. The cycle length is the period between two successive
electrograms. This is generally reserved for discussion of intracardiac electrograms,
but can also be used for surface recordings. For example, the RR interval and
ventricular cycle length refer to the same thing.
Error correction - Prior to running the QT analysis programme, electrogram
recordings are automatically edited to exclude noisy segments or segments with very
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frequent ectopic beats that would introduce errors into the calculations. Recordings
were not analysed if greater that 20% error correction was required.
Fridericia's QT correction Formula - QTc = QT/3VRR, which can also be written as
QT/RR0 333, with time intervals in seconds.
J - Throughout the thesis, we model the QT/RR relationship to a general exponential
formula, which is expressed as QT = QTo. RRJ, with an X and Y intercept at 0,0. The
repolarisation characteristics (or QT/RR relationship) can be expressed as a curve at
any point in time by knowing the two variables QTo and J. J is used to denote the
variable exponent, and does not have units. During analysis of Holter recordings, J is
continuously calculated from a 5 minute window of data, which scrolls through the
entire recording. Throughout most of the thesis, the 24h mean value is expressed, but
instantaneous values can also be quoted.
QT adaptation lag — The QT interval is sensitive to changes in heart rate. However,
the relationship between changes in rate and changes in QT is complex, with a fast
component that is effectively instantaneous (within one beat), and a second
component which takes several minutes to reach a steady state. This delay in
adaptation is referred to as QT adaptation lag' throughout the thesis.
QT - The QT interval is measured on electrocardiograms from the onset of the Q
wave to the offset (or end) of the T wave.
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QTc - The heart rate 'corrected' QT interval. As there are several formulae to correct
the QT interval for heart rate, it is usual to state which formula is being employed.
The most common and widely accepted is Bazett's formula (QTc=QT/VRR).
QTd - QT dispersion, which is calculated as the difference between the longest and
shortest QT intervals on a standard 12 lead ECG. It is felt to probably reflect
heterogeneity of cardiac repolarisation and has been associated with an increased risk
of death in some conditions.
QT Hysteresis - If consecutive QT intervals are plotted against preceding RR
intervals, as heart rate changes the QT interval will adapt to the changes in heart rate.
However, due to the aforementioned Tag' in adaptation, the plot will consist of loops
created by accelerations and decelerations in heart rate, with QT lagging behind.
QTo - This describes the Y axis value at an X-axis ordinate ofRRo on a calculated
QT/RR curve which by convention is chosen as 1000ms. It can be considered the
equivalent to QTc. As the relationship between QT and RR varies independently of
heart rate, it is not sufficient to quote QTo to describe an individuals repolarisation
characteristics. This is discussed in the text.
RR - The time interval between two successive QRS complexes on an ECG. By
convention this should be measured from the peak of the R wave to the next R wave.
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RR' - This refers to RR interval data from Holter recordings to which a delay has
been applied in order to temporally 'align' the continuously changing QT intervals
with the RR intervals that have brought about the change in QT ('lag compensated'
RR intervals). This is necessary in order to compensate for the phenomenon ofQT
adaptation lag.
SD of J - Throughout the day, the QT/RR relationship varies. Normally this is around
fairly constant mean values ofQTo and J. In order to express the degree of variation
in the relationship, the standard deviation of J is calculated by calculating the
standard deviation of the continuously calculated values of J from the 24h recording.
Slope (S) - Slope is used in this work to describe the tangent to a point on the QT/RR
curve. During the process of analysing QT and RR data, QT data is compared with
Tag compensated' RR data (RR', see above). By plotting consecutive QT and RR
pairs, it is possible to measure the slope of these points. As the QT/RR relationship is
not linear but curved over the physiological range of heart rates, slope cannot be used
to describe the overall relationship. Therefore, slope is used, along with QT and RR,
to calculate the 'best-fitting' exponential curve, expressed as QT=QTo.RRJ. Slope
does not have units.




Introduction to cardiac action potentials
and the QT interval
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1.1 Introduction
The cardiac action potential (AP) is responsible for the spontaneous cardiac rhythm
which keeps the heart beating. In the sino-atrial node (SAN), pacemaker cells exhibit
a diastolic outward current that results in spontaneous depolarisation once a threshold
has been reached. The rate at which the SAN cells depolarise in diastole is
determined by autonomic tone and mechano-electrical feedback.
The AV node also displays automaticity, albeit at a slower rate, hence sinus rhythm
dominates under normal circumstances. The specialised conduction tissues of the His-
Purkinje system conduct impulses throughout both ventricles rapidly to produce a co¬
ordinated contraction of the muscular chambers with ejection of blood to the lungs
and body. In ventricular myocytes, the action potential is of longer duration than the
cells of the conduction system and it is during the plateau phase of the action
potential that the myocyte, and hence the heart, contracts.
1.1.1 Generation of the Ventricular Action Potential
The ventricular action potential as shown in figure 1 is composed of four phases.
Phase 0 is the rapid upstroke, due primarily to opening of voltage dependent sodium
channels, with influx ofpositively charged sodium ions and a net depolarisation of
the cell. Phase 1 is the sharp downward notch. Phase 2 is the plateau phase which
prolongs the action potential, during which there is an efflux of potassium ions with
net repolarisation of the cell. During this phase there is also an influx of calcium ions,
with release of stored calcium from the sarcoplasmic reticulum (SR) (counteracting
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the repolarising currents) that enables contraction of the myocyte. Phase 3 is termed
delayed repolarisation and ends when the resting membrane potential has been
achieved. Phase 4 often starts from a point of hyper-polarisation whereby the
membrane potential is more negative than baseline and this renders the cell less
excitable. The timing of the various currents involved are shown in Figure 1.
Ks
Figure 1.1 : The action potential and QT interval are aligned in the left panel to
demonstrate the relationship between the surface ECG and the AP. The right panel
indicates the various currents active in the different phases of the action potential. The
QRS complex is a reflection of ventricular myocytes depolarisation caused by the
rapid influx of sodium ions. During the ST segment of the ECG, most myocytes are
in the plateau phase of the action potential, which is due to a balance of currents
created by the influx of calcium, and calcium release from the sarcoplasmic
reticulum, and the efflux of potassium ions. The end of the T wave marks the
completion of repolarisation of all the ventricular myocytes.
23
1.1.2 Surface recording of Cardiac Electrical Activity
Willem Einthoven (1860-1927) invented the string galvanometer, the forerunner of
the electrocardiographic recorders in use today. Although primitive by modern
standards, it laid the foundations for what has become a vast field. He originally
proposed the labelling P,Q,R,S,T for the various reflections on the surface
electrocardiogram (ECG), although the precise reasons for this are unclear. According
to Henson (Henson 1971), Einthoven was influenced by the mathematician
Descartes, who employed letters to substitute numbers in calculations and diagrams.
Others suggested that he chose these letters as they were fairly central in the alphabet
and would therefore permit additional letters either side (such as the subsequent
labelling of the 'U' wave (Snellen 1995). In recognition of his work, Einthoven
received a Nobel Prize in 1924. Between 1903 and his death in 1927 he published 79
papers on electrocardiography, and is regarded as the undisputed Father of clinical
electrocardiography.
The QT interval was later shown to correspond with the timing of ventricular systole
by comparing the onset of the first and second heart sounds with the timing of
deflections on ECG (Lewis 1912). While the AP reflects the duration of the electrical
cycle of a single cell, the QT interval mainly reflects electrical activity of an area of
the heart where thousands of cells are repolarising and depolarising slightly out of
synchrony. As the electrical wavefront passes through the Purkinje system and
through the ventricular muscle, groups of cells depolarise, similar to a line of
dominoes falling one after another. This occurs rapidly, and is assisted in normal
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hearts by intercellular gap junctions that allow ion exchange and facilitate
depolarisation of adjacent cells. The duration of ventricular depolarisation is indicated
by the QRS duration. The T wave represents net repolarisation, and T wave duration
is a reflection of temporal dispersion of the end of repolarisation within the
myocardium. The T wave is of longer duration than the QRS as there is considerable
intra-myocardial variation in action potential duration, with endocardial cells tending
to have a shorter AP duration (APD) than epicardial cells. In addition, in many
animal models, so-called mid myocardial M-cells have been discovered which have a
significantly longer APD.
Franz et. al have demonstrated small but significant trans-mural differences in human
hearts (Franz et al. 1987). Moore (Moore 1993) published a review on the generation
of T waves and temporal heterogeneity in 1993.
Prolongation of the action potential, whether it be due to changes in the electrolytic
milieu, pharmacological action or cardiac disease can lead to triggered activity in
myocytes due to spontaneous early- (occurring in phase 2 or 3 of the AP) or delayed-
(occurring in phase 4) after depolarisations. This, in association with spatial
dispersion of refractoriness or anatomical barriers to electrical propagation (such as
the scar of an old myocardial infarction) can provide a substrate for sustained
ventricular arrhythmias that can ultimately lead to death.
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The QT interval is the most easily measured marker of ventricular repolarisation. QT
prolongation has been linked to the initiation of arrhythmias in both congenital and
acquired conditions. Measurement ofQT, and the establishment of 'normal ranges' is
essential ifwe are to be able to compare and contrast patients and populations.
1.2 Factors influencing the QT Interval
Multiple factors have been shown to influence QT interval duration. The most
obvious and well known of these is heart rate. This will be discussed in detail below,
and in later chapters.
Electrolyte Abnormalities:
Electrolyte abnormalities such as alterations in the concentration of serum potassium
(K+), magnesium (Mg2+), Calcium (Ca2+) can all influence QT by affecting the trans¬
membrane currents responsible for the cellular action potential, the
electrophysiological equivalent of the QT interval. In clinical practice, hypokalaemia
is the most commonly observed abnormality responsible for QT prolongation, and in
severe cases, or in conjunction with many cardiac and non-cardiac drugs, arrhythmias
can occur.
Pharmacological Agents:
Many drugs, both cardiac and non-cardiac have been associated with QT
prolongation and have been implicated in the initiation ofmalignant arrhythmias,
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particularly Torsades des Pointes (TdP), an unusual polymorphic ventricular
tachycardia virtually pathognomonic of QT prolongation. Unfortunately, many drugs
cause QT prolongation and TdP as a collateral effect when their primary use is non-
cardiac. Macrolide antibiotics such as erythromycin, or antihistamines such as
terfenadine are well known examples. More recently, the gutmotility drug cisapride
was withdrawn due to concerns over the incidence of pro-arrhythmia. Today, almost
all new pharmaceutical agents must be screened to some extent for clinical evidence
ofQT prolongation. There is some evidence to suggest that the risk of arrhythmias is
related to the rate corrected QT (QTc) prolongation (Moss 1993) although there is
considerable debate as to how best to measure QT, and correct for heart rate. Reasons
for this debate will become apparent in later sections.
Pathological States:
As awareness of the significance ofQT prolongation increased, over the years we
have found evidence ofQT prolongation in many conditions including
hypothyroidism, anorexia nervosa, depression, heart failure, hypertrophic
cardiomyopathy and others. As a consequence, interest has continued to grow in the
field.
Given that the QT interval and its prolongation are important in arrhythmogenesis, it
has become customary to measure the QT interval. As the most important influencing
factor is heart rate, it is necessary to correct for this ifwe are to be able to comment
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on differences between subjects, and different physiological and pathological states.
Investigators have been searching for the best way to do this since 1920. Below is a
summary of some of the important milestones in methods for the rate correction of
the QT interval.
1.3 Correcting QT for changes in Heart Rate:
Early studies in animals made the observation that mechanical systole was shorter at
higher heart rates. Waller (Waller 1891) measured the duration of mechanical systole
at various heart rates and from the data derived a formula:
systole = KVcycle
where 'cycle' refers to the inter-beat interval. K was calculated as 0.343 .
In 1920, Bazett published his much quoted paper 'An Analysis Of The Time
Relations OfElectrocardiograms' (Bazett 1920). In this work, with Waller's formula
as a starting point, he set out to establish whether the same general formula could be
applied to the duration of electrical systole in men, women, children and even some
infants. Using a number ofECG traces acquired by him, some supplied by a
colleague and tracings found in the literature of the time, he calculated K in men and
women. He also acquired some data from subjects before and after exercise giving a
wide range of heart rates (60 to 180+ beats per minute). From the pooled data he
calculated the value ofK for men to be 0.368s for electrical systole. In women the
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average value ofK was longer at 0.399s. He concluded that the duration of the
ventricular complex on ECG is a function of the pulse rate and could be readily
determined by using Waller's square root formula, and his own value ofK. This
formula was subsequently relabelled and became QTc = QT / VRR, with the corrected
QT (QT at an RR interval of one second) replacing K. Bazett was under no illusion
that these figures were universally applicable as he states himself that the study was
small and the population groups heterogeneous (age ranged from 1 day old infants to
octogenarians. In addition, the 'exercise' data was not acquired during exercise but
was recorded , on average, several minutes, after the end of exercise. The importance
of this point will become apparent in subsequent chapters.
Fridericia published a similar paper in German a few months prior to Bazett
(Fridericia 1920). He examined the relationship between QT and heart rate, but
differed from Bazett in that he set out by taking QT measurements from ECGs and
then calculated the formula which best fitted the QT/RR curves. From his data, he
calculated the relationship between QT and the RR interval as QTc = QT/ 3a/RR.
Unfortunately, perhaps because the article was published in German in a less
prominent journal, Fridericia's formula was foreshadowed by Bazett's.
Because of the perceived importance of absolute prolongation ofQT and its rate
dependence, work has carried on over the ensuing decades in search of the 'perfect'
rate correction formula. These are too numerous to mention in detail and instead I
will concentrate only on those which have endured the passage of time.
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In 1983 Morrison Hodges proposed a linear rate correction formula for QT in steady
state conditions in abstract form (Hodges, Salerno and Erlien 1983). From a large
database of 607 healthy volunteers (50% male) they calculated a linear best fit
correction formula :
QTc = QT + 1.75 x (heart rate - 60)
which they showed provided a better fit of data than the exponential model of Bazett.
In addition, when the corrected QT is plotted against heart rate there is no correlation
(r=0.0) compared to QTc (r=0.38, p<0.001). It should be pointed out however that
this 'linear' formula is linear only when heart rate is used. It is now more
conventional to measure QT against the RR interval, and when this formula is
converted to use RR, it becomes non-linear.
In 1984, Sarma et al (Sarma et al. 1984) studied 10 volunteers exercising on a bicycle
ergometer and six subjects with rate programmable VYI pacemakers. From their
previous work in which they found that the relationship between heart rate and
repolarisation in conscious dogs was best presented as an empirical exponential
formula with variable exponent:
QT = Al - B1 * Exp (-kl*RR)
They assessed the surface QT and its relationship with heart rate in these groups in
the same fashion. They found that the fit ofQT and RR interval data was far better
when the exponential formulae were applied rather than Bazett's formula. Of
particular interest, they found that the residuals were far greater for Bazett's formula
30
when the paced group were studied, showing a great dependence on heart rate. They
suggest that the estimation of the variables in their empirical exponential formula
would lead to improved correction for heart rate and would be better placed to assess,
for example, drug induced changes in repolarisation at varying heart rates than would
a fixed formula such as Bazett's.
This was followed in 1992 by another correction formula derived from analysis of a
large data-set from the Framingham heart study. The Framingham correction formula
(Sagie and Larson and Goldberg 1992), as it came to be known, was derived from
analysis of resting ECGs from 5,018 subjects (2,239 mean) with mean age 44 years.
The derived formula was:
QTlc (linearly corrected) = QT + 0.154.(1-RR)
This formula applied equally well to both men and women. Plotting QTLc against the
range ofRR intervals, the corrected QT is constant. This was in contrast to QTc,
where a significant correlation remained between the rate corrected QT and RR,
implying that it could not be correcting adequately for rate.
1.4 Comparative Studies ofQT Correction Formulae
In 1996, the controversy over which correction formula to use prompted James
Molnar et al (Molnar et al. 1996) to perform a comparative study. They analysed
ambulatory ECG data to examine the accuracy of 5 formulae: simple Bazett's,
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modified Bazett's, linear (Framingham), modified Fridericia's, and exponential
(Sarma's) (Sarma et al. 1984). Their methodology was to divide Holter data into 5
minute segments and calculate the mean RR and QT with a computer assisted method
for QT measurement. They then calculated the corrected QT at an RR interval of one
second (QT60) and generated best fit lines for each of the 5 correction formulae.
The relative goodness of fit of the data when 'corrected' by each of the 5 formulae
was assessed from mean square residuals (MSRs):
MSR = RSS/(N-P)
where RSS is the residual sum of squares, N is the number of observations and P the
number of regression parameters in the formula. They then went on to compare
separately the pooled data from all 21 subjects with generated ideal curves from the
correction formulae, and curves generated for each individual with the correction
formulae. They ranked the formulae by the MSRs and found that the grouped
population data was best corrected by Fridericia's formula but there was little overall
difference between each of the formulae. When curves constructed for each
individual were compared with individual curves generated by the correction
formulae, Sarma's exponential formula was best. They also plotted calculated
corrected QT intervals through a range of heart rates for all formulae, again with the
hypothesis that an ideal correction formula would give a regression line with gradient
zero. They found that for individual data, all but Bazett's formula achieved this. For
the group data, all the formulae failed in this respect, with deviations in QTc of as
much as 80 ms over a Is range of RR interval.
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They concluded from this study that none of the formulae is ideal. They also raised
the important point that although heart rate is the most important determinant ofQT
interval, other variables such as autonomic tone, drugs, electrolyte abnormalities and
disease states also have an important role. Nonetheless, they stated that all formulae
using individually calculated regression parameters provided excellent and equivalent
QT correction. When group based data was used, acceptable correction for rate was
not obtained. They also proposed that when small changes in QT are important,
Holter data should be used to provide a sufficiently wide range of heart rates.
In September 1999, Marek Malik's group (Aytemir et al. 1999) published an article
regarding the abilities of the various rate correction formulae in exercise ECGs. They
studied 21 healthy volunteers who were subjected to a bicycle exercise protocol with
15W effort increments every 2 minutes until a target heart rate of 120 beats per
minute was achieved. 12-lead digital ECGs were taken every 30 seconds. Using a
Marquette package for QT analysis, the average QT waveform from the 12 leads was
processed automatically. Heart rate measurements were converted to RR intervals and
for each pair ofQT and RR values, a QTc was calculated with each of 5 formulae
(Bazett's, Fridericia, Hodges, Framingham and nomogram (QTc = QT + correction
factor). Again, QTc/RR regression slopes were calculated.
The Framingham formula led to a positive relationship between QTc and RR
(0.0228+/- 0.0451) whereas all the others produced a negative relationship of similar
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amplitude. The null hypothesis, i.e. that QTc values are independent of the RR
interval was accepted only for Fridericias formula (p=0.44). Comparing rest with
peak exercise, they demonstrated, as expected from the QTc/RR regression slopes,
that with the Framingham formula, QTc decreases with exercise while the others
show an apparent increase. Again, differences in QTc with exercise are not significant
when Fridericia's cube root formula is used.
The span ofQTc values was narrow at rest and the difference betweeen formulae was
small (14ms) whereas at peak exercise, there was a much larger difference (376ms for
Fridericia to 419ms for Bazett's). Their conclusions are similar to those ofMolnar et
al., namely, that it is dangerous to apply one ad hoc correction formula in any study
as important over- or under-correction may arise. They raised the point that during
exercise, not only does heart rate increase, but sympathetic drive increases, acidosis
occurs and body temperature rises. All of these factors are likely to alter the
relationship between heart rate and repolarisation.
Later that year, Malik's group published another paper examining several generic
formulae each with three degrees of freedom (Hnatkova and Malik 1999). These
included hyperparabolic, hyperhyperbolic, algorithmic, negative exponential, inverse
tangent, hyperbolic tangent and inverse hyperbolic sign functions. Resting ECGs
from 1100 healthy subjects were studied, and for each correction formula, the
different combinations of variables was found that provided the best fit. Linear
regression analysis was used to estimate values for the adjustable parameters of each
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formula. Gradual adjustment of one parameter allowed estimation of the other two
parameters to give the best fit of data.
The appropriateness and success of each QT prediction was assessed by calculating
the sum of squared residuals (RS= QT- QTestimated)- They found in this comprehensive
study of correction formula that almost identical best-fit lines can be achieved
regardless of the specific form of the regression model. They also suggested that
"further search for a more complicated and more advanced correction formula is
likely to be fruitless". They concluded that different datasets of QT/RR would lead to
different optimum regression fits and suggest that it would be better to construct an
optimum regression model for each particular dataset.
1.5 Influence of the Autonomic Nervous System on QT
Duration
The heart receives rich autonomic innervation from both the sympathetic and
parasympathetic nervous system which contain both efferent and afferent fibres. Pre¬
ganglionic sympathetic fibres emerge from the spine and synapse in the cervical and
upper thoracic ganglia (the stellate ganglia). From these emerge the cardiac
sympathetic nerves, the endings ofwhich can be found in both atria and ventricles
alike. The parasympathetic nerves arise in the vagal nucleus in the medulla and
synapse in intra-cardiac ganglia.
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Stimulation of the sympathetic nerves results in a more rapid rate of diastolic
depolarisation in the sino-atrial node, increasing the heart rate. In addition,
conduction in the atrioventricular node is also accelerated with reduction in the
refractory period. This maintains an appropriate A-V delay for optimum cardiac
filling and enables conduction ofmore frequent impulses, preventing AV block at
higher atrial rates. At ventricular level, the force of contraction is increased by
catecholamines and the action potential duration (APD) shortens. The influence of the
sympathetic nervous system on the ventricles is modulated to some extent by
cholinergic activity and is therefore dependent to some extent on vagal innervation.
Vagal stimulation prolongs action potential duration by antagonising sympathetic
activity at muscarinic receptors, and ventricular refractory period is shortened by
atropine. At rest, vagal tone exerts a significant effect on ventricular repolarisation
and this effect is seen in the presence of beta-blockade. This may be the mechanism
whereby increased parasympathetic activity has been shown to protect against
ventricular fibrillation (Schwartz and Stone and Brown 1976).
In 1983, Fananapazir et. al (Fananapazir and Bennett and Faragher 1983) conducted
an elegant study which highlighted the contribution the autonomic nervous system
makes to QT shortening on exercise. Their hypothesis was that the catecholamines
from increased activity of the sympathetic nervous system were responsible for a
significant proportion of the shortening seen in the QT interval. They studied 24
patients with dual chamber (DDD) pacemakers. They measured QT shortening during
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Bruce protocol exercise testing during both fixed rate ventricular pacing (VVI) and
atrial synchronised ventricular pacing DDD). They then repeated the exercise tests
after acute administration of beta blockade with lOOmg of oral atenolol. They also
used incremental atrial and ventricular pacing at rest to assess purely rate related QT
shortening. They demonstrated that only about 50% of the QT shortening seen during
exercise is due to rate change. They also demonstrated that the QT shortening seen in
the fixed rate ventricular pacing group on exercise was abolished by beta blockade.
Compelling evidence that catecholamines exert an independent action on QT interval
and that this, in terms ofmagnitude, is at least as important as heart rate.
In 1986, Bexton, Vallin and Camm published further evidence of the impact of the
autonomic nervous system on circadian variation of the QT interval (Bexton and
Vallin and Camm 1986). They studied three distinct groups for comparison. The first
group consisted of 6 patients with fixed rate ventricular pacemakers. The second
group was composed of 6 patients who had received heart transplants (and the heart
was therefore denervate). The third group was made up of nine insulin dependent
diabetics with autonomic neuropathy. All subjects underwent 24h ambulatory ECG
recordings. Hourly QT and RR intervals were measured for each subject by taking
mean values from 10 consecutive beats. QT intervals were corrected for heart rate
using Bazett's formula. Variation in QTc duration was expressed as percentage
deviation from the 24h mean QT for each individual.
In the pacemaker group there was considerable circadian variation in QTc, with
significantly longer values during sleep. In the transplant group there was little
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variation in heart rate during the 24h period. Circadian variation in QTc was present
however, although blunted. QTc was longer during the night when circulating
catecholamines were at their lowest level.
In the diabetic group who all had proven autonomic neuropathy, there was no
circadian variation in QT interval. These patients are said not to respond to neurally
mediated changes in autonomic tone. These patients would also be expected to have
reduced circulating catecholamine levels as has been shown in previous studies
(Barnes, Fitzgerald and Dollery 1982). They concluded from this that the normal
circadian variation in QT and QTc duration is influenced by the autonomic nervous
system and by circulating catecholamines.
It is thought, from research involving patients with the long QT syndrome, that
sympathovagal balance plays a critical role in the triggering of arrhythmias. Certain
subsets of patients, particularly those with LQT1 which corresponds with a mutation
in the gene KVLQT1 (which codes for a potassium channel), are more likely to
experience arrhythmias associated with acute arousal (Ali et al. 2000). These events
are more likely to be triggered when sympathetic activity is high and increasing, and
vagal tone is withdrawn. Indeed, one of the accepted therapies for patients with this
disorder was ablation or transection of the left cervical stellate ganglion (Schwartz et
al. 1991). Indeed, prior to the identification of mutations of genes encoding for ion
channels, the aetiology of the long QT syndromes was thought to be due to an
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asymmetry in the balance between the right and left sided sympathetic innervation of
the heart (Schwartz, Periti and Malliani 1975).
1.6 Influence ofAnti-arrhythmic medication on the QT
Interval
Anti-arrhythmic medications exert their effects by modifying one or more of the ion
currents and therefore affecting excitability, automaticity, or the action potential
duration. The Vaughan-Williams classification initially divided anti-arrhythmic drugs
into four groups based upon their mode of action. This was later expanded into the
Singh-Hauswirth-Harrison-Vaughan Williams (S-H-H-VW) Classification with
subdivision of class 1 into three subgroups. This classification is laid out in the table
1.1. While the modification of the action potential is designed to slow the propagation
of impulses and reduce the possibility of a re-entrant circuit sustaining arrhythmias,
they can, in some individuals, promote triggered activity. This is particularly true of
the class 1C and class 3 agents. Major studies assessing the ability of these drugs to
improve survival following myocardial infarction in individuals without a history of
malignant arrhythmias (e.g. CAST (1989) - class Ic), SWORD- class III (Waldo,
Camm and de Ruyter 1996) produced an excess of deaths in the treatment arms. The
excess of deaths is a reflection of the ability of these agents to promote arrhythmia
through triggered activity. If the risk of proarrhythmia exceeds the patients intrinsic
risk ofmalignant arrhythmias, then no benefit, or an adverse outcome may be seen.
These studies enrolled patients who had not had malignant arrhythmias, but had
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ventricular ectopy on Holter monitoring. With the benefit of hindsight, we are able to
say that their relatively low risk of arrhythmias was outweighed by the slightly higher
risk of drug induced pro-arrhythmia.



































current, Ca current and
Na current and delayed
rectifier (iks)
Tachyarrhythmias
Amiodarone A> V, AVN, SAN, HP, Increased APD by AF, Aflutter, SVT,
Sotalol AccP blocking lKr, hence AVNRT, AVRT, VT,
prolonged QT. SAN and VF
AVN slightly
suppressed.
4 Calcium channel AVN
antagonists e.g.
verapamil
Depress phase 2 and 3 of Atrial arrhythmias,
the action potential by AVNRT
blocking the slow Ca
current.
Table 1.1 : The Singh-Hauswirth-Harrison-Vaughan Williams (S-H-H-VW) Classification. A, Atrium.
V, ventricle. AVN, atrioventricular node. SAN, sino-atrial node. HP, His-Purkinje system, AccP,
accessory pathway. Aflutter, atrial flutter. SVT, supraventricular tachycardia. VT, ventricular
tachycardia. AVNRT, AV node reciprocating tachycardia. AVRT, atrioventricular reciprocating
tachycardia. VF, ventricular fibrillation.
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These two studies have highlighted two important points: firstly, that our existing
non-invasive methods of risk stratification of patients with heart disease are lacking
specificity. Secondly, as a consequence of the first, powerful anti-arrhythmic agents
which exert effects on the action potential can result in death. Unfortunately, as a
consequence of these studies, sotalol and class Ic agents have fallen out of favour for
the treatment of patients with ischaemic heart disease.
Further discussion of the effects of class 3 agents is merited as it highlights one of the
problems associated with estimation of rate independent QT change. Class 3 agents
such as sotalol and dofetilide cause QT prolongation by interfering with the normal
function of the inward potassium rectifier current (IKr). However, they exert more
effect on the action potential at low heart rates than at high heart rates ('reverse use
dependence'). This was proposed to be due to the binding of these agents to closed or
inactive channels in diastole. More recently, this theory has come under scrutiny as it
is found that with cloned channels this does not appear to be true. Other agents such
as almokalant have been shown to block IKr in a use-dependent fashion yet show
reverse-use-dependent prolongation of the action potential. This means that at low
heart rates, regardless of the exact mechanism at a cellular or channel level, the
consequence of this phenomenon is greater prolongation of action potential and QT
interval during bradycardias or following a post extrasystolic beat. This is obviously
not the ideal situation, as an anti-arrhythmic drug which had maintained or enhanced
anti-arrhythmic efficacy during tachycardias would be an advantage, particularly for
terminating arrhythmias.
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The rate dependent effects of antiarrhythmic agents are important in the context of
rate correction formulae. Ifwe were to use Bazett's formula to calculate the corrected
QT interval for a patient taking sotalol, this would enforce a constant relationship
between QT and RR at all heart rates. During bradycardias, the QT would be more
prolonged by the sotalol, leading to an even greater value ofQTc. If however we
correct QT for heart rate during a tachycardia, the sotalol will be having far less effect
of repolarisation and QT, and the QTc may be normal. Therefore, when this
approach to QT correction also makes the assumption that the QT/RR curve bears a
square-root relationship to heart rate under both circumstances. Rate correction
formulae must therefore be applied with caution when these agents are in use, with
particular attention being paid to heart rates on serial recordings.
1.7 Conclusions
The QT interval is always affected by heart rate but the relationship differs according
to the populations studied. The method of acquiring QT and RR data and the
physiological circumstances of the data recording (e.g. resting ECG, ambulatory
Holter or exercise ECG) will also affect the estimated relationship. Everyone agrees
that the QT interval is important, but no one can agree how best to correct for heart
rate. All correction formulae have been shown to be better than others in certain
populations, but, as Malik suggests, one should perhaps find which one works best
for the given population before making comparisons.
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Given that sympathetic tone has been shown to influence QT interval, even when
changes in heart rate are absent (as in paced individuals), and that in normal subjects,
exercise produces an increase in sympathetic drive and an increase in heart rate, is it
realistic to expect the relationship between QT and heart rate to be the same at rest as
during exercise? The fact that it has been shown that the slope of QT/RR curves or
lines varies throughout the day, as does QTc (to varying degrees, depending on the
correction formula used), and to differing extents depending on pathologies, this
would suggest that the mode of describing QT dynamics should be more detailed.
As we enter an era when technology allows us to automatically analyse large
quantities of data from, for example, Holter recordings, new approaches are needed
to assess the relationship between QT and heart rate or the RR interval. Holter
recordings give us the opportunity to see 'a day in the life' of ventricular
repolarisation from patients. The opportunity also arises in some cases to assess
changes in the relationship with time, perhaps leading up to arrhythmias. Indeed, the
way the relationship between QT and RR changes in response to internal and external
factors may be more important than QTc alone. We should perhaps be thinking not
just in terms ofQTc, but also attempt to describe the curve or line on which QTc sits.
This line or curve may be allowed to vary throughout the day and should perhaps be
determined for each individual separately, and mean values ofQTc and the variable
used to describe the curve for population groups could be compared for each study.
The ultimate goal of research into QT should be to describe cardiac repolarisation as
it exists in individuals most of the time, when heart rate is changing over a wide
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physiological range. The forced application of a 'universal' rate correction formula to
distinct populations is questionable when differences have already been shown to
exist between men and women, patients and volunteers, those on anti-arrhythmics and
those not, both in terms of 'QTc' and the slope of QT/RR plots. When so many
correction formulae exist, all with merits and demerits, why do we continue to pursue
the 'Holy Grail' of a universal method for the heart rate correction ofQT?
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Chapter 2
Adaptation of the QT Interval to
Sudden and Gradual Rate Changes:
Implications for the analysis of non-
steady state ECG recordings.
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2.1 Introduction
The adaptation of the QT interval to changes in heart rate is not instantaneous. This
complicates estimation of the QT/RR relationship, particularly when the underlying
relationship is likely to be influenced by the concomitant variation in autonomic tone
that often occurs when heart rate changes. Many investigators have studied the
characteristics of the adaptation ofQT to changes in RR. It has been widely shown
that there are two phases of adaptation: 1) A fast component which depends on the
preceding RR interval and causes an immediate small change in QT, and 2) A slow
component which contributes to long term adaptation. I will discuss below some of
the work which has furthered our understanding of this phenomenon.
2.2 Characteristics of the Adaptation of QT to Heart Rate
Changes
In 1998 Michael Franz and colleagues published a paper on measured intracardiac
monophasic action potentials (MAPs) in human hearts in-vivo (Franz et al 1998).
They showed that after a single premature stimulus, the APD of the subsequent beat
was related to the extra-stimulus cycle length. By plotting the post-extra-stimulus
APD against the extrastimulus cycle length (CL) one can construct the 'electrical
restitution curve' for the myocardium. The earlier the extrastimulus becomes, the
greater the change in APD. After a sudden sustained step in cycle length, the APD
underwent the initial small sudden change in APD followed by a delayed adaptation
before reaching a new steady state only after several minutes. They found that the
initial small jump in APD equated to an average of approximately 25% of the
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adaptation required to reach steady state (range 8.9-45%). The delayed component of
adaptation which corresponds to (100-rapid component) % required an average of 2.6
minutes to reach steady state (range 1.8- 3.2). They concluded that the overall
relationship between the steady state APD and CL was linear (r=0.995) although they
excluded all the data at CL>900ms at which point all the plots clearly plateaued. If
these data were included, their plots clearly show a curvilinear relationship. They
concluded that the divergence between steady state and non-steady state APDs was
an important factor to be considered in rate correction formulae.
Shortly after the publication of this paper, Lau et al demonstrated the same
phenomenon in changes in the surface QT interval in ventricular paced subjects with
new onset complete heart block(Lau et al. 1988). They chose this model to avoid
interference from changes in the autonomic nervous system. They found that the
mean time for the QT interval to reach 90% of steady state was 136+/16 seconds
(SEM) when the heart rate was increasing and 189+/-25 when the heart rate was
decreasing. They found the time course of QT adaptation to be exponential and
characterised by time constants of 49s and 60s when the heart rate was increasing and
decreasing respectively. They concluded that the adaptation is biphasic with rapid
change in the first minute accounting for 50% of the adaptation and a slower phase
lasting for several minutes. The sudden instantaneous change relating to the first CL
at the new heart rate was not identified due to their methodology, however it would
seem that the first QT sampling point was at 15 seconds. One of the important points
in the discussion is that they highlight the influence measurement ofQT prior to
attainment of steady state would have on the modified Bazett corrected QT. Namely
that for increasing heart rates (decreasing RR), if measured early in adaptation QTc
would be overestimated and conversely, underestimated for decreasing heart rates.
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A study undertaken by Jonnalagedda et al (Jonnalagedda et al. 1987) studied QT
hysteresis in men during exercise. They exercised 14 subjects, ranging in age from 16
to 71 on a treadmill following the Bruce protocol. ECGs were measured continuously
on magnetic tape and QT and RR intervals were measured semi-automatically. They
fitted the QT and RR data to an exponential formula (QT = A - B x Exp (-k.RR) )
where A, B and k are the regression parameters. They then compared the best-fit
curves for exercise and recovery and found that the recovery QT values were shorter
than on exercise for similar RR intervals. In some individuals the late recovery QT
intervals were longer than the early exercise values, i.e the QT/RR lines crossed over.
The recovery hysteresis curves were S shaped in many individuals. Considerable
variation was seen in the relationship between exercise and recovery curves between
individuals and they attributed this to the wide variation in age, cardiac disease and
medications in their heterogeneous group.
If one reviews this study in the context of the data from Franz, it would appear to fit
quite well. The QT changes on exercise would be affected by adaptation lag and
therefore during exercise QT would lag behind RR change and be longer than a
steady state QT at that heart rate. Equally, in recovery, QT may still be shortening in
initial recovery, and subsequent lengthening in QT will lag behind RR lengthening,
explaining the curves. Knowing that the sympathetic nervous system will increase in
activity, with withdrawal of parasympathetic tone on exercise, the two combining to
affect QT shortening. It has been shown that plasma adrenaline and noradrenaline
levels increase for up to 3 minutes into recovery despite a decrease in heart rate
(Hagberg et al. 1979, Dimsdale et al. 1984) followed by a sharp decline. This may be
partly responsible for the initial further shortening ofQT in recovery seen in some
subjects.
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Through the years, other investigators have demonstrated a similar biphasic
relationship between RR change and QT in various species and and have also
assessed the impact ofQT prolonging drugs on QT adaptation. Lee et al (Lee et al.
1999) studied the adaptation of QT to changes in RR as measured through a
permanent pacemaker lead for sudden steps in RR. They validated this method
against the epicardial APD measured with the intracardiac catheters described by
Franz. They demonstrated that the stimulus to Tend time correlated well with APD.
They also described the QT adaptation as being biphasic, with the early adaptation
having a very short time constant, with a X\a of 1 beat. The slower adaptation phase
had a ti/2 of 1,386 beats at an RR interval of 400ms (9.24 minutes).
Padrini et al studied QT shortening in an isolated guinea pig heart model under the
effects of d-sotalol and amiodarone (Padrini et al. 1997). As class III drugs can be
associated with pro-arrhythmia, often in the context of a sudden pause in heart rate or
during bradycardias, they assessed the two phases ofQT rate adaptation. They found
that at high heart rates, d-sotalol and amiodarone did not cause significant QT
lengthening and that they may enhance adaptation to rate, reducing the possibility of
'R on T' phenomena inducing malignant arrhythmias. This, they concluded, was
mainly due to an enhancement of the rapid early phase of adaptation.
Clearly, QT rate adaptation is an essential consideration in the estimation of the
QT/RR relationship from data where heart rate varies, and hence QTc. It raises a
question mark over the validity of the calculation and application ofQT/RR
correction formulae derived in exercise studies if the peak heart rate for any stage of
the protocol was not maintained for several minutes before measurements were made.
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2.3 Estimation of the QT/RR Relationship From
Ambulatory Recordings
Technology has progressed at an incredible rate over the past decade. With increased
computer processing power it has become possible to create sophisticated automated
algorithms for detection of the end of the T wave. This has allowed the analysis of
long-term ECG recordings. From this, interest has grown in the assessment of
dynamic changes in QT measured from Holter recordings. Taking into consideration
the work covered in previous pages, a new approach to the analysis ofQT may be
needed.
Early attempts to estimate the QT/RR relationship from long term recordings have
divided the recording into lengthy periods and constructing QT/RR plots for these
sections to allow comparison between time periods. These long segments of
recording have the advantage of providing data over a wide range of heart rates, and
also of reducing the impact of errors introduce by noisy or ectopic beats. In addition,
the QT adaptation lag will tend to be averaged out to some extent as the value derived
for the QT/RR relationship will be a best-fit line of the hysteresis loops. All beats are
included in these QT/RR plots and best-fit lines are estimated usually using a linear
regression model. Using this approach it is possible to demonstrate that the QT
interval is longer at night compared to identical heart rates during the day, a reflection
of the differences in autonomic tone.
In 1992, Merri et al (Merri et al. 1992) used such a method to compare normal
subjects (NS) with patients with the long QT syndrome (LQTS). They measured the
interval from the peak of the R wave to the peak of the T wave (RTm). Their reasons
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for doing this were that the onset of the Q wave is variable relative to the peak of the
R wave, and Tend detection is technically difficult to determine in many subjects and
is subject to interference from noisy recordings. In addition, they have shown in
previous work that the rate dependent change in QT is mainly concentrated in the
initial portion of the T wave to the apex. They demonstrated that the mean 24h slope
of the RTm/RR chart was greater in LQTS than in NS. In addition, as some of the
LQTS patients were P-blocked, they repeated recordings in 6 NS after P-blockade.
This further reduced the mean RTm/RR slopes in the normal subjects, implying that
an even greater difference may exist in slope between LQTS and NS.
A more sophisticated method was proposed in 1998 by Badilini, Maison-Blanche,
Childers and Coumel (Badilini et al. 1998). They recognised the significance ofQT
adaptation lag on QT dynamics and developed a sophisticated automated method to
minimise its impact on measurements of the QT/RR relationship. Their 'Selective
Beat Averaging' (SBA) approach is a means of analysing recordings taking paired
QT and RR intervals but only using QT intervals where heart rate has been stable
within a predefined narrow range for the preceding minute. This thereby attempts to
exclude most non-steady state data. They found using this method that the steady-
state QT/RR slope was modelled well by a linear formula QTo = 0.161RR+0.254 (r=
0.97), whereas analysing non-steady-state periods, the slope was much lower and
described by QTo = 0.094RR + 304; r = 0.94, where QTo is the interval from the start
of the Q wave to the end of the T wave (T0ffset)- Again, by dividing the QT/RR
relationship into day and night segments, they demonstrated lower slopes during
sleep. Unfortunately, as they state themselves, the main limitation of the method is
that SBA provides a long-term analysis of repolarisation at steady-state and by
definition, 'all transient phenomena have been ruled out and cannot be taken into
account when using this approach'.
Another method which deserves mention has taken an entirely different approach to
the description ofQT/RR dynamics. 'Beat-to-beat QT Interval Variability' was
described by Berger et al in 1997 (Berger et al. 1997). Their hypothesis was that in
many cardiac conditions, the heart rate variability (HRV) is reduced. This has been
shown to correspond with a relative reduction in parasympathetic tone and an
increase in sympathetic tone. Despite this, the QT interval shows considerable
variation. Their method uses an automated technique for measurement of QT and RR
from Holter recordings. By comparing a subjects variation in RR with the variation in
QT over a period of time, it may be possible to show that, relative to changes in RR
intervals, there is a greater change in QT, potentially indicating a discordance
between the two that may predispose to arrhythmias. One of the methodological
differences is that a reference QT interval is selected by the operator to act as a
template and is defined beat k. Each beat of a 256 second epoch is then compared
with k . From this, the QT variance (QTv) and mean QT (QTm) are calculated and
compared with heart rate variance (HRV) and mean heart rate (HRm). QT variability
index is calculated for each epoch as being:
QTVI = logio [ (QTv/QTm2) / (HRv/HRm2) ]
Coherence between changes in heart rate and QT is calculated by comparing the
frequency and magnitude ofQT change relative to the frequency and magnitude of
RR change. In this paper, they compared 60 controls (NS) to 83 patients with cardiac
failure (HF). They found, as expected from heart rate variability studies, that HRV
was low in HF. In contrast, QTV was elevated relative to controls and varied in an
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unpredictable fashion. This resulted in a marked elevation in the QTVI in HF. They
found that this correlated with NYHA class but not with ejection fraction, a finding
that may point more towards derangements in autonomic tone being responsible for
this. The coherence between HR and QT was much lower in HF. They conclude that
this method, although not actually describing the relationship between QT and RR but
the sensitivity ofQT to changes in RR, may be implicated in the arrhythmic risk of
patients with HF.
Using the same method, Atiga et al (Atiga et al. 2000) demonstrated a similar finding
in patients with hypertrophic cardiomyopathy. In addition, they found that in patients
with a particular mutation felt to be responsible for a high risk of arrhythmias, the
QTVI and coherence were more abnormal than patients with more 'benign'
mutations. This method shows great promise and is based upon the analysis of a short
ECG recording (256s). It links the changes in QT to changes in RR. One of the
distinct advantages is that the problems of rate dependence ofQT and QT adaptation
lag do not seem to be confounding factors with this approach. It may also allow
examination of pre-event periods from Holter to allow comparison with reference
periods to assess changes in QT interval dynamicity. To date, no publications have
appeared using this method in that context.
2.4 Conclusions
The analysis of ambulatory data from patients should provide a more balanced picture
of their cardiac repolarisation properties. Apart from the technical difficulties of
accurate and reliable measurement of the end of the T wave, exclusion of noisy
segments and the limited number of leads available, we must also consider the
53
phenomenon ofQT adaptation lag. In order to be able to comment on short and long
term changes we must either find an approach that circumvents or tackles this issue.
As other investigators have shown, the analysis of non-steady state data provides
significantly different results.
Investigators have shown that patients and healthy subjects not only have a longer
'corrected' QT but also steeper QT/RR slopes. These slopes will be influenced by the
time of day and medications such as sympatholytic agents not to mention anti¬
arrhythmic drugs.
Ifwe are to assess repolarisation changes in humans from ambulatory recordings, it
would seem that several things are essential. The method must be able to:
1. Reliably measure RR and QT intervals
2. Measurements must be reproducible
3. QT adaptation lag must be taken into account
4. The QT/RR relationship over short and long term segments must be expressible in
rate independent variables
5. Individual QT/RR characteristics should be calculated for individual subjects and
these variables averaged for the population, rather than grouping QT and RR data.
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Chapter 3
Methodology for the Acquisition and
Analysis ofBeat-to Beat QT Interval




In May 1998 at the International Society of Holter and Non-invasive
Electrocardiology (ISHNE) congress in Ulm, James Neilson of the Department of
Medical Physics, University of Edinburgh proposed a novel method for continuous
estimation of the QT/RR relationship (Neilson 2000). This method differed from
previous methods in many ways.
Methods for analysis of the QT/RR relationship have attempted to bypass the
problem ofQT adaptation lag by concentrating on the steady-state periods. Neilson's
method attempts to compensate for the adaptation lag by applying a mathematical
model to remove it and therefore allow continuous assessment of the underlying
QT/RR relationship. As mentioned in the preceding chapters, most methods for
estimating the rate corrected QT assumed that the QT/RR relationship was constant,
yet investigators had shown that the relationship varies between populations,
individuals, and also exhibits considerable circadian variation. The Neilson method
has the added advantage that the relationship is continuously calculated and can be
described at any time or heart rate by a formula with only two variables
The following pages explain the various stages in acquiring and analysing the
dynamic QT-RR data. As this is the method used throughout the thesis, it will be
explained in detail now to avoid repetition is required in subsequent chapters.
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3.2 Acquisition of Ambulatory ECG Recordings
ECG recordings were acquired using standard analogue 2 channel 'Tracker 2'
recorders (Reynolds Medical, Hertford, England). Electrodes were of the type R-00-5
(Blue Sensor) for all recordings. The importance of good skin preparation cannot be
understated as recordings of high quality are required for measurement of the T wave.
The skin was prepared by shaving any chest hairs that might interfere with electrode
contact. The skin is then gently abraded to remove dry skin cells with a gauze swab
and granular ECG jelly. The chest electrodes are then placed in standard positions to
give bipolar thoracic leads CM1 and CM5 (Figure 3.1).
The quality of the 'hook-up' for each electrode was tested using an in-house
impedance testing module. This measures the electrical impedance between the
individual electrodes in turn versus an additional reference electrode. If the
impedance was considered unacceptably high for any one electrode, it was replaced
and/or re-positioned. The morphology of the T waves for each channel was assessed
at the time of electrode placement using a portable oscilloscope. If T waves were of
low amplitude in one or both channels, the electrodes were re-positioned to rectify
this. Repositioning of electrodes was generally not necessary as there was usually a
signal of sufficient amplitude with clear T wave morphology in at least one channel.
Recordings were made onto standard audiocassettes (TDK D90) which will record
over 24 hours ofECG in two channels. Time track data is also recorded, and the
Trackers have internal clocks set to real-time. This time-track data enables
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compensation ofminor fluctuations in recording or playback speed and
synchronisation of the recording with events reported or times of day.
2 channels/4 electrodes
Figure 3.1 Diagrammatic illustration of the position of the 4 electrodes to give
two channels, CM1 (green and white) and CM5 (red and black)
3.3 Measurement ofQT and RR data
The recordings were analysed at high speed on a 'Pathfinder' Arrhythmia Analyser.
The Pathfinder measures each RR interval and the associated QT interval. Beats were
automatically excluded if they:
a) were of abnormal shape (e.g. aberrants or distorted by noise)
b) had an RR interval <66% or > 180% of the prevailing beat,
c) were beats with an RR cycle length of> 2.5s.
d) The beat preceding and the beat following aberrants were also excluded.
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After the exclusion of these beats, the timing of each RR interval was established.
Following this, time windows were set up relative to the QRS wave. The Q onset is
determined by first determining the centre of the R wave (zero slope turnover point of
the first derivative). Q onset is set by default at a fixed period prior to the centre of
the QRS. Minor manual adjustment of Q onset is possible and occasionally required
prior to starting and sometimes during playback due to the natural variations in QRS
duration.
A T wave 'window' relative to the QRS waves is set up to exclude false readings of T
wave parameters from other parts of the ECG due to U waves, P waves and noise.
The T wave window adjusts automatically for changes in heart rate. Tapex is
determined as the zero slope turnover point between the upstroke and downstroke of
the T wave (figure 3.2). The end of the T wave (Tend) is determined as being the point
at which the slope of the T wave falls below a pre-determined fraction of the
maximum slope. Although Tend is also adjustable, the settings used in default mode
have been determined as the average point of Tend as determined by the mean values
ofQT from rhythm strips from the Pathfinder measured by a panel of seven clinicians
experienced in measurement of the QT interval.
During playback, on-screen continuous markers of QonSet and Tend allow visual
validation ofmeasurements by the operator. Noisy segments were automatically
edited out, along with premature supra-ventricular and ventricular beats. Continuous
checks are made for non-physiological changes in QT or RR and these beats were
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auto-rejected and acquisition suspended until stability returned. All QT and RR
interval data is stored on a personal computer for offline analysis. The accuracy and
correlation of the automatic versus manual measurement of the QT interval has been
independently validated and reported elsewhere (Lande et al. 2000).
R wave
Inverse 1st derivative of ECG with respect to time (dV/dt) gradients of ECG
I \ waveform
R wave peak
All values of gradient then converted to positive values
A j. Zero slope turnover of QRS
'Zero Slope turnover point'
of T waveR or Q onset
Figure 3.2:
Electronically acquired ECG waveform (upper panel), the inverse first derivative of
the wave form (-dV/dt) (middle panel), and the modulated derivative (lower panel)
indicating how the analyser recognises Tapex (zero-slope turnover point, lower panel),
which 'opens' the time-window to start looking for Tend (defined as when the gradient
of the T downslope drops below a preset threshold.
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3.4 Assessment of the QT/RR Relationship with QT Lag
Compensation
The estimation of the dynamic QT/RR relationship takes place in stages that are
detailed below
3.4.1 Error correction
The QT and RR data are replayed at high speed and compared with a simultaneously
acquired (at the time of tape playback) noise signal. When the signal to noise (S/N)
ratio crosses a pre-determined threshold, the QT and RR data are edited out. This
'error correction' gives a final result for percentage of data corrected. This value is
then taken into consideration when deciding whether acquired data is suitable for
further analysis. In addition, beats with sudden non-physiological changes in the QT
which are due to errors in measurement of Tend, generally due to noise or morphology
change in the T wave, are edited out automatically.
This 'error correction' programme gives a value in percent of the data edited out from
recordings. As a rule, only recordings where less than 20% has been edited are used
for analysis.
3.4.2 Compensation for QT adaptation lag
Theoretical aspects of the method
From watching dynamic QT/RR plots from ambulatory recordings, it is possible to
see that the plot displays hysteresis loops due to the lag in adaptation ofQT to RR. If
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the heart rate remains stable for long enough (several minutes), the QT is able to
'catch up' with the RR interval and will lie on the QT/RR curve described as the
'steady state characteristic' (SSC). As mentioned previously, establishing the QT/RR
relationship from data acquired in this way would result in the loss of large amounts
of data. In addition, as the QT/RR relationship changes constantly during the day,
comparing points at different heart rates at different times of day may be comparing
points on different steady state curves.
From this it becomes clear that if the QT adaptation lag can be compensated for, the
changes in QT and RR would be synchronised in time, thus displaying them on the
chart as if they were tracing out the underlying SSC.
After experimental evaluation of several possible models ofQT adaptation lag, with
knowledge of the two-time constant characteristic ofQT adaptation (Franz et al.
1988, Lee et al. 1999) a model of the functional relationship between the dynamic
changes in QT with respect to RR emerged.
For any given change in RR, the change in QT is related to the slope of the QT/RR
plot at that heart rate. If changes in RR were infinitely slow, the plot would describe
the steady state characteristic and the change in QT (AQT) due to a change in RR
(ARR) would be given by the formula:
AQT= S. ARR
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For more physiological changes in RR, one must incorporate a model for the lag
phenomenon. The change in QT comprises an immediate undelayed fraction
described as:
<x(S . ARR)
and the remainder as the fraction:
(1 - a). (S . ARR)
which has suffered a single pole lag with a time constant of x seconds. In Laplace
transform notation the lag function is thus:
AQT (s) = [ a + (1 - a) / (1 + sx) ] . S . ARR(s)
This model was refined electronically by adjusting the time constants and applying
the same lag function to the RR signal to create RR', an identically laging version of
the RR signal.
From analysis of recordings from 40 normal individuals, it was found that a remained
relatively constant throughout the 24h period, with a population range of 0.15 - 0.30.
When the time constants of the lag function are correctly adjusted, the QT/RR plot no
longer has hysteresis loops but traces out a curve which is presumed to be the
63
underlying steady state characteristic. Technically however this is now a QT/RR' plot
as the QT data is the same but the RR data has been delayed by applying the lag
function and is thus labelled RR'. The QT lag compensation is represented
diagrammatically in figure 3.3. An example of the QT lag compensation is shown
graphically in figure 3.4.
Figure 3.3: Diagrammatic Representation of the QT analyser's functions.
Raw ECG interval data enters the QT analyser, and the QT interval data passes
untreated, while the RR data is delayed according to the application of the two
component lag (blue boxes), which realigns the delayed RR data (RR') with the
undelayed QT data to allow estimation of the QT/RR relationship (QT/RR').
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QT (ms)
RR (ms) RR* (ms)
Figure 3.4
An example of the QT lag compensation model in action.
The QT/RR plots contain approximately 3 minutes ofQT data. The left panel is a plot
ofQT against the preceding RR interval. Several loops are visible as the heart rate
speeds up and slows down due to the presence ofQT adaptation lag. The right panel
contains the same QT intervals but they have been plotted against the lag
compensated RR (RR'). The hysteresis loops are no longer present and the plot
demonstrates a curve.
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As these 'pseudo-steady-state' plots are not linear but curved, the relationship is
estimated by fitting the data against a general exponential formula with an X/Y
intercept at zero. The curve can be described in terms of two variables- the exponent J
and QTo which is the QT interval at RRo, a reference RR interval (chosen as 1000ms
for reasons of convention).
3.4.3 Continuous Assessment of the QT/RR' Relationship
Having established the relative proportion of alpha for each recording, the QT and
RR' intervals are replayed and continuously cross correlated against one another
within a continuously scrolling time window, the duration ofwhich can be varied. In
this thesis, the window is of five minutes duration unless otherwise stated. A
continuous estimate of the cross correlation coefficient is derived. Data are only used
when the correlation at that time is greater than 0.8. Low correlations generally occur
during noisy segments of recording or when the analyser is unable to determine Tend
correctly due to a change in morphology or amplitude. The slope of the steady state
characteristic is continuously calculated as the linear regression coefficient within the
window and used to further define the underlying characteristic.
The assumption is made that the curve conforms to the general formula:
QT = QTo (RR'/RRo)J
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This formula is of the same form as those derived by Bazett (QT - QTc . RR°5), and
• • 0 TTT
Fridencia (QT = QTc . RR ' ), although these formulae were derived largely from
grouped data, mainly in the resting state and it is unclear whether subjects had been in
a resting state for any length of time (the stabilisation time of the QT interval was
unrecognised in that era).
For equations of the general formula, only one curve can pass through a given point
(RR'1,QT1) with slope S. The exponent describing this curve can be shown to derive
mathematically from:
J = S . (RR'/QT)
In a dynamic situation with non-steady state data, when RR', QT and S are all varying
continuously, J is also varying. The QT/RR relationship can therefore be continuously
calculated over the scrolling time window with the formula:
QTo (t) = QT(t). (RR(t) / RRo)J
The analysis will therefore generate continuous outputs ofRR'(t), QT(t), S(t), J(t) and
QTo(t) which are plotted as trends for the duration of the recording.
Recordings can therefore be analysed to give mean values of the entire recording,
selected segments, or trend data over segments.
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3.5 Conclusions
This approach offers a significant advantage over existing methods which result in a
greater loss of data and/or underestimation of the QT/RR relationship due to
hysteresis. The description of the QT/RR relationship in terms of the two variables
QTo and J will determine a unique curve for those values, allowing the graphical
description ofQT over the entire physiological range of heart rates at that point in
time.
When heart rate changes dramatically such as on sustained exercise, it is generally
accompanied by changes in autonomic tone, posture, body temperature and
circulating catecholamines. In these circumstances, it is then not generally acceptable
to extrapolate to say what the QT interval would be at 50 beats per minute, but it is
possible to say that the relationship has changed. In this case, the graphical
representation of the curves is often more helpful that quoting a value ofQTo and J.
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Chapter 4
The impact of QT Lag Compensation
on Dynamic Assessment of Ventricular
Repolarisation: Long-term




In previous chapters we have discussed the various factors influencing the QT
interval, the numerous methods for correcting QT interval for heart rate and the
reasons why none of these may be suitable. In the last chapter we discussed the
Neilson method for the dynamic assessment of the QT/RR relationship from Holter
recordings. In the previous sections, we discussed the likely effect ofQT hysteresis
on the estimation ofQTc from non-steady state data. Here we present data which
demonstrate the difference in the estimation of the QT/RR relationship from Holter
data in healthy volunteers.
In order for any test to be reliable, it is essential that it is reproducible so that any
observed differences cannot be dismissed as being due to natural variation in the
parameter being assessed .In addition, it is important that we are aware of the impact
of other potential variables which in the case ofHolter recordings for QT analysis,
could include the use of one or other channel for the analysis.
4.2 Hypotheses
The primary hypothesis was that due to the QT adaptation lag, continuous assessment
of the QT/RR relationship would lead to underestimation of the slope and shape of
the QT/RR curves. The secondary aims were to establish the reproducibility of the
method and the impact of using different leads.
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4.3 Method
Fifteen healthy male volunteers (mean age 28) without a cardiac history and on no
medication underwent 24 hour ECG recordings using 2 channel 'Tracker 2' recorders
(Reynolds Medical, Hertford, England) on two occasions one week apart. Standard
bipolar thoracic leads CM5 and CM1 were used. All subjects were asked to abstain
from alcohol and follow their normal daily routines on both recording days. One
subject was excluded from further analysis due to the presence of frequent
supraventricular ectopics. Consent was obtained in all subjects in accordance with our
local ethics committee requirements.
The tapes were replayed on a Pathfinder Analyser (Reynolds Medical Limited,
Hertford England) which excluded ectopic complexes and those which were
significantly distorted by artefact. The analyser measured each RR interval and its
associated QT interval. The Tend was measured using the slope method whereby the
end of the T wave is determined as being the point at which the current slope of the T
wave drops below a pre-determined proportion of the maximum slope. The accuracy
of the automated QT interval measurement has been validated independently (Lande
et al. 2000).
Twenty four hour files ofRR and QT intervals are then processed on a personal
computer using a novel technique to determine the QT:RR relationship. The three
stage process is described briefly below, but the theoretical aspects have been covered
in more detail in chapter 3.
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First, the well known two component time lag (Franz et al. 1988, Lee et al. 1999)
with which the QT interval follows changes in RR interval is 'compensated' by
applying a matching two component time lag to the RR data. This re-synchronises the
QT and RR variations so that, when the compensation is correctly adjusted, a screen
display ofQT against RR no longer shows the characteristic loops due to "QT
Hysteresis" but retraces the corresponding part of the underlying 'steady state'
QT/RR curve. This is the curve that would have been traced ifRR had changed
slowly enough so the effect of the QT delay on the plot would be negligible. During
analysis the operator can confirm the absence of 'hysteresis loops' and hence correct
compensation for the QT lag.
Secondly, throughout the analysis, the RR and QT signals are cross-correlated within
a moving five minute time window that is scrolled through the 24-hour data. So long
as the correlation between QT and RR remains high (r> 0.8), the slope (S) of the
QT/RR plot around each successive (RR, QT) point is computed as the best-fitting
line in the time window currently centred on that point. Thus a continuously updated
measure of the slope of the QT/RR characteristic curve is generated.
Thirdly, it is found that this slope decreases at longer RR intervals, providing
evidence that the steady state QT/RR characteristic is curved. To avoid the necessity
of reporting the value ofRR at each measure of slope, the simple exponential
empirical formula used by both Fridericia and Bazett is adopted.
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To allow for the known variation in the QT/RR relationship, a formula with variable
exponent is used:
QT = QTo * (RR/RRo)J
Here QTo is the intercept of the curve with the ordinate at RRo, a chosen reference
RR interval, and J is the exponent determining the shape of the curve. (Bazett's
formula assumes that J is constant and equal to 0.5, while the Fridericia formula is
equivalent to adopting a fixed value of 0.33 for J) In the present method the value of
J is continuously computed from J = S . (RR'/QT) , where RR' is the compensated
value ofRR.
4.4 Statistical Analysis
Recordings were excluded from statistical analysis if they did not fulfil the following
criteria: data used > 90%, pooled 24h QT:RR correlation >0.8, recording duration
>18h. A breakdown of the number of recordings available in each channel is given in
table 1. Of the 14 pairs of recordings, 13 pairs were of sufficient quality for
assessment of 24h reproducibility in one or both channels. When comparing the
difference in the calculated QT/RR relationship between compensated and
uncompensated data, all analysable channels were used. This produced a total of 35
acquired recordings that were then analysed with and without lag correction and
compared by paired t-test. Due to a low yield of high quality recordings in channel 2
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(CM1), only 11 tapes were available for comparison of inter-lead differences when
quality criteria were applied. Reproducibility of the technique was assessed by
calculation of the coefficient of variation (CV) defined as the standard deviation of
the mean difference between recordings, divided by the mean of the population and
expressed as a percentage. Inter-lead differences were assessed using paired t-tests.
4.5 Results
The mean pooled 24h correlation coefficient was 0.86 for compensated data,
implying that throughout the 24 hour period the correlation between QT and RR data
was high. This contrasts with the correlation for the uncompensated data (r = 0.63).
Although the mean pooled correlation for the population is 0.86, for the duration of
most of the recordings it is actually much higher, as can be seen in figure 4.1, a 24h
chart from a typical normal subject. Figure 4.2 is a further example of the lag
compensation in action during a five-minute excerpt of the playback. The left panel
shows raw QT and RR data-points whereas the in the right panel, the lag correction
has been applied, increasing the correlation between QT and RR.
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24h Chart from a Normal Subject
24hr. Pooled r
0.905
Figure 4.1: A 24h printout of compensated QT and RR (RR'), along with the
parameters S and J used to describe the QT/RR relationship. Recording was
commenced at 11 OOh. It can be seen that while the patient is sleeping (OOOOh -
0730h), there is a slight lengthening of QTo, with reduction in the variation seen
during waking hours. Slope is also seen to decrease, secondary to a longer RR
interval, meaning the QT intervals are on the flatter portion of the QT/RR curve.
There is a slight reduction in J during sleep relative to waking hours. The figures on
the right hand side are mean 24h values.
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Uncompensated QT/RR Plot Compensated QT/RR Plot
Figure 4.2:
A further example of the QT lag compensation in action. The figure represents a three
minute excerpt from a 24h recording. The left panel is raw QT:RR data. Each QT/RR
point has been joined to the next by a line. The right panel is the same QT data, but
matching lag has been placed on the RR data (RR')- This has resulted in an improved
correlation between QT and RR, with accelerations and decelerations in heart rate
tracing out one curve. This enables the measurement of the underlying QT/RR
relationship as though it were derived from steady state data.
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The mean 24h results for compensated and uncompensated values are given in table
4.2. QTo is significantly shorter when data were not compensated. Lack of
compensation also results in a reduction in the mean 24h slope which, in turn, reduces
the observed 24h mean J. Constructed QT/RR plots using mean 24h compensated and
uncompensated results are shown in figure 4.3.
The reproducibility of the method was assessed by comparing mean 24-hour values.
Where two channels were of sufficient quality in both recordings, both channels were
included in analysis. Table 4.3 gives the mean differences and CV for each of the
parameters. The standardised QT at an RR interval of 1000ms (QTo) is highly
reproducible despite a 7% variation in mean 24h RR. Slope and J also had a low CV
(11% and 7% respectively).
In 11 recordings, both channels were of sufficiently high quality to allow assessment
of the impact of lead selection on the value of the parameters. Table 4 details the
differences between channel 1 (CM5) and channel 2 (CM1). The slight difference in
mean 24h RR is due to automatic editing of noisy segments which differ according to
the channel analysed. There was a 15 ms difference in QT and a 13ms difference in
QTo between Chi and Ch2, with the CM5 lead having a longer mean 24h QT and
QTo. CM5 lead also tended to have a steeper slope and higher J.
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Figure 4.3: Demonstration of the different curves derived by analysing QT/RR data
over a scrolling short time frame. The uncompensated data gives a lower value of
QTo (red). Mean slope is also lower. The exponent describing the curve (J) is also
lower for the uncompensated data. This demonstrates that the continuous assessment
of the QT/RR relationship on a beat by beat basis will yield an underestimation of the
slope and the rate dependence of the curve.
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Summary of Suitability of Recordings for Analysis
Tape 1 Tape 2 Total of
analysable
recordings
Pairs where both tape
land tape 2 analysable
in the same channel
Total Pairs
(either channel)
Channel 1 (CM5) 12/14 12/14 24/28 11/14 13/28












Table 4.1: Breakdown of recordings suitable for analysis by channel and tape
number. Where the same channel was available for analysis in both recordings (tape 1
and tape 2) this is used as a pair for assessment of the reproducibility. Where both
channels were of sufficient quality in the same recording (tape 1 or tape 2), the pair is
used to assess the effect of using different leads on mean 24h values. All recordings
of sufficient quality, irrespective of channel or tape number, were combined to assess
the effect of applying lag compensation on the estimated QT/RR relationship.
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Comparison of Lag Compensated versus Uncompensated Data
n=35 RR QT (ms) QTo S J 24h SD 24h pooled
(ms) (ms) of J correlation
Uncompensated 901.4 396 406 0.06 0.127 0.009 0.650
(86.65) (23.6) (19) (0.01) (0.019) (0.002 (0.08)
6)
Compensated 901.4 396 415.74 0.146 0.320 0.018 0.87
(86.65) (23.6) (17) (0.02) (0.04) (0.014) (0.06)
p value N/A N/A <0.001 <0.001 <0.001 <0.001 <0.00001
Table 4.2:Comparison of lag compensated versus uncompensated ambulatory data.
All results are 24 hour means (standard deviation). Correlation between QT and RR is
less good when data is uncompensated. There are significant differences in the
estimated mean 24h QTo, S and J.
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Reproducibility of Parameters for Paired Recordings One
Week Apart (Compensated Data)




























CV 7.44% 3.04% 1.95% 11.1% 7.42% 5.2%
Table 4.3: Reproducibility of parameters from paired recordings one week apart. The
coefficient of variation (CV) is calculated as the standard deviation of the differences
between recordings, divided by the mean value for the population x 100% (SD/mean
*100%). All values are mean (SD).
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Interlead Differences in 24h Parameters (Compensated Data)




























p value NS <0.05 <0.05 <0.05 0.06 <0.05
Table 4.4: Interlead differences in 24h parameters. Paired t-test used to assess the




Compensating for QT lag by delaying RR data improves the correlation between QT
and RR, as evidenced by the high pooled 24h correlation coefficient. This
demonstrates the ability of the method to compensate for hysteresis and enable
estimation of the underlying QT/RR relationship using short-term non-steady state
data. QT lag compensation also corrects for the underestimation of slope that occurs
with beat-by-beat assessment of QT dynamics. Other researchers have shown that
when non-steady state data is used, the QT/RR slope is less steep (Badilini et al.
1998).
The use of a short (5 minute) time window offers the possibility of high temporal
resolution for assessment of the underlying QT/RR characteristic.
4.6.2 Diurnal Variation
We found that J varies constantly throughout the day, usually within a fairly narrow
range, as indicated by the small average 24h standard deviation of J (24h SD of J,
table 2). However, occasional peaks and troughs can occur. An example of circadian
changes in J can be seen in figure 1. Whether the degree of variation in J, which can
be described by the 24h mean SD of J for the recording, reflects the degree and
frequency of alteration in factors such as the autonomic nervous system remains to be
seen. In contrast, QTo seems to vary little with this method, showing a trend to be
longer at night, rather than varying constantly. Again, occasional peaks and troughs
are seen in QTo, most commonly on waking in the morning. These changes may
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reflect the interaction of numerous physiological factors which are known to affect
QT independently of rate, such as posture, autonomic tone and circulating factors
such as corticosteroids and catecholamines. The peaks on waking may be linked to
the increased incidence of arrhythmias seen in the early hours of the day. Acute
arousal events have been shown to be important triggers in the initiation of
ventricular arrhythmias in some patients with the congenital long QT syndromes (Ali
et al. 2000, Moss 1986).
4.6.3 Inter- and Intra- Subject Variation
Even in this small study, there was a considerable spread of 24h mean values of both
QTo and J across the population. The range ofmean 24h QTo was from 384ms to
448ms, although this has been accentuated by analysing channels 1 and 2 together.
Equally, there was a spread of values for J (0.28 - 0.382).
Despite the constantly changing nature of J, and the range of values seen in both QTo
and J across the population, the intra-subject mean 24h values of both are
reproducible. The 2% CV in QTo corresponding to an 8ms difference between
recordings is small when compared with the observed 17ms SD ofQTo across our
population. A similarly small difference is seen in J. This suggests that genuine
differences exist between individuals, and that the 24h mean QT/RR curve is
reproducible under stable conditions. The high reproducibility of this new method
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Figure 4.4: Graphical illustration of QT/RR curves with varying values of QTo (black curves)
and J (white curves). This is intended to illustrate that both QTo and J influence the QT/RR
relationship. Changes in QTo will tend to alter the 'height' of the curve, whereas changes in J
will affect the shape (i.e. straightness or curve). From this illustration, it can be seen that the
slope, s, which is the tangent to the curve at any individual point will vary according to the
position on the curve.
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4.6.4 Implications for Rate Correction Formulae
The variation of J with time and among subjects highlights the problems associated
with the search for a universally applicable rate correction formula, as discussed by
others (Hnatkova and Malik 1999). Figure 4.4 is a constructed plot of families of
curves created by varying either QTo or J. It can be seen that as QTo or J varies,
significant differences in QT occur over a range of heart rates. It can be seen that
under certain circumstances, a 'normal' QTo at a standardised heart rate of 60 beats
per minute can be associated with very abnormal QT intervals at fast or slow heart
rates if J is significantly different from 'normal'. By describing the QT/RR
relationship in terms of both QTo and J, a more informed judgement can be made as
to whether the QT/RR relationship is abnormal.
4.6.5 Significance of Lead Selection
Lead selection has been shown in this study to produce a small but significant
difference in observed QT and QTo. There is also a small absolute difference in
estimated values of S (0.01) and J (0.01). Estimation of the spatial dispersion of
repolarisation by measurement of the QT dispersion has generated a huge number of
publications over the years. Controversy exists over whether the measured dispersion
in QT intervals is truly a reflection of spatial differences in repolarisation or whether
it is due the geometrical projection of the T wave on the ECG (Lee et al. 1998, Kors
and van Herpen and Van Bemmel 1999) and there have been numerous editorials on
the use and significance ofQT dispersion. These recent editorials have questioned the
significance of QT dispersion (Malik 2000, Coumel and Maison-Blanche and Badilini
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1998, Sahu et al. 2000) and one even dubbed it the 'greatest fallacy in
electrocardiography in the 1990's (Rautaharju 1999). Whether QT dispersion is real
or not, the significance of lead differences in the context of analysis of the QT/RR
relationship is unknown. From a technical standpoint, the use of a standardised lead
with a low amplitude T wave and an unfavourable signal to noise (S/N) ratio is more
likely to provide erroneous results than selecting the lead with the most accurately
determinable Tend, even if it lies on a different axis.
4.7 Limitations
This study was relatively small and examined only normal subjects. Further work
would be required to establish normal ranges and the influence of gender. As with all
methods for the analysis ofQT dynamics from ambulatory recordings, the quality of
acquired ECG waveforms, both in terms of signal quality and the accurate editing out
of frequent premature or aberrant beats, is essential. T wave morphology may be
abnormal or of low amplitude in many patients with heart disease and ectopy more
frequent. This will affect the yield of recordings of sufficiently high quality where
accurate Tend measurement is possible. In this study, mean 24h values are quoted and
an average of 72,000 beats was analysed per recording. A few non-edited abnormal
beats are unlikely to influence results. The yield of high quality recordings in this
population was good, particularly for the CM5 channel. Individuals were young, slim
and had normal hearts with normal T wave morphology. This is often not the case in
clinical practice. It can readily be seen that when analysing CM1, T waves were of
lower amplitude, degrading the S/N ratio so that when our selection criteria are
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applied, the yield drops from more than 90% to less than 50% of recordings suitable
for analysis. This finding reinforces the importance of ranking a good T wave
morphology over lead position when selecting electrode sites for ECG recordings
intended for QT analysis.
4.8 Conclusions
This method shows potential for the assessment of both the short and long term
characteristics of the QT/RR relationship in healthy volunteers. It represents a
significant change from previous approaches to the analysis of dynamic recordings in
that it is the first to employ a method for compensating for QT lag. As the QT/RR
relationship appears to follow a curve over a broad range of heart rates in ambulatory
data, the QT/RR characteristic is described in terms of an exponential formula with
two variables, QTo and the exponent J. It removes the need for quoting a slope for
variations in the RR interval. It may be well suited to the assessment of the effect of
medications on aspects of ventricular repolarisation. Further work is required to





in Patients with Heart Failure:
Correlation with Functional Class
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5.1 Introduction
Heart failure is a clinical syndrome due to impaired heart muscle function, with
subsequent changes in neurohumoral activation, fluid retention and shortness of
breath. It can be a primary disorder due to myocardial disease or can occur as the end
result of a long list of conditions which can result in failure of the heart to maintain
the circulatory requirements of the body. To an extent, the final pathway is the same
in that chronic pressure overload in the ventricle results in dilatation of one or both
ventricles with impairment of contractile function. At a histological level, there is an
increase in myocardial fibrosis and the individual myocytes are hypertrophied in
response to activation of the sympathetic nervous system and the release of growth
factors.
In the western world, the commonest cause of heart failure is ischaemic heart disease,
with previous myocardial infarction or chronic ischemia. Valvular heart disease is
also a major cause, and can be divided into two groups- those with pressure overload
(such as aortic or mitral stenosis) and those with volume overload as a consequence
of valvular regurgitation (mitral or aortic regurgitation).
5.2 Epidemiology and Prognosis
Congestive Cardiac Failure (CCF) is a common condition, with an estimated 2
million patients in the United States with the condition, with an estimated 900,000
hospital admissions per year due to CCF. Mortality rates are as high as 50% per year
in some studies and 200,000 people die annually from CHF. Despite recent advances
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in medical therapy, the mortality remains high. The natural history of the disease is a
gradual progression in haemodynamic dysfunction with worsening symptoms and
ultimately death due to a failure of the circulation to maintain other organ systems.
However, many of these patients die suddenly and unexpectedly (Kannel and Plehn
and Cupples 1988) and in many cases, ventricular tachyarrhythmias are responsible
(Luu et al. 1989, Wilber et al. 1974, Roberts 1986). Sudden cardiac death may even
occur in those patients with less severe disease, and some studies have suggested that
those with less severe disease, in relative terms are more likely to die suddenly than
those in the worst functional classes. In one series of unexpected in-hospital cardiac
arrests in patients with NYHA class III or IV HF, 15 of 29 cases of sudden death
were due to ventricular tachycardia (VT) or fibrillation (VF) (Stevenson et al. 1993).
Macroreentry is one mechanism by which malignant arrhythmias can arise, in areas
where there is slow conduction, such as around the border zones of previous
myocardial infarction. This typically results in sustained ventricular tachycardia (VT).
However, ventricular fibrillation (VF) without preceding VT is often seen either
clinically or at electrophysiological (EP) testing in patients with impaired ventricular
function.
5.3 Electrophysiological Changes in the Failing Heart
The failing ventricle is known to exhibit prolongation of action potential duration
(APD) compared to those of normal hearts (Beuckelmann and Nabauer and Erdmann
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1992, Gwthmey et al. 1987, Vermeulen et al. 1994, Beuckelmann and Nabauer and
Erdmann 1993). The prolongation of action potential duration is most probably an
apaptive phenomenon to prolong the duration ofmyocytes contraction to help
maximise stroke volume. In animal models this prolongation is progressive with the
degree of heart failure, and occurs in the absence of other electrophysiological
abnormalities such as changes in resting membrane potential, action potential
amplitude or upstroke velocity. The plateau phase of the action potential is quite
labile and exquisitely sensitive to small changes in currents, which can lead to
changes in the duration of repolarisation. Reductions in serum potassium can further
lengthen the AP and lead to early after-depolarisations (EADs), particularly at low
heart rates (de Groot et al. 2000). These after depolarisation can trigger ventricular
ectopy or even sustained ventricular arrhythmias.
Studies of the changes in ion currents in heart failure have shown that several
abnormalities exist although there is considerable variation between species. In
human cells the most consistently reported finding is a reduction in It0. It0 is a brief
current occurring during phases 0 and 1 of the action potential. Although brief, its
down regulation by factors such as a-adrenergic stimulation will affect the level of
the plateau, therefore influencing the magnitude of all the currents responsible for
repolarisation.
Down-regulation of inward potassium mediated currents (an efflux of potassium from
the cell resulting in net repolarisation) has also been noted in human tissue but the
results are less consistent than the finding of reduced Ito. Certainly, these inward
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currents are responsible for the prolonged plateau phase and reduction in these
currents increases the propensity to the development of arrhythmogenic EADs.
Intracellular calcium handling is also abnormal in heart failure and is thought to
account for the prolongation of relaxation and impaired frequency dependent
facilitation of contraction. Ventricular myocytes from failing hearts show a reduced
density of current mediated through the L-type calcium channels. There is also a
reduced augmentation in the current in response to adrenergic stimulation which
would normally increase the force of contraction. The rate related potentiation in Ic3l
is also attenuated. All of these changes in ion currents will produce a prolongation of
action potential duration and a reduction in excitation contraction coupling.
5.4 Hypotheses
Although extrapolation from cellular studies across species is not ideal, prolongation
in APD and QT is certainly present in failing human hearts and these changes may
predispose the subjects to triggered activity and the initiation and maintenance of
malignant rhythms. To allow comparisons ofQT duration between individuals and
populations, it is necessary to correct the QT duration for heart rate, as this is the
greatest single influence upon QT. However, autonomic tone and the effects ofmany
cardiac drugs may also influence QT duration. As discussed in the previous chapters,
correcting QT for rate is problematic and has led to the development of numerous
formulae of linear, logarithmic and exponential type, although recently researchers
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have concluded that no single formula is universally applicable (Hnatkova and Malik
1999).
This chapter examines the repolarisation dynamics of patients with heart failure
versus healthy volunteers using the method ofNeilson as described in the previous
chapters. Our hypotheses were that in light of the evidence ofmembrane current and
action potential abnormalities in patients with heart failure it is likely that they will
also exhibit abnormalities of repolarisation. The rate dependence of the QT interval
may also be abnormal in heart failure given that many of the currents responsible for
the action potential are also rate dependent. If this is the case then the abnormal rate
dependence will have serious implications for any method to correct QT for heart
rate, whether from resting ECGs or ambulatory data. A secondary hypothesis was that
the degree of any observed abnormalities may correlate with the severity of heart
failure.
As discussed in chapter 1, previous methods for analysis of ambulatory recordings
have been limited through methodology in the continuous assessment of the QT/RR
relationship, relying on averaging of long segments or steady state periods to produce
a reliable result. In addition, the QT/RR relationship is often quoted in terms of rate
dependent variables such as slope. Using Neilson's method we again quote results in
terms ofmean 24h QTo and 24h mean J.
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5.5 Methods
5.5.1 Patient Population and Data Acquisition
Patients with ischaemic heart disease and either symptoms of heart failure or left
ventricular impairment (or both) who had been stable on cardiac medications for at
least one month were suitable for inclusion in the study. Left-ventricular ejection
fraction was estimated by echocardiographic, radionucleide or angiographic methods,
and patients were divided into broad groups according to the severity of impairment
(severe = EF<15%, moderate = 16-25%, mild = 26-40%, and near normal = EF
>40%). Patients on agents known to prolong the QT interval were excluded, as were
all patients with bundle branch block (BBB) or atrial fibrillation (AF). Data from
recordings in 41 patients from NYE1A class I - IV were compared with 15 age
matched healthy volunteers. NYE1A functional class was assessed by a clinician
(ADF) blinded to the results of the ambulatory ECG data. The characteristics of
patients and controls are shown in table 5.1, and the characteristics of the CE1F group
are presented in table 5.2 by NYHA class. Twenty-four hour ambulatory ECG
recordings were acquired with Tracker recorders (Reynolds Medical, Hertford,
England) with standard bipolar thoracic leads CM1 and CM5.
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Age 53 (6) 57(14)
Sex 10 male 35 male
EF Not assessed 25% (14)
Mean heart rate (SD) 71 (6) 70 (11)
Beta blockers N/A 50%
ACE lnhibitors/A2 antagonists N/A 90%
Diuretics N/A 90%
Digoxin N/A 5%
Class III agents N/A 0%
Table 5. 2: Breakdown of patient characteristics by NYHA class. These data
highlight the importance of factors other than ejection fraction which
determine symptoms, such as obesity, hypertension and diastolic dysfunction.
NYHA 1 NYHA 2 NYHA 3 NYHA 4
(n= 6) (n=22) (n=12) (n=4)
Ejection ~36% (14) 24% (14) 29% (*12) 28% (27)
Fraction
Beta- 25% 43% 75% 25%
blockers
ACEI 75% 87% 100% 75%
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5.5.2 Dynamic QT/RR Measurements
The tapes were replayed on a Pathfinder Analyser (Reynolds Medical Limited,
Hertford England) which excluded ectopic complexes and those which were
significantly distorted by artefact. The analyser measured each RR interval and
associated QT interval. The Tend was measured using the slope method whereby the
end of the T wave is determined as being the point at which the current slope of the T
wave drops below a pre-determined proportion of the maximum slope. The 24h
QT/RR relationship is calculated using the method described in the previous chapters.
5.5.3 Statistical Analysis
To minimise the impact of noisy recordings on results, only tapes from subjects
where the percentage data analysed was greater than 80% and the mean 24h
correlation between QT and RR was greater than 0.7 were included. Mean 24h
parameters from Holter recordings were compared between populations by unpaired
t-test.
5.6 Results
5.6.1 Characteristics of RR and QT
There was not a significant difference in mean 24h RR or QT between the two groups
although there was a trend towards a shorter mean 24h RR interval in the CHF group.
The mean 24h QTo was significantly prolonged in the CHF group (461 vs 426ms,
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p<0.005). Examples of 24h ambulatory QT/RR data from a control and a healthy
volunteer is shown in figure 5.1.
5.6.2 Rate Dependence of the QT/RR Relationship
The mean 24h slope (S) was also steeper in CHF (0.195 vs 0.140, p < 0.01). The
mean 24h J (the exponent of the general formula that determines the form of the
QT/RR curve) was significantly elevated in CHF (0.38 vs 0.28). In contrast to the
slope, J is independent of heart rate.













HV 845 402 426 0.14 0.28 0.05 0.742
(n=15)
(105) (24) (20) (0.02) (0.05) (0.05) (0.08)
CHF 859 420 461 0.20 0.38 0.181 0.77
(n=41)
(152) (45) (37) (0.07) (0.11) (0.25) (0.10)
p value 0.76 0.18 <0.01 <0.01 <0.01 <0.01 0.25
Constructed QT/RR curves created by using the mean population values ofQTo and J
are shown in figure 5.2 to illustrate the different characteristics over a range of heart
rates.
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5.6.3 Variation in the QT/RR Relationship
The spread of values of J throughout the 24h period indicated by the mean 24h SD of
J is much greater in the CHF group (0.181 vs 0.059, p< 0.01), reflecting an increased
variation in the relationship between QT and heart rate. This data is summarised in
table 5.4. The increased variation in J cannot be explained by differences in the lag
compensation as the overall correlation between QT and RR for compensated data is
comparable between the two groups, as indicated by the similar pooled mean 24h
correlation (r).
5.6.4: Correlation with the degree of symptoms or severity of LV Impairment
When the CHF group is sub-divided according to NYHA class, the values of S, QTo
and J increase with worsening functional class (figure 5.3). Analysis of variance
(ANOVA) confirmed statistical significance (table 5.4). In contrast, when patients
were sub-grouped according to ejection fraction (0-15%, 16-25%, 25-40% and
>40%), no significant difference is seen between the subgroups (figures 5.4).
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Table 5.4: Statistical analysis of NYHA and EF subgroups by analysis of
variance (ANOVA). In this table, p values are shown for each parameter
measured, according to whether patients were sub-grouped according to







24h SD of J 0.11 0.59
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Figure 5.2: Curves generated from the mean population data in heart failure
and healthy subjects. This illustrates how at higher heart rates, little difference
is observed between HF subjects and HV subjects. However, at lower rates,
the combination of a higher J and longer QTo leads to a separation of the two
curves.
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Figure 5.3: Comparison of the correlation between functional class and
repolarisation characteristics. Error bars indicate standard errors of the
means.
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Figure 5.4: Comparison of the correlation between ejection fraction and
repolarisation characteristics. Points are mean 24h values. Error bars indicate


















EF 0- EF 16- EF 26- EF















EF 0- EF 16- EF 26- EF HV



































P24h mean SD of J







There is much debate over the best method for the assessment of ventricular
repolarisation characteristics. The simplest approach would be to take a resting 12
lead ECG and use one of the available correction formulae to correct for differences
is heart rate. Unfortunately, the use of formulae to correct for heart rate are limited by
the fact that they assume and impose the same underlying QT/RR relationship on
both population groups. Investigators have shown that different subjects have
different overall QT/RR relationships, and patients with previous myocardial
infarction (Horns et al. 1997) and cardiac arrest survivors (Yi et al. 1999) have steeper
QT/RR slopes and longer QT intervals, making direct comparison between
populations using the same correction formula at best erroneous, and at worst
meaningless. These methods however assume a linear relationship between QT and
RR and used grouped data to establish values. Using ambulatory data, the opportunity
arises to take long periods ofECG data and from this compute the overall QT/RR
relationship, allowing comparison of the QT/RR relationship between groups. This
again demonstrates significant differences between patients with heart disease and
those without. Unfortunately, most methods do not lend themselves well to the
assessment of short-term changes or variability in the QT/RR relationship.
Using this method, it has been possible to assess the 24h relationship in patients with
heart failure and healthy subjects. Several differences have become apparent.
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5.7.1 24h Characteristics of the QT/RR Relationship
In this study we have demonstrated that with continuous assessment ofQT and lag
corrected RR, it is possible to describe the relationship between QT and RR in terms
of a variable exponential formula with two variables, QTo and J. Figure 5.1 is an
example of 24h printouts from a healthy volunteer and a patient with heart failure. In
the figure, the values for QTo do not vary dramatically during the day, although there
is a slight prolongation at night. J, the exponent of the general formula, is seen to vary
constantly throughout the day and night, although generally around a fairly stable
mean value. This is in contrast to slope which is lower at higher RR intervals,
confirming that the QT/RR characteristic is curved rather than linear.
5.7.2 Differences in the QT/RR Relationship between Heart Failure Subjects and
Controls
Although no significant difference was seen between mean 24h RR or QT in these
groups, the HF group had a slightly higher mean 24h heart rate (shorter RR) and a
slightly longer mean 24h QT. When the overall QT/RR characteristic is established
by fitting the data continuously against the general formula, a marked difference
emerges between the two groups. The extrapolated QTo (QT at an RR interval of Is)
is significantly prolonged, and the exponent J is greater. The resultant effect of these
two abnormalities is that the curves are separated over a broad range of heart rates,
with the differences most marked at low heart rates. The steeper curve means that the
rate dependence ofQT is greater in heart failure.
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The ability to detect prolongation ofQT is dependent on the method employed for
correction of rate related changes. Previous studies have shown that survivors of out
of hospital cardiac arrests can have a normal QTc when traditional rate correction
formulae are applied, but abnormal rate dependence when QT/RR plots are
constructed with raw data (Fei et al. 1994). This is an important point, as if one
considers that in this study RRo is chosen arbitrarily as one second for no reason
other than convention, it can be seen from figure 5.2 that ifRRo was set at, for
example, 300ms, little difference would be observed between the groups. QTo as a
stand alone measure of repolarisation may show differences between populations, but
when combined with the exponent J it takes on a much more useful role, as it allows
description of the entire QT/RR characteristic, irrespective of heart rate. Knowledge
of both of these variables allows us to more usefully describe repolarisation
properties at any point in time, and at any heart rate.
Prolongation of repolarisation has been recognised in animal models of heart failure,
irrespective ofwhether pressure overload, genetic or pacing models are studied. In all
models, including human hearts, abnormalities of inward repolarising currents are
present, the most consistent being a reduction in Ito, but also reductions in the inward
rectifier potassium current (Iki)- The net result of a reduction in these currents is to
prolong the plateau phase of repolarisation, increasing the possibility of after-
depolarisation mediated triggered activity. This will, on the surface ECG, be manifest
as a prolongation of the QT interval.
107
5.7.3 Increased Variability in the QT/RR Relationship
By calculating the mean 24h standard deviation of J, information is obtained about
the frequency and magnitude of changes occurring in the QT/RR characteristic
throughout the day. In both healthy volunteers and CHF variation is seen, although
the magnitude of this variation is greater in heart failure. This increased variation in
the QT/RR relationship bears similarities with the study of Berger et al (Berger et al.
1997) as discussed in chapter 2. They employed a novel approach to the assessment
of repolarisation dynamics that assesses changes in QT with respect to changes in RR
over relatively short time periods (256s). When they compared healthy volunteers
with heart failure patients they found that there was decreased heart rate variance but
an increase in QT variance in the heart failure group. When these two parameters are
combined to produce the QT variability index (QTVI) they found that it discriminated
between HV and CHF. This increased variability in the QT/RR relationship may
reflect an inability of the myocardium to regulate repolarisation for changes in heart
rate.
5.7.4 Correlation with NYHA Functional Class
Although this study was small in size, the subjects were distributed across all NYHA
functional classes. When subgroups were analysed, it became apparent that the
abnormalities of the QT/RR relationship show a worsening trend with functional
class. It is felt that NYHA functional class may correlate with the degree of
neurohumoral activation in heart failure. The maladaptive mechanisms of increased
sympathetic tone, decreased parasympathetic activity and activation of the renin-
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angiotensin-aldosterone system (RAAS) are well described and, either directly or
indirectly, can influence cardiac repolarisation, with down-regulation of ion currents
and abnormal expression of adrenergic receptors. These factors are likely to be partly
responsible for the progressive changes in repolarisation dynamics that we have
described. Other investigators (Hintze et al. 1998, Singh et al. 1998, Merri et al.
1992) have shown that beta-blockade reduces the slope of the QT/RR relationship in
both healthy subjects and patients with heart disease, and this implies that increased
sympathetic drive is at least one of the factors responsible for the increases seen in J
and QTo relative to controls. However, caution must be exercised when interpreting
data from these studies as heart rate will be lower following beta-blockade, and their
method measured slopes of linear QT/RR plots. Given that the QT/RR relationship is
likely to be non-linear, we cannot interpret slope as being independent of heart rate.
This highlights the advantage ofmeasuring the rate independent quantity J in our
study.
The fact that previous studies have suggested that sudden death is disproportionately
common in relatively asymptomatic patients NYHA class (Merri et al. 1992), our
findings would seem to be discordant. However, arrhythmic death is frequently hard
to determine as it is often unwitnessed and rhythms undocumented in the community.
Certainly, patients with NYHA IV failure are more likely to die from pump failure
compared to NYHA I patients, but it would seem that they are also likely to die of
arrhythmias. One study of in-hospital deaths in patients with severe heart failure
showed a 50% incidence of arrhythmic death where the terminal rhythm was VT/VF
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(Stevenson et al. 1993). Although this population is not representative of our
ambulatory out-patients, it would imply that arrhythmias are still very likely to occur
in severely limited subjects.
5.8 Limitations
As with all techniques for measurement of the QT interval, accurate and consistent
measurement of Tend is often difficult to obtain. The results obtained are therefore
dependent on the quality of the data. Many patients with heart disease have low
amplitude T waves with a T0ffSet that is difficult to determine. In this small study, this
was not the case as only patients with high quality recordings were included.
Ejection fraction was estimated by a combination of techniques in this study. It may
be that an ejection fraction measured by ventriculography at the time of cardiac
catheterisation may be greater than that meaured by echo in the same patient, and this
may lead to an error in the analyses. However, as the patients were placed in broad
groups according to the ejection fraction, this error is likely to be minimal.
Patients with cardiac disease are frequently prescribed agents that influence the QT
interval, particularly those who have had arrhythmias. In addition, the use of diuretics
may influence electrolyte levels causing changes in QT duration. Patients with
ischaemic heart disease or heart failure may be taking beta-blockers that will have an
effect on the QT/RR relationship, as shown in previous studies (Emori et al. 1997,
Hintze et al. 1998, Singh et al. 1998), however, this has generally been shown to
reduce the rate dependence ofQT on RR. While the abnormalities shown in this
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paper are intriguing, further studies are required to establish whether this method can
offer any useful prognostic information in cardiac failure with respect to arrhythmic
death. In the era of implantable defibrillators and increasing economic pressures, a







Hypertrophic cardiomyopathy (HCM) is a myocardial disease inherited as an
autosomal dominant trait. Numerous mutations in at least nine genes have been
identified. All genes thus far identified code for components of the cardiac contractile
apparatus, or sarcomere. These abnormal gene products result in altered sarcomere
function, for example by altering actin binding, ATP hydrolysis or calcium sensitivity
(Sata and Ikebe 1997). In response to the impaired contractility and higher pressures,
growth factors are released which result in myocyte hypertrophy and fibrosis. It is
hypothesised that myocardial hypertrophy results as a compensatory response to
impaired contractile function. The extreme degree of hypertrophy adversely affects
other aspects of cardiac physiology and is considered maladaptive.
The prevalence of the disease in the general population is estimated at 0.2% (Maron
et al. 1995) Phenotypically the disease is characterised by inappropriate myocardial
hypertrophy occurring in the absence of increased pre- or after-load. Although the
exaggerated hypertrophy may be concentric and similar to that seen in severe cases of
hypertrophy secondary to hypertension or aortic stenosis, it is more commonly
asymmetrical affecting predominantly the interventricular septum. Systolic function
appears hyperdynamic, although it is becoming increasingly recognised that a 'burnt
out' stage may ultimately occur where the left ventricle becomes dilated with
thinning of the walls with an appearance similar to dilated cardiomyopathy.
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Myocardial hypertrophy may compensate for sarcomeric dysfunction by increasing
the numbers and size of the basic contractile elements and by reducing LV cavity size
to lower wall tension. Lower LV wall tension and small end-diastolic volumes lead to
an apparent hyper-contractile systolic function. Resting ejection fractions are
typically normal or high, but stroke volume (SV) remains in the low to normal range.
There are many patho-physiological consequences of LV hypertrophy. LV
myocardium has reduced compliance and impaired relaxation leading to diastolic
dysfunction, further reducing the stroke volume. Rapid LV ejection along with a
smaller LV outflow tract (LVOT) in approximately 25% of cases can lead to systolic
anterior motion (SAM) of the mitral valve and dynamic LVOT obstruction.
The increase oxygen demands of the greater muscle mass, in conjunction with small
vessel disease, can render the ventricle ischaemic during exercise.
Myocardial bridging of epicardial coronary arteries is not infrequently found in
patients with HCM and has been reported to be associated with QT prolongation and
sudden cardiac death (Yetman et al. 1998, Mohiddin, Begley and Fananapazir 2000).
6.2 Histological Abnormalities in Hypertrophic
Cardiomyopathy
The histological findings in HCM are marked, with disarray of the normally well
organised myocardial architecture and hypertrophy ofmyocytes. There is an increase
in fibroblast numbers, extracellular matrix and also considerable small vessel disease.
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A large study of post-mortem hearts from patients with hypertrophic cardiomyopathy
(Varnava et al. 2000) characterises the histological abnormalities but also
demonstrates some interesting associations between the histological findings and one
of the least well understood and arguably most serious consequence of the disease-
sudden unexpected cardiac death. They conclude in their paper that the myocardial
disarray is a primary abnormality due to the mutation in the sarcomeric protein,
whereas the fibrosis and small vessel disease appear to be secondary phenomena
which are modified by age, left ventricular (LV) mass and sex. They also found that
the degree of hypertrophy, both in terms of heart weight and maximum wall thickness
has an inverse relationship with age at death, implying that the patients with more
hypertrophied hearts were at increased risk of sudden death. This supports the
findings of Spirito et al who published a paper which showed that in a long term
follow up of a large cohort of patients, the maximum LV wall thickness was an
independent predictor of sudden death, particularly if in excess of 30mm (Spirito et
al. 2000).
6.3 Sudden Death in Hypertrophic Cardiomyopathy
HCM is a heterogeneous disease with considerable variation in the severity of
symptoms and prognosis. Some patients have progressive disease with increasing
fibrosis, small vessel disease, atrial distension and worsening symptoms of heart
failure due to either diastolic dysfunction in a stiff ventricle or to pressure overload
from sub-valvar outflow tract obstruction. Other patients have an indolent course and
have little or no progression over decades. Although the clinical course may be
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relatively stable over time, a significant proportion of patients will experience
unexpected catastrophic events such as cardiac arrest.
Overall, the mortality statistics from studies in tertiary referral centres quote mortality
rates of between 3 and 6% per year for HCM related premature death. However, there
is felt to be significant referral bias in these studies as patients tend to be referred due
to the severity of the disease or relative youthfulness (Maron and Spirito 1993). More
unselected population studies suggest a lower mortality of around 0.5 - 1.5% with
overall survival similar to that of the general population (Cecchi et al. 1995,Spirito et
al. 1989,Kofflard et al. 1993,Maron et al. 1996).
Although the overall mortality statistics do not suggest that the risk of death is great,
the fact that many of the patients who die do so suddenly, unexpectedly and often at a
young age underlines the need for accurate risk assessment of these subjects. In an
investigation into the cause of sudden death of 158 young athletes in the USA, a post
mortem diagnosis ofHCM was made in 36%. The next largest subgroup was of
coronary anomalies in 19% (Maron et al. 1996b). Given that non-sustained
ventricular arrhythmias are common in HCM patients on 24h ECG recordings, it is
natural to assume that sustained VT or VF accounts for the vast majority of deaths. In
fact, there is evidence that sustained rapid supraventricular arrhythmias such as atrial
fibrillation or re-entrant SVTs account for at least some and death is probably due to
the associated hypotension accompanying high heart rates in many of these patients.
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In addition, myocardial ischemia can occur, with subsequent LV dysfunction and/or
arrhythmias.
An association between non-sustained ventricular tachycardia (NSVT) and sudden
death has been shown (McKenna 1987), although the presence of this on 24 or 48h
Holter monitoring is common in these patients and therefore as a prognostic tool
lacks specificity and positive predictive power. A later study by Fananapazir
proposed that only NSVT with a history of pre-syncope or syncope or easy
inducibility ofVT or VF at electrophysiological testing were of use in the estimation
of risk (Fananapazir et al. 1992). A strong family history of SCD (Maron et al. 1978),
and a patient history of syncope or previous cardiac arrest are more predictive in this
group, but as HCM is often diagnosed at post-mortem, one cannot always afford to
wait for an episode of syncope prior to initiating action as this is an ominous sign.
QT dispersion has also been shown to be increased in patients who died suddenly on
pre-mortem ECGs(Buja et al. 1993). In the era where identification of the specific
genes involved is becoming possible, certain mutations have been identified as being
associated with a very high mortality at a young age (Fananapazir and Epstein
1994,Epstein et al. 1992). Severe LVH on echo (Spirito et al. 2000) has been shown
to be associated with an increased risk of sudden cardiac death in a large long-term
prospective study. The search continues for a better clinically applicable, widely
accessible and ideally non-invasive tool for the assessment of arrhythmic risk.
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6.4 Cardiac Repolarisation in HCM
Little is known about cardiac repolarisation in HCM. In 1973, Coltart and Meldrum
studied the intracellular myocardial action potential in tissue specimens obtained at
operation from two patients with HCM (Coltart and Meldrum 1972). They compared
the data with action potentials from hearts with secondary hypertrophy. They noted a
marked prolongation of the action potential relative to the hypertrophic controls. In
addition there was slowing of depolarisation (phase 0) of the action potential. On
surface ECG recordings, the QT has also been shown to be prolonged, independently
ofQRS widening (Martin and Garson Jr and Perry 1994, Dritsas et al. 1992) in
children diagnosed with HCM.
In a paper by Atiga et al, evidence of an abnormal coupling between changes in QT
and changes in heart rate was shown (Atiga et al. 2000). There also appeared to be an
increase in the variability of the QT interval relative to heart rate. These abnormalities
were more marked in the sub-groups of patients known to have genetic mutations
associated with an increased risk of SCD (Arg403Gln) and a survival rate of 50% at
the age of 30 years in one study (Epstein et al. 1992).
Cellular electrophysiological studies in animal and human models of hypertrophy
have demonstrated that cells from hypertrophic hearts have a prolonged action
potential, and this appears to be an adaptive response to the increased pressure
loading. This prolongation may be secondary to decreases in the inward currents
generated by the efflux of potassium and/or calcium through the membrane ion
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channels. Although hypertrophic cardiomyopathy differs from secondary hypertrophy
at several levels, it is conceivable that the prolongation of repolarisation in HCM
occurs either as a response to the abnormal loading on the ventricle, or that the
mutations causing HCM may also be responsible for the electrophysiologic changes.
6.5 Hypotheses
There is very little experimental evidence of abnormalities of the rate dependence of
QT in HCM. Given that QT and QTc have been shown to be prolonged by
conventional measurement of resting recordings, our hypothesis was that the
prolongation in QTo may be associated with an increased value of J, indicative of a
steeper QT/RR curve. Incorporating the evidence of increased QT variability from
Berger's group, we also hypothesised that there may be a greater spread in the values
dictating the QT/RR relationship, and looked for an increase in the 24 hour standard
deviation of J relative to controls. We assessed the dynamic characteristics of the
QT/RR relationship in sixty patients with non-obstructive HCM (forty male).
6.6 Methods
60 patients (40 male) referred to the National Heart Lung and Blood Institute, (NIH,
Bethesda, Maryland, USA)for assessment were recruited. These subjects were either
relatives of patients diagnosed with HCM and diagnosed as part of a family screening
programme, or were diagnosed by their referring physicians. All HCM patients were
asymptomatic (NYHA I) or mildly symptomatic on moderate exertion (NYHA II).
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None had evidence of LV outflow obstruction on echocardiography or at cardiac
catheterisation. Patients had been off all medication for at least four half lives. None
was taking amiodarone. Forty age and sex matched normal subjects from an existing
database acted as the control group. All patients and controls underwent 24h
ambulatory ECG recordings using 2-channel recording devices. Bipolar thoracic
leads CM1 and CM5 were used. 24h ECG recordings were analysed using the best
available channel (see section 4.4) Calculation of the 24h QT/RR relationship was
performed as described in chapters 3 and 4.
Exclusion criteria were as follows:
1. The presence of bundle branch block or intra-ventricular conduction defects with
a QRS duration of > 120ms.
2. Frequent ventricular or supraventricular ectopics (> 5/minute)
3. Atrial fibrillation
4. Holter recordings of poor quality for QT analysis
A total of 29 (50%) of the HCM patients were excluded from further analysis at this
stage due to recordings of insufficiently high quality.
Statistical Analysis
HCM and control group data were compared using student's t-test. Statistical
significance was defined as a P value < 0.05.
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6.7 Results
Baseline characteristics and results ofHo Iter analysis are laid out in table 6.1.
Table 6.1 Baseline characteristics
Controls n=36 HCM n=31 P-value
Age (years) 39±13 41 ±10 ns
Female Gender 11 9 ns
RR (ms) 849±105 852 ± 94 ns
QT (ms) 388± 64 420 ± 26 <0.05
QTo (ms) 426± 18 457± 27 <0.0001
Slope 0.16 ±0.03 0.21± 0.05 <0.0001
J 0.32±0.05 0.41± 0.08 <0.0001
24h SD of J 0.03 ±0.03 0.09 ±0.14 <0.05
Mean 24h correlation
(r)
0.826 ±0.09 0.87± 0.05 ns
Despite being suitably matched in terms of age, sex and 24h mean RR interval, the
HCM group had a significantly prolonged mean 24h QT (420ms vs 388ms, p<0.05)
and QTo (457ms vs 426ms, p<0.001). In the HCM group, slope and J were also
significantly increased. Using the grouped population variables QTo and J it is
possible to construct mean population QT/RR curves, as shown in figure 6.1. Again,
similar to patients with heart failure, the curves are most widely separated at low
heart rates.
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The mean spread of values of J throughout the 24h period, calculated for each
individual as the mean 24h standard deviation of J (24h SD of J), was elevated in the
HCM group (0.088 vs 0.033, p< 0.05). This increased spread of values was unlikely
to have been due to measurement error attributable to noise as the pooled 24h QT-RR
correlation coefficient (r) for the HCM population was higher in the HCM group
(0.87 vs 0.826).
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6.8.1 Prolonged Repolarisation and Increased Rate Dependence of QT
The observed differences between these populations have several implications for the
assessment of repolarisation dynamics. Firstly, as can be seen in figure 6.1, values of
QT are significantly longer throughout most of the physiological range of heart rates,
but with more marked prolongation at slow rates. Correcting QT in a dynamic setting
using one of the many rate correction formulae for QT (eg Bazett's), imposes the
same QT/RR relationship on both populations and therefore would mean an
underestimation ofQT at most rates in patients, particularly during bradycardias.
This prolongation of repolarisation and increased rate dependence is similar to that
seen in patients with heart failure, as demonstrated in the previous chapter. To our
knowledge, this is the first time that such abnormal rate dependence has been shown
in HCM.
Since the discovery of the congenital long QT syndromes, prolongation of
repolarisation has been shown to play a role in various cardiac conditions. Potential
mechanisms for this altered repolarisation and rate dependence could lie in the
cellular handling of calcium. In animal models such as the chronic AV block model
in dogs, there is adaptive hypertrophy in response to bradycardia in order to increase
the stroke volume and maintain cardiac output. HJ Wellens' group have employed
this technique in several projects. After inducing complete atrio-ventricular block in
dogs, they are able to monitor the haemodynamic and electrophysiological changes
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that take place over time in this in-vivo model. They have demonstrated (Vos et al.
1998) that after 6 weeks of chronic A-V block (CAVB) heart weight increased by
more than 50% on average. Action potential was prolonged in both ventricles and
surface QT was prolonged compared to acute AV block. It was easier to induce
Torsades des Pointes ventricular tachycardia (TdP) in these animals. This was further
facilitated by the infusion of the potassium channel blocking agent d-sotalol. In a later
article (Sipido et al. 2000) they describe the cellular changes taking place in the same
model, with particular reference to the cellular handling of calcium. They
demonstrated that in isolated myocytes from the aforementioned CAVB model, cell
shortening, calcium release from the sarcoplasmic reticulum (SR) and SR Ca2+
content were enhanced at low stimulation frequencies. This is an adaptive response to
bradycardia to maintain the cardiac output by increasing the stroke volume. The
frequency response of the calcium currents in these hypertrophied hearts produces a
greater influx of calcium from outside the cell and a greater release of Ca2+ from the
SR at low heart rates. This means a greater net outward current (i.e. maintenance of a
relatively positive membrane potential) during the plateau of the action potential and
therefore prolongation of repolarisation. These findings would appear to be consistent
with the findings of our study, in that we have demonstrated a change in the
repolarisation characteristic in inherited cardiac hypertrophy which results in
prolongation of repolarisation which is more marked at low heart rates, with little
difference at higher rates. These findings corroborate our observation of an increased
separation of the QT/RR curves at slower heart rates, and may implicate abnormal
calcium handling as the causative factor for the repolarisation abnormalities.
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These changes in cellular electrophysiology appear to be indicated in the genesis of
triggered activity mediated arrhythmias due to the potentiation of early after-
depolarisations (EADs) and delayed after-depolarisations (DADs) in this model (Vos
et al. 1998), and are known to be important in clinical cases of congenital or acquired
long QT syndromes. It is possible therefore that the ability to assess the rate
responsiveness ofQT using this method may provide useful prognostic information in
patients with hypertrophic cardiomyopathy.
6.8.2 Increased Variation in The QT-RR Relationship
The finding in our study of an increased mean 24h SD of J indicates that the range of
values of J (which dictate the gradient and shape of the exponential curves) is
increased relative to controls. This in some ways may be indicative of the same
phenomenon described by Atiga et al who elegantly demonstrated mutation specific
changes in the QT-Variability Index (QTVI) (Atiga et al. 2000). In their study, the
degree of variation of QT relative to variations in heart rate was far greater in patients
with HCM mutations considered to be associated with a higher risk of SCD. On top
of this, the coherence between changes in QT and RR was much lower in this same
group. In our study, the patients were similar on symptomatic criteria but we had no
genotypic data to enable us to create subgroups.
6.8.3 Limitations
HCM is defined on the morphological criterion ofmagnitude of LVH. However, a
genetic perspective identifies several hundred, or more, diseases of the cardiac
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sarcomere. In this context, it is important to determine whether the repolarisation
differences demonstrated in papers such as that ofAtiga (Atiga et al. 2000) are related
to SCD irrespective of the mutation present. In other words, are repolarisation
abnormalities predictors of adverse outcome independent of genetic cause. In this
study, the genetic mutations were unknown and the rates of SCD and positive
electrophysiological study were zero. Some of these issues will be dealt with in the
next chapter.
Although the group sizes in this study were of reasonable size, a significant
percentage of patients with HCM were excluded from the analysis due to the quality
of the recordings. Sixty-five percent of unsuitable recordings were excluded because
of noisy recordings that interfere with the automated measurement of Tend- This may
be improved by a better 'hook-up' of electrodes to the patient as many of the patients
put the electrodes on themselves, having been supplied with a pack and instructions.
In addition, there was no ECG monitoring of the T wave morphology or quality of the
signal at the time of hook-up. This was in part due to the fact that the recordings were
taken for assessment of arrhythmias and QT analysis was performed as an 'add-on'
study.
The remaining 35% of subjects were excluded because of the inability of the analyser
to determine the end of the T wave. This can occur with this method if the T waves
are of complex morphology with a biphasic component. The combination of a
prolonged QT interval along with a biphasic wave causes the analyser to open the T
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gate early relative to the end of the T wave. If the ST segment is down-sloping,
followed by a positive T wave, the apex of T will be determined as the junction
between the ST and the upward limb of the T wave as this is a zero slope point (see
chapters 3 and 4 for further explanation). The Tend will subsequently be defined by the
automated algorithm as the point at which the slope of the T wave (on the upward
limb) crosses a threshold and will therefore measure Tapex rather than Tend- The fact
that several subjects with such complex T waves have been excluded may have
introduced bias into the study as one might expect these findings to be associated
with more marked abnormalities of repolarisation. At present, an additional hardware
component is currently under development which will enable the user to define a
'region of interest' window that should enable the blinding of the analyser to all
segments of the T wave apart from the intended segment, namely Tapex to Tend- For
further reassurance, the included and excluded patients will be compared in more in
the next chapter
6.9 Conclusions
This study provides evidence that in patients with hypertrophic cardiomyopathy there
are marked abnormalities of repolarisation, including prolongation of repolarisation
(QT) which is more marked at low heart rates. In addition, there is an increased
variation in the relationship between QT and RR. Although it is dangerous to
extrapolate directly from animal studies, there do appear to be some parallels with
studies that have shown similar changes which have been described as
'electrophysiological remodelling' (Tomaselli and Marban 1999) and go hand-in-
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hand with the adaptive structural changes that enable the heart to contract under
adverse haemodynamic or structural circumstances. These changes are likely to be
implicated in triggered activity mediated arrhythmias and it would therefore seem
appropriate to engage this method in a larger prospective study to assess its ability to
risk stratify these patients.
In the era of implantable defibrillators, which have been shown to be effective in
secondary (and to a lesser extent primary) prevention of SCD in many conditions
including HCM (Maron 2000), the importance of further tools for the (preferably








In the previous chapter we demonstrated significant abnormalities in repolarisation
parameters in an unselected group of patients with HCM relative to healthy controls.
Previous clinical studies designed to assess the risk of SCD in HCM have proposed
several risk factors to stratify these subjects and these are summarised in table 7.1 .
To be clinically useful, a test must be specific, so as not to include a large proportion
of patients who will never have an event, and also sensitive, that is to say that there
will be few people who slip through the net with a negative result yet go on to have
an event. Due to the overall low risk of SCD in HCM, populations must be large and
follow-up protracted to increase our ability to determine risk factors.
One clinical feature that has been shown to be more prominent in groups of patients
with sudden death is the presence of severe left ventricular hypertrophy. The reasons
for this are not immediately apparent. However, if one considers that a greater wall
thickness causes a greater loss of ventricular compliance, a subject may experience
more symptoms attributable to diastolic dysfunction with impaired filling of a stiff
ventricle. This could lead to greater haemodynamic intolerance of tachyarrhythmias,
whether supra-ventricular or ventricular in origin. Another possibility is that the
increased myocardial oxygen demand of the excessively hypertrophied ventricle
results in ischaemia and subsequent arrhythmias or further diastolic and/or systolic
impairment. A third potential explanation could be that the electrophysiological
remodelling associated with myocyte hypertrophy (Tomaselli and Marban 1999,
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Holter recordings were analysed for arrhythmias and all episodes of supraventricular
tachycardia (SVT), non-sustained ventricular tachycardia (NSVT), or VT were
logged. Holter recordings were also analysed for repolarisation behaviour, as
described in previous chapters. Exclusion criteria were as documented in chapter six,
and in total, 32 patients' recordings were analysed in the best available channel for
QT dynamics.
7.4 Results
Statistical Differences between Included and Excluded Patients:
To reduce the possibility of a false positive result due to the exclusion of 50% of
patients' recordings, we compared the MRI data of the patients whose recordings
were excluded with those included by unpaired t-tests. There was a slightly higher
ejection fraction in the excluded group (75% vs 70%, p<0.01) but all other
measurements were comparable, with no statistically significant differences (Table
7.1). This suggests that the patients who were excluded had overall similar
characteristics with a similar degree of severity of disease. It can be seen that there
was a considerable range in the degree of hypertrophy and LV mass. In addition,
there was no difference in the incidence of arrhythmias between the included and
excluded groups (Table 7.3).
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Table 7.2: Clinical and MRI characteristics of HCM patients whose Holter
recordings were included in the analysis compared with those excluded. Data
are expressed as mean 24h values ± SD (range)
Included Excluded P value
(n=31) (n=29)
Age 38 ± 9 (46) 40 ± 11 (33) 0.73
BSA (kg/m2) 2.02 ±0.22 1.920+0.15 0.06
SV (ml) 88+30 (139) 75+19 (84) 0.03
EDV (ml) 115+37 (166) 107+27 (104) 0.15
LV mass (g) 230+101 (413) 204+75 (286) 0.12
LV mass index (g/m2) 112+41 (151) 106+39 (171) 0.28
Max end systolic thickness 32.1+6.7 (23) 32.4+5.9 (25) 0.42
(mm
Max end diastolic thickness 26.1+5.8 (22) 26.5+4.6 (20) 0.38
(mm)
Relationship between Arrhythmias and QT Analyses:
Results of the Holter arrhythmia analyses are laid out in table 7.3. On Holter analysis,
the presence of non-sustained VT and SVT (>3 beats) was commonplace and present
in almost 30% of subjects. None had atrial fibrillation. As the presence ofNSVT and
LV wall thickness have both been proposed as independent risk factors for SCD, we
compared the patients with and without NSVT, in terms of both the MRI data and the
QT data(Figs 7.1 A-C). There was no significant difference between the groups in
either MRI measurements or QT analysis. Mean values and significance levels are set
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out in table 7.4. Equally there were no differences seen in any of the MRI
measurements in those patients with NSVT and those without.





AF 0/ 31 (0%) 0/29 (0%)
SVT (>3 beats) 8/ 31 (26%) 9/29 (31%)
Non-sustained VT (>3
beats)
9/ 31 (29%) 8/29 (28%)






QTo (ms) 454 (24.5) 459 (33) COoiiQ.
J 0.41 (0.08) 0.41 (0.09) p =0.97
24h SD of J 0.16 (0.43) 0.19 (0.23) p = 0.88
Ejection fraction (%) 72 (7) 74 (6.3) p = 0.33
Stroke Volume 77 (21) 90 (32) p = 0.07
End diastolic volume (ml) 107 (27) 121 (38) p = 0.11
End systolic volume (ml) 29.6 (11) 30.7 (11) p = 0.71
















Relationship between QT Analyses and MRI Data:
Having established that the presence ofNSVT on Holter in this group is relatively
commonplace, and that there do not appear to be differences in other parameters in
those with NSVT, we compared the MRI data with the results of the 24h QT-RR
analysis. There was a strong and statistically significant relationship between the
mean 24h value ofQTo and the MRI assessment of LV average mass (r = 0.52, p <
0.005) and LV mass index (r = 0.49, p < 0.01). A relationship was also present,
although less strong, for maximum end systolic thickness (r = 0.39, p < 0.05).
Statistical significance was not reached for end diastolic maximum thickness (r = 0.2,
p = 0.27). The correlation plots are shown in figures 7.2 (A - C).
No significant relationship was demonstrated between the exponent J and the MRI
data. In light of a recent post-mortem study (Varnava et al. 2000) which demonstrated
a significant inverse relationship between heart mass and age of death, we compared
the MRI data with age and found no correlation.
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Figure 7.1 A
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7.5.1 Comparison of subjects with and without Non-sustained ventricular
tachycardia on Holter monitoring.
No difference was observed between any of the 24h QT-RR when patients were
divided according to the presence ofNSVT on 24 or 48h Holter monitoring. This is in
keeping with the previous studies of risk factors in HCM which have shown that the
presence ofNSVT is seen in up to 50% (Fananapazir et al. 1992). In Fananapazir's
article, they demonstrated that it was present in only 41% of patients who had a
cardiac arrest. Of 115 patients with NSVT on Holter, 10% had a cardiac event
compared with 5 of 155 patients without VT on Holter (4%). Only when patients had
experienced episodes of pre-syncope did the presence ofNSVT carry any prognostic
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information. In our small study, it is not surprising that there is no apparent difference
between the two groups in light of the existing evidence on the frequency of
occurrence ofNSVT in these subjects.
7.5.2 Comparison of QT data with MRI Findings
Magnetic resonance imaging was employed to assess left-ventricular dimensions and
mass in this study as it has been shown to be more accurate and reproducible than
methods employing two-dimensional echocardiography in several patient groups
including dilated and hypertrophic cardiomyopathy, hypertension and athletic hearts
(Bellenger et al. 2000, Allison et al. 1993, Bottini et al. 1995, Pons-Llado et al. 1997,
Pluim et al. 1997, Chuang et al. 2000). There is the additional advantage that high
quality images can be obtained in many more patients than could be expected with
echo (Bellenger et al. 2000b).
Calculating each individual's mean 24h 'rate corrected' QT (QTo) by continuous
assessment of the QT/RR relationship using Neilson's variable exponential model
has allowed us to compare cardiac repolarisation characteristics independently of
heart rate with measurements of hypertrophy.
A strong correlation is seen between QTo and both LV average mass and LV mass
index. This suggests that the 'electrophysiological remodelling' seen in hypertrophic
heart disease is a progressive phenomenon that occurs either in response to, or as a
direct compensatory mechanism of impaired sarcomeric function. Spirito and Maron
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have published two large scale studies on the association between hypertrophy and
sudden cardiac death. In the earlier of the two (Spirito and Maron 1990) which was a
retrospective study, they demonstrated that the HCM patient group which had died
suddenly was more likely to exhibit marked left ventricular hypertrophy than the
control group ofHCM patients who had not. Maximal LV wall thickness was greater
(26±7mm vs 21±5mm). A more discriminating measurement however was the left
ventricular wall thickness index (LVWTI). This was calculated by dividing the
ventricle into four segments and adding the wall thicknesses together to reflect the
degree of overall hypertrophy. The SCD group had a higher LVWTI (76 ± 20mm)
compared to the control group (62 ± 13 mm). Particularly marked and diffuse
hypertrophy with a maximum wall thickness of > 30mm or > 25mm in two or more
segments was eight times more common in patients with SCD. A few patients with
SCD had less marked hypertrophy (4/29), although three of these were pre-adolescent
children and they remark that the hypertrophy would have been more marked had
they corrected the values for body weight. The patients in this study were all
relatively asymptomatic (NYHA I to II), similar to our own group.
In the more recent article, Spirito et al published the results of a long-term follow-up
study of patients with HCM (Spirito et al. 2000). Of 480 patients followed over a
mean of 6.5 years, 65 patients died (14%), 23 suddenly, 15 of heart failure and 27 of
non-cardiac disease or stroke. The risk of SCD increased progressively and in direct
relation to wall thickness. Risk ranged from 0 per 1000 person years for a LVMWT
of 19mm or less, to 18.2 per 1000 patient years for wall thicknesses of 30mm or
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more. Left ventricular wall thickness index (see previous paper) was not measured in
these subjects. The recent article by Varnava et al (Varnava et al. 2000) which
examined hearts of patients with HCM who had died, they found a significant
negative inverse relationship between age and heart weight, implying that patients are
likely to die younger if gross hypertrophy is present.
7.6 Conclusions
The measurement of 24h repolarisation dynamics, with extrapolation of the QT/RR
curves to give mean 24h values ofQTo has provided valuable information regarding
the nature of the electrophysiological remodelling in HCM. The QT (and by inference
the action potential) prolongation in HCM appears to progress with the degree of
hypertrophy. The findings in our study support a potential causative role of abnormal
repolarisation in the sudden death due to massive hypertrophy. From the MRI data a
closer correlation was found between left ventricular average mass and LV mass
index than the maximum left-ventricular wall thickness. It may be that the MRI
assessment of LV mass or LVMI may provide more useful information for risk
stratification than echocardiographic parameters. A prospective study to assess the
value of 24h dynamic QT-RR and MRI assessment of patients is necessary to
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Sympathetic activity is known to be arrhythmogenie in many clinical and
experimental situations. Indications for the use of (3-blockers have broadened in
recent years due to the increasing evidence supporting their use in the management of
patients with heart failure. Several large studies have shown a marked reduction in all
cause mortality, sudden cardiac death, worsening of heart failure and hospital
admissions (Merit-HF, CIBIS II, COPERNICUS). One of the most striking
reductions in mortality is in the subgroup of sudden cardiac death. In all of the major
trials of beta-blockade in heart failure there is a 40-50% reduction in the incidence in
sudden death. This appears to be largely due to a reduction in arrhythmic death. There
is also evidence that P-blockers reduce the incidence of sudden death in patients
following myocardial infarction (Olsson and Wikstrand and Warnold 1992) and
hypertensive patients.
The mechanisms for catecholamine induced cardiac arrest are numerous, including
ischemia and infarction, macro-reentrant arrhythmias and ventricular fibrillation.
Given that the likelihood of triggered activity is increased in patients with
prolongation of the QT interval, and having demonstrated that patients with
hypertrophic cardiomyopathy and heart failure have prolongation ofQTo and J
(chapters 4,5,6), we evaluated 24h Holter recordings from a group of patients who
had survived out of hospital cardiac arrest (OHCA) and had received implantable
146
cardioverter defibrillators (ICDs) for secondary prevention. We compared patients
who were taking p-blockers with those who were in order to assess whether
differences existed in the QT/RR relationship.
8. 2 Hypotheses
In chapter four we examined the repolarisation characteristics of a group of patients
with heart failure who were subsequently divided into NYHA classes. We
demonstrated a progressive prolongation in QTo and an increase in J with worsening
functional class. We hypothesised that the increase in J may have been due to an
increase in the sympathetic tone. In this study we set out from that hypothesis to
study this heterogeneous group of patients who have varying degrees of heart failure
and reduced ejection fractions. The goal was to determine whether those subjects on
beta-blocker therapy have increased values ofQTo (as one would expect as
sympathetic stimulation shortens APD and QT), but also a reduction in J which
should be a rate-independent marker of the rate dependence ofQT, in contrast to
slope.
8.3 Subjects and Methods
123 patients who were under follow up for their ICD at the Royal Infirmary of
Edinburgh (n=20) or Glasgow Royal Infirmary (n=103) were enrolled into the study.
Note was taken of their diagnosis, past medical history, ejection fraction as
determined by angiography, echocardiography or radio-nucleide methods, medication
at the time of enrolment and an assessment of their functional (NYHA) class was
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made. Baseline resting ECG recordings were taken on all patients. All patients had
been stable on therapy for at least one month. All patients had ambulatory 24h ECG
recordings made at the time of enrolment. Exclusion criteria were: 1) Bundle branch
block or QRS duration > 0.14s; 2) Background bradycardia pacing; 3) Atrial
fibrillation or frequent (>5%) ectopic beats; 4) Regular medication of amiodarone or
sotalol.
A total of eighty-three 24h ECG recordings were made, ofwhich forty-one were of
sufficient quality for QT and RR interval analysis. 24h QT/RR parameters for
individuals which were then averaged for the two groups. The groups were compared
using student's unpaired t-test.
8.4 Results
8.4.1 Baseline characteristics
Baseline characteristics of the two groups are given in table 8.1. The significance
continuous data was assessed by t-test, and categorical data by % testing.
Patients were well matched for age, sex, ejection fraction and NYHA class. Although
the two groups contained subjects with heterogeneous aetiologies for their
arrhythmias, these were balanced between the two groups
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Table 8.1: Baseline characteristics of ICD patients divided into two groups







Sex (m/f/total) 20 /5 / 25 15/1/16 NS
Age 56 54 NS
Ejection 31% 29% NS
fraction
NYHA Class 1.6±0.7 1.8±0.7 NS
Previous Ml 17/25 (68%) 13/16 (81%) NS
Primary VF 3/25 (12%) 1/16 (6.3%) NS
HCM 1/25 (4%) 1/16 (4%) NS
ARVD 2/25 (8%) 1/16 (6.3%) NS
Table 8.2: 24h QT-RR Characteristics. Data are mean 24h values (SD)
RR QT QTo S J 24h SD
of J
NBB 885 (102) 417 (36) 448 (31) 0.18 0.38 0.114
n = 25 (0.05) (0.10) (0.036)
BB 1005 452 (44) 461 (35) 0.15 0.31 0.151
n = 16 (131) (0.06) (0.13) (0.088)
P <0.01 <0.01 0.2 0.06 <0.05 0.6
value
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8.4.2 24h QT-RR Characteristics
As expected, the group taking p-blockers had a slower heart rate, as indicated by the
longer mean 24h RR interval (1005ms vs 886ms, p<0.005) with a correspondingly
longer mean 24h QT (452ms vs 417ms, p<0.01). When both groups are compared
with the control group in chapter 5 (heart failure) it can be seen that QTo is longer
and J is greater in this group compared to healthy volunteers. The abnormalities are
less marked than the group of patients with heart failure, but the degree of LV
impairment was more marked and the functional class worse in that group.
The average mean 24h QTo (QT at an RR interval of 1000ms) was not significantly
different (461ms vs 448ms, p=NS) between the BB and NBB groups. When the mean
slopes are compared between the two groups, it was significantly shallower in the BB
group (0.149 vs 0.186, p<0.05), however this parameter is rate dependent as the
QT/RR relationship is described by an exponential curve and is less steep at low heart
rates. The exponent J which describes the shape and gradient of the QT/RR
relationship was also reduced in the P-blocker group (0.379 vs 0.313, p<0.05),
indicating that overall, the curve in the group taking these agents was indeed less
steep (see figure 8.1) throughout the physiological range of heart rates. The variation
in the QT/RR relationship (indicated by the mean 24h SD of J) was slightly greater in
the group on P-blockers (p=NS).
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Constructed QT/RR curves from grouped population values of mean 24h
QTo and J. It can be seen that the patients on p-blockers tend to have a
flatter curve with less shortening of QT at higher heart rates and overall tend
to have a slightly longer QT interval.
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8.5 Discussion
The influence of the sympathetic nervous system on cardiac repolarisation has been
studied in the past using several different approaches. Due to the blunting effects of
beta-blockade on heart rate, it is often difficult to make comparisons. In pacing
studies it has been possible to show that incremental atrial or ventricular pacing
produces less shortening of the QT interval than exercising to similar rates. Also, (3-
blockade reduces the exercise induced shortening of the QT interval for any given
heart rate (Fananapazir and Bennett and Faragher 1983). In patients with autonomic
neuropathy or denervated (transplanted) hearts, there is less diurnal variation in QTc
than one sees in health (Bexton and Vallin and Camm 1986). However, these studies
used linear models of the QT-RR relationship and were performed in patients who by
and large had normal left ventricular function.
This study, although not a prospective study, appears to indicate that the rate
dependence of the QT interval is indeed reduced in the group of patients on P-
blockers. The two groups were well matched for age, sex, left-ventricular function
and functional class and these factors which have been shown to influence the QT
interval are therefore unlikely to have skewed the results.
The mechanisms through which the sympathetic nervous system can precipitate
arrhythmias have been extensively studied (Malliani and Schwartz and Zanchetti
1980) and beta blockers have been shown to prevent this (Schwartz et al. 1985). In
patients with the congenital long QT syndrome, left cervical stellectomy was an
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accepted treatment (Schwartz et al. 1991). This surgical treatment has been shown to
increase the ventricular fibrillation threshold in animals susceptible to arrhythmias
(Schwartz and Stone and Brown 1976, Schwartz and Stone 1980). More recently, the
use of p-blockers in association with the implantable defibrillator has become more
accepted.
The role of P-blockers in prevention of SCD in man has been established in the post-
myocardial infarction population for many years (Chadda et al. 1986). More recently,
a beneficial effect in terms ofmortality due to worsening of heart failure or SCD has
also been shown in patients with ischaemic or idiopathic cardiomyopathy (CIBIS-II
Investigators and Committees 1997, Merit-HF Study Group 1999). Much of this
reduction in mortality is due to a reduction in SCD, a feature that has not been shown
to exist with established agents such angiotensin converting enzyme inhibitors
(ACEI) or angiotensin II antagonists (AHA) (Garg and Yusuf 1995,The SOLVD
Investigators 1991, ELITE II).
One of the interesting observations in our study is that p-blockers tended to produce a
rate-independent lengthening ofQT (although not statistically significant), but what
was more marked was the reduction in the rate dependence, indicated by the lower
slope of the curve throughout most of the physiological range, reflected by the lower
value of J (see figure 8.1). It may be that this reduced rate dependence may be
prolonging the refractoriness of the ventricle at higher heart rates, making it more
difficult for re-entrant circuits to be activated and maintained (reduced excitable gap).
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Secondly, increased sympathetic activity has been shown to increase the propensity to
delayed afiter-depolarisations and triggered arrhythmias. Thirdly, heart rate will not
accelerate with sympathetic activation, reducing the ischaemic burden which can
create regional variations in refractoriness.
If repolarisation is important in arrhythmogenesis in heart failure and other conditions
(Tomaselli et al. 1994), we must conclude from these results that it is not purely a
lengthening ofQT that is critical, as this occurs in healthy subjects when sleeping
(Browne et al. 1983). In previous chapters we questioned the relevance of quoting a
value of corrected QT at an arbitrarily chosen reference heart rate if the overall
characteristic of the QT-RR relationship differs between the two groups. This study
would appear to underline those comments as here we see a normal or slightly
increased QT at an RR interval of one second in the group likely to be more protected
against arrhythmias, but a flatter response to changes in RR when patients are on P-
blockers. This raises the question of whether the slope or shape of the QT/RR curve is
more important in the risk of arrhythmias due to abnormal repolarisation.
8.6 Limitations
The patients in this study had varying aetiologies for ventricular arrhythmias. The
majority of patients had a history of previous myocardial infarction and resuscitated
out-of-hospital cardiac arrest. The arrhythmia responsible for the index events varied
from ventricular to polymorphic VT and VF. The substrate for these arrhythmias
differs, with VT usually being due to a macro re-entrant circuit involving the border-
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zone of an old infarct site. To initiate and maintain VT in this situation requires two
conditions: a suitably timed ectopic beat and; secondly unidirectional block or slowed
conduction in one of the limbs of the circuit. Ventricular fibrillation is often a result
of degeneration of the re-entrant circuit but can arise directly from the ectopic beat in
unstable situations. It is not clear whether the influence of repolarisation in both these
situations is likely to produce the same results. While one might expect prolongation
of repolarisation to generate more ectopy due to early or delayed after-
depolarisations, a prolongation of the refractory period can in certain situations be
anti-arrhythmic, and this forms the basis for many of the anti-arrhythmic agents in
use today. In cases of ventricular tachycardia, prolongation of refractoriness may
produce prolonged refractoriness in one limb and render the arrhythmia non-
inducible.
The patients in this group were divided according to whether they had been on
chronic therapy at stable dosages for one month. While this has the advantage of
increasing the likelihood of steady-state plasma levels (assuming 100% compliance),
it increases the risk that the observations are chance findings and that the differences
observed are due to population differences. Fortunately the groups were well matched
for several factors known to influence repolarisation and this is therefore less likely,
however, a prospective study with assessment of repolarisation before and after beta-
blockade would have been more valuable.
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The spatial dispersion of repolarisation is known to be important in increasing the
likelihood of initiation and maintenance of ventricular arrhythmias and measurement
ofQT dispersion has shown that in many groups at risk of sudden death the spread of
surface QT intervals is greater. Using 24h Holter recordings restricts our ability to
comment on this.
8.7 Conclusions
Long-term treatment with (3-blockers appears to result in a reduced rate dependence
ofQT. There are theoretical reasons why this might be advantageous for preventing
arrhythmias in patients with impaired ventricles or a history of aborted sudden
cardiac death. Further research is required to assess whether increases in the rate
dependence of QT can be implicated in the onset of arrhythmias.
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Chapter 9
Circadian Variation in the incidence of
Sustained and Non-Sustained




Sudden cardiac death is generally defined as an unexpected cardiac death preceded by
no apparent symptoms or by symptoms with a duration of less than one hour. In the
United States 300,000 cases of SCD occur each year (Kuller 1980). Most cases of
SCD are caused by ventricular fibrillation, often preceded by ventricular tachycardia
(Schaffer and Cobb 1975, Pratt and Francis and Luck 1983). Eighty percent of SCD
occurs in association with coronary artery disease (CAD). A healed myocardial
infarction is a frequent post-mortem finding, although acute myocardial infarction is
less common (Reichenbach and Moss and Meyer 1977). Most of the remaining 20%
of patients have one of the cardiomyopathies although sudden death is sometimes
seen in subjects with no evidence of structural heart disease.
Unfortunately, despite increased resuscitation training amongst the public and health¬
care professionals and the wider availability of semi-automatic defibrillators for
ambulance teams (and even automatic defibrillators in public places), the mortality
remains high. In recent years, internal implantable cardioverter-defibrillators (ICDs)
have been shown to be effective in improving survival in high risk patients (e.g.
cardiac arrest survivors) when compared to treatment with amiodarone or EP guided
anti-arrhythmic therapy (Anderson et al 1997 (AVID), Connolly et al 2000 (CIDS),
Wever et al 1995). In addition, ICDs have been shown to dramatically improve
survival in selected post-MI patients (Buxton et al 1999 (MUSTT), Moss et al 1996)
(MADIT), Moss et al 2002 (MADIT II) ), albeit at substantial cost, estimated at
$22,800 per life-year saved (Mushlin et al 1998)
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9.1.2 Circadian Variation of SCD
There is significant circadian variation in the frequency of sudden death with a
relative excess during the morning. It is frequently difficult to determine whether the
cause of death is a primary arrhythmia or secondary to another event such as acute
myocardial infarction, which is thought to account for a third of SCD. In 1987 results
of the prospective Framingham Heart Study (Willich et al. 1987) helped to resolve
this problem. They analysed data on the time of death of 264 definite sudden cardiac
deaths. This showed that there was a peak prevalence of death in the morning, which
started to fall by 10 am. Even when additional cases of sudden death ofpossible
cardiac cause were included, this peak remained. As the investigators wished to
clarify whether there was a morning excess of sudden cardiac deaths independent of
the morning excess of myocardial infarctions, they compared data from a previous
study (Muller et al. 1985) which described the circadian variation ofmyocardial
infarction in a similar population. Using this data they subtracted the estimated hourly
incidence of death due to myocardial infarction from their own data, with the
assumption that only those subjects with primary SCD remained. Following this
manipulation, a striking morning peak is seen, beginning between 7 am and 8 am,
peaking at around 9am and falling back to baseline levels after around 10 am. The
average hourly risk of SCD was 70% greater between 7am and 9am relative to the
remaining 22 hours. There were several problems with this study - firstly one of
identifying all cases of SCD in a population, and secondly of determining the exact
time of occurrence ofwhat may be an unwitnessed event with the absence of a
retrospective history. The conclusion of the study was that the early morning is a
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high-risk period for subjects prone to arrhythmia, even in the absence of a history of
arrhythmia.
The implantable cardioverter defibrillator (ICD) is one of the most ingenious
advances in medical technology of the last century. These devices, from the first
implant in the early 1980s, have become small enough to implant subcutaneously,
with transvenous insertion ofmonitoring and defibrillating leads. The latest devices
are now far smaller than early pacemakers, yet have the capability to continuously
monitor the rhythm in both atrium and ventricle, store local electrograms (EGMs) and
appropriately deliver therapies to terminate arrhythmias in a precise and timely
fashion over a lifespan of several years. One of the advantages of the more modern
devices is that the stored event data allows one to determine the precise nature, timing
and frequency of arrhythmias, and with the additional EGM traces, determine
whether the arrhythmia was supraventricular or ventricular in origin, enabling simpler
reprogramming and avoidance of inappropriate therapies. This chapter assesses the
circadian variation of ventricular arrhythmias in a cohort of 123 patients with ICDs
under follow-up in Scotland. The purpose is to determine whether an arrhythmia
'danger period' exists in survivors of previous SCD. If this is the case, then it would
urge closer scrutiny of events and circumstances at that time of day. In the case ofmy




The principal hypothesis in this chapter is that primary sustained ventricular
arrhythmias exhibit circadian variation in cardiac arrest survivors with implantable
defibrillator devices. In addition we compare the timing of sustained ventricular
arrhythmias with non-sustained arrhythmias, to establish whether their distributions
vary. To assess whether any observed circadian variation was influenced by increased
sympathetic activity, we divided patients into two groups according to whether they
were established on regular beta-blocker therapy.
9.3 Method
One hundred and twenty three consecutive patients (24 female) were recruited into
the study between June 1999 and March 2000. This represented approximately sixty
percent of the Scottish ICD population at the start of the recruitment period. The
conditions responsible for the arrhythmias were various, although in the majority,
coronary artery disease (CAD) was the primary diagnosis. One patient had received a
device for primary prevention on the grounds of perceived high risk of sudden cardiac
death due to familial hypertrophic cardiomyopathy, with several family members
having died suddenly. At the time of recruitment, a record was made of past cardiac
and other history, medication, LV ejection fraction (by radio-nucleide,
echocardiography or angiographic methods), standard 12 lead F.CG and estimation of
NYHA class. Every patient was seen for routine device interrogation at quarterly
intervals. The mean follow up was 12 +/- 2 months. Patients were divided into two
groups according to whether or not they were taking beta-blockers (BB). Episodes of
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non-sustained ventricular tachycardia (NSVT) and sustained ventricular tachycardia
or ventricular fibrillation (VT/VF) recorded by the devices were documented. Supra¬
ventricular arrhythmias such as atrial fibrillation, sinus tachycardia or re-entrant
SVTs were excluded where possible using the stored information and previously
obtained patient data regarding the nature of their clinical arrhythmia. Where the
timing of events was available, this was documented. Events were classified as NSVT
or VT/VF by the defibrillators' internal algorithms. Episodes logged by the devices
were considered discrete when separated by more than ten minutes. The significance
of variation in the hourly distribution of arrhythmias was assessed by Chi-squared
test.
9.4 Results
Patients were followed up for a mean period of 12 months (+1-2 months). Overall,
during this period, 43 (35%) patients had ventricular arrhythmias requiring therapy
from the ICD, and non-sustained VT (NSVT) was recorded in 56 patients (46%). 43
patients were taking regular beta-blocker therapy. None of the episodes occurred in
the context of a history consistent with myocardial infarction. Fourteen patients
(11.4%) received therapy inappropriately (usually in the form ofDC shocks). These
inappropriate therapies were principally due to the misinterpretation of sinus rhythm
in younger patients, or due to atrial fibrillation with a rapid ventricular response rate.
There was considerable overlap between the groups, as demonstrated in the Venn
diagram (figure 9.1). The breakdown of the diagnostic groups, and incidence of
arrhythmias is laid out in table 9.1 below. 43 patients were taking regular beta-
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blockers. In this group, 51% of patients had episodes of non-sustained VT, and 33%
had episodes of VT/VF compared to 34% and 37% in the group not taking beta-
blockers.
Impact of Beta-blockade on the Circadian Variation ofArrhythmias
Timing data was available for 151 episodes ofVT/VF and 1402 episodes ofNSVT.
Timing of arrhythmias was broken down into hourly intervals, and the significance of
circadian variation was calculated using Chi-squared testing. For both NSVT and
VT/VF, there was no significant circadian variation in those patients on BB (p=0.72,
0.74 respectively). In those not on BB, there was again no significant variation in the
hourly incidence ofNSVT (p=0.42). However, there was a large peak in the
incidence ofVT/VF between 0900h and lOOOh, and the circadian variation was
highly significant (p<0.0001). These data are represented graphically in figures 9.2
and 9.3.).
Figure 9.1: Venn diagram illustrating the number of patients experiencing
arrhythmias during follow-up. The overlap between groups is most marked for those




Table 9.1 Breakdown of patient characteristics according to primary
diagnosis. The group with ischaemic heart disease contains those with
previous myocardial infarction, with or without subsequent LV impairment,
and also those subjects with CAD felt to be inoperable with a probable




Dilated Cardiomyopathy 7 (9%) 5 (11%)
HCM 2 (2.6%) 3 (6.4%)
Arrhythmogenic RV 2 (4.3%) 2 (2.6%)
Dysplasia (ARVD)
Long QT Syndrome 2 (4.3%) 1 (1.3%)
Idiopathic VTA/F 2 (4.3%) 11 (14%)
Ischaemic heart disease 52 (68%) 34 (72%)
No. of patients with VTA/F 27 (34%) 16 (37%)
No of patients with NSVT 41 (51%) 15 (34%)
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Figure 9.2
Graphical representation of the absolute number of episodes of NSVT by
hour of the day. The patients have been divided into two groups according to
whether or not they were taking beta-blockers. Data for both groups
combined is also shown.
Ml imher of Eoisodes of NSVT by Hour of the Day




Graphical representation of the absolute number of episodes of VTA/F by
hour of the day. The patients have been divided into two groups according to
whether or not they were taking beta-blockers. Data for both groups
combined is also shown.




In studying this population of patients with ICDs, and by making use of the event
recording capabilities of these devices, it has been possible to demonstrate a
significant circadian variation in the incidence of sustained ventricular arrhythmias,
relative to both expected values, and non-sustained arrhythmias. However, no
significant variation was seen in the incidence of non-sustained arrhythmias relative
to the expected values. This confirms the findings of the Framingham paper and
others which have shown that there is a morning excess of cardiac arrests and SCD. It
has the advantage however that the effective treatment of the arrhythmias by either
anti-tachycardia pacing or internal DC cardioversion, and the subsequent
interrogation of the EGM data and patient history, we have effectively removed the
confounding factor of events caused by myocardial infarction which account for a
third of cases of SCD in most studies. One limitation however is that ICDs do not
generally store all EGM recordings ofNSVT, and it is possible that some episodes of
supraventricular arrhythmias may have been counted as ventricular. However, many
devices have algorithms that assist differentiation of ventricular and supraventricular
arrhythmias, and with dual chamber devices, this is clearly less of a problem. It is
therefore difficult to be absolutely certain that all logged non-sustained events were
truly ventricular in origin.
By examining the hourly incidence of arrhythmias in patients according to whether
they are beta-blocked, we have been able to show that the morning excess of
malignant arrhythmias is not present when sympathetic activity is blocked. This
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strongly implicates increased adrenergic activity as a factor facilitating if not being
primarily responsible for the increased incidence ofmorning arrhythmias. It is
perhaps not surprising that a significant difference exists between the distribution of
sustained VT/VF and NSVT, the former showing a large morning peak, whereas
NSVT was more evenly distributed throughout the 24h period (although there do
appear to be more non-sustained arrhythmias during the day with respect to night¬
time). This suggests that short bursts of tachycardia are commonly seen, but that in
the morning, additional factors conspire to facilitate the maintenance of arrhythmias.
During sleep there is a relatively higher level of parasympathetic tone, with reduced
sympathetic activity. It is well known that vagal activity increases the threshold for
ventricular fibrillation and is generally considered to be cardioprotective. On rising in
the morning, the balance swings toward increased sympathetic activity and
withdrawal of vagal tone. Levels of circulating factors including catecholamines and
corticosteroids also increase. Previous studies in patients with ischaemic heart disease
and heart failure have shown that reduced heart rate variability, a surrogate marker of
increased sympathetic and reduced parasympathetic activity, is a risk factor for
increased mortality. P-blockers reduce the incidence of SCD in the post-MI
population and those with heart failure, again pointing towards increased sympathetic
tone as the arrhythmogenic factor. In the electrophysiology laboratory, isoprenaline, a
P-agonist, is used to enable the initiation of both supra-ventricular and ventricular
arrhythmias. It is likely therefore, that this increase in sympathetic activity in the
morning is responsible for the excess of events.
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Given that sympathetic activity is known to influence cardiac repolarisation, and
therefore the QT interval, it is possible that these patients, the majority ofwhom have
structural heart disease, exhibit an abnormal increase in sympathetic activity in the
early morning. Yi et al (Yi et al. 1999) studied QT dynamics in patients with and
without SCD following myocardial infarction and compared the grouped hourly
values ofQT/RR slopes and extrapolated QT intervals at a standardised heart-rate of
one second. They demonstrated increased mean hourly QT/RR slopes and relatively
prolonged QT intervals in the SCD victims relative to both the MI survivors and the
normal controls.
Our data would appear to support the influence of sympathetic activity as being
responsible for the morning excess ofVT and VF, as the morning peak is not seen in
those subjects on beta-blockers. Assessment of the short term changes in early
morning QT/RR dynamics is necessary to assess whether abnormal changes occur
during this 'dangerous' time of the day.
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Chapter 10
Short Term Changes In The
Continuously Assessed Early Morning
QT/RR Relationship In Cardiac Arrest




In the previous chapter a clear circadian variation in the incidence of sustained
ventricular tachyarrhythmias relative to non-sustained VT was elicited in a group of
patients with implantable cardioverter defibrillators. When the subjects were divided
into two groups according to whether they were taking beta-blockers, a morning
excess of arrhythmias was seen only in those subjects not on beta-blockers.
Having demonstrated in earlier chapters that the repolarisation abnormalities in heart
failure and hypertrophy are abnormal and progressive, and that chronic beta blockade
has a beneficial influence over the rate dependence of QT, we hypothesised that there
may be short term repolarisation abnormalities in the morning during the transition
period from sleep to becoming ambulant.
It is well known that the 'corrected' QT (QTc) interval is longer during the night, and
that this is due to the influence of the autonomic nervous system (Bexton and Vallin
and Camm 1986). Beta-blockers have been shown to reduce the rate dependence of
QT and also to prolong the QT interval slightly (Merri et al. 1992).
Due to the problems associated with hysteresis and QT adaptation lag, which have
been discussed at length in previous chapters, it has proved difficult to obtain
accurate assessments of the short term changes that occur at specific intervals, such as
those preceding arrhythmias, or in this case, on awakening. In this chapter, using data
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collected from the ICD group in the previous chapter, we assess the short-term
changes in QT relative to heart rate and compare them to healthy controls.
10.2 Hypotheses
The primary hypothesis is that changes in the relationship between the QT interval
and heart rate occur in the early waking hours in patients with a history of ventricular
arrhythmias. These abnormalities are likely to be sympathetically mediated and
therefore attenuated by beta-blockade. This information may provide insights into the
mechanisms of arrhythmogenesis with particular reference to cardiac repolarisation.
10.3 Subjects and Method
Patients recruited into the study in the previous chapter underwent 24h ambulatory
ECG recordings. Standard exclusion criteria for QT interval analysis were applied,
namely the presence of conduction abnormalities, the presence of bradycardia pacing,
atrial fibrillation and very frequent ventricular ectopics. A total of eighty-three 24h
recordings were made, ofwhich forty-one were suitable for continuous assessment of
the QT/RR relationship. Where recordings were commenced / terminated during the
period of interest, data was considered to be circular and continuous (Yi et al. 1999).
Recordings from 20 age and sex matched healthy controls were also assessed for
comparison. The ICD patients were divided into two sub-groups according to whether
they were taking chronic beta-blocking therapy (BB). The characteristics of the ICD
patients are laid out in table 10.1.
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Table 10.1: Patient Characteristics
Values are means (SD).
ICD patients ICD Patients ([3-
(no p-blockers) blockers)
n=25 n=16
Age 56 (14) 55 (12)
Sex 4 female 2 female
Previous myocardial 68% 81%
infarct
Primary arrhythmia 11% 0%
ARVD/HCM/DCM 12% 20%
Ejection fraction 29% (16%) 31% (16%)
NYHA class 1.6 (0.7) 1.8 (0.7)
Amiodarone 4/25 2/16
10.2.1 Method for assessment of dynamic changes in the QT/RR relationship
The recordings were analysed using the previously described method for dynamic
assessment of the QT/RR relationship. From the 24h graphic display of the
continuously measured parameters, the time of patients' waking was determined as
the point at which the RR interval was seen to decrease in the morning, which usually
occurred between 0700h and 0800h. The timing of baseline measurements was 30
minutes prior to this point. From studying 24h printouts ofQT and RR' data, it
appeared that the changes in the repolarisation characteristics took place within the
first 90-120 minutes after waking, and then reached a new steady state about one hour
after this. For this reason, and taking into consideration the peak incidence of
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arrhythmias between 9 and 10 am (roughly one to two hours after most people rise),
values ofRR, QTo, slope and J were then measured with on-screen callipers at
baseline (30 minutes prior to waking), two hours after this to give a peak value and a
further two hours later. This gave a total of three points which were felt to suitably
cover the period when an excess of arrhythmic events occurred in the previous
chapter. All measurements were performed by an observer blinded to patient group
and medical therapy. Absolute values ofRR, QT, Slope and J were compared
between the three time points and also between the groups by unpaired t-tests. QT/RR




The healthy volunteers showed a significantly longer RR interval than the ICD
patients, irrespective of whether they were taking (3-blockers or not. The p-blocker
subgroup had a longer RR interval than those not on this medication. During sleep the
patient groups had relative prolongation ofQTo. The use of P-blockers did not appear
to produce any further lengthening ofQTo, perhaps due to lower sympathetic activity
during sleep. There was no significant difference in either slope or J between any of
the three groups during sleep. In summary, this would appear to indicate that although
repolarisation is prolonged in the group of patients with a history of cardiac arrest,
there was no difference in the rate dependence of repolarisation.
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10.4.2 Waking hour repolarisation characteristics
The absolute values of the parameters and the relative changes were compared
separately. On waking, all subjects showed a decrease in the RR interval. This was
most marked in the healthy volunteers. Patients on beta-blockers showed a reduced
shortening of the RR interval relative to those not (-255 vs -393 ms, p<0.005). There
was a paradoxical lengthening ofQTo in both the ICD groups, although this was most
marked in the group not taking p-blockers compared with a shortening ofQTo in the
healthy volunteers (+31 vs -10 ms, p=0.01). The group on p-blockers showed a small
but significant increase relative to the healthy volunteers (+5ms vs -10 ms).
10.4.3 Two-hour control period
In all three groups, RR interval increased, indicating a slowing of heart rate after the
initial early morning peak. QTo shortened further in the HV group (-10ms) . Both
ICD groups showed a shortening ofQTo. S and J returned towards nocturnal values
during this period.
The described differences between groups and time points are laid out in tables 10.2
and 10.3 below. The absolute values ofRR, QTo, Slope and J at each time point are




parameters in the QT-
RR relationship at the
three time-points.
Significant differences
are indicated in bold.
Both patient groups
Absolute changes in
the parameters of the
QT-RR relationship.
Delta 1 is the change
from sleeping to
waking, and delta 2 is
the change from 2h





ICD Patients (no p-blockers)
vs
ICD Patients (on P-blockers)
Delta 1 Delta 2
NBB BB NBB BB








S 0.121 vs 0.06 -0.105 vs -0.061
(p<0.01) (p <0.05)
J 0.213 vs 0.120 -0.189 vs -0.113
(p<0.05) (p=NS)
10.2 a
ICD Patients (no p-blockers)
vs
Healthy Volunteers
Delta 1 Delta 2
HV NBB HV NBB
RR -393 vs —360 111 vs 207
(p=NS) (p=0.06)
QTo -10 vs 31 -4 vs -31
(p< 0.0001) (p<0.005)
S 0.052 vs 0.121 -0.022 vs-0.105
(p<0.001) (p= 0.001)
J 0.025 vs 0.213 -0.051 vs-0.189
(p<0.0001) (p<0.0001)
10.2 b
ICD Patients (on p-blockers)
vs
Healthy Volunteers
Delta 1 Delta 2
HV BB HV BB
RR -393 vs -255 111 vs 137
(p<0.005) (p=NS)
QTo -10 vs 5 -4 vs -12
(p=0.05) (p=NS)
S 0.052 vs 0.059 -0.022 vs -0.061
(p=NS) (p=NS)
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Figure 10.1: Absolute Values of RR at each of the three time points for each
group
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Figure 10.2: Absolute values of QTo at each of the three time-points for each
group
Early Morning Values of QTo




Figure 10.3: Absolute values of Slope at each time point in the three groups
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Figure 10.4: Absolute values of J at each time point in the three groups








10.5.1 Changes in heart rate
From the data, several differences between the groups have come to light. The most
obvious and expected abnormality is the damped heart rate response on waking in the
group of patients taking P-blocking agents. During sleep, there is lower sympathetic
activity, although in patients with severe congestive cardiac failure, elevated
sympathetic tone is felt to be present throughout the day and night (Panina et al. 1995,
Saul et al. 1988). Our population consisted mainly of patients with previous
myocardial infarction although symptoms of heart failure and impairment of
ventricular function were not marked. The reduced increases in heart rate is indicative
of the inability of cardiac sympathetic activity and circulating catecholamines to exert
their normal effect due to the sympathetic antagonism from the beta-blockers.
10.5.2 Changes in the relationship between QT and heart rate
In earlier chapters, we have shown that the repolarisation characteristics of patients
with heart muscle disease such as those with cardiac failure or HCM have abnormally
prolonged QT intervals but also an increase in the rate dependence ofQT (using J as
a rate-independent marker). There is also evidence that these abnormalities progress
with severity of the underlying condition.The results in this section suggest that the
same is true of patients with a history of previous cardiac arrest. This population
differs in that they have heterogeneous conditions and are symptomatic to varying
degrees. In the previous chapter we examined the circadian variation in the incidence
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ofmalignant arrhythmias requiring ICD intervention in this group and uncovered a
morning excess of events between 9 and 1 Oam, corresponding to a period
approximately one to two hours after waking or rising. This chapter has focussed on
the repolarisation dynamics at that time to assess whether an abnormal or exaggerated
response is seen at that time of day.
One of the most striking abnormalities present on many of the recordings from the
defibrillator patients was an increase in the value ofQTo in the group not on p-
blockers. This was accompanied by a significant increase in slope and J. In contrast,
the rise in QTo and J was much smaller in the P-blocked group. Other investigators,
using hourly estimates of the QT/RR slope (Fei et al. 1994) or Bazett's corrected QTc
(Yi et al. 1999) have also shown changes in the 'waking hour' QT/RR relationship to
be more marked in similar patient populations. As we have previously discussed,
limitations of these methods restrict the classification of the whole QT/RR curve and
complicate the continuous assessment of the relationship.
We postulated in an earlier chapter that increased sympathetic activity was
responsible for the increased rate dependence of QT seen in heart failure. This was
upheld by the later chapter in the ICD study of 24h repolarisation characteristics that
showed a slight increase in the length ofQTo in patients on P-blockers but a
reduction in J. The results in this section would appear to support the role of
sympathetic activity in the morning surge in slope and J. Other investigators have
studied the circadian variation in the levels of circulating catecholamines and showed
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that noradrenaline (NA) levels peaked at 0800h, and a smaller peak was also seen in
adrenaline levels (Kong et al. 1995). The fact that p-blockade in our population
resulted in a dampening of the rise in QTo and J points to a surge in sympathetic
activity and circulating catecholamines on rising as being responsible.
In the early morning there is a complex interaction between autonomic changes,
circulating factors and changes in activity and posture that result in changes in heart
rate and repolarisation. This makes it difficult to appreciate what is truly occurring in
the relationship between QT and RR. The elevated value ofQTo that is seen to occur
in the ICD group would imply that the excessive risk of arrhythmias at this time of
day in this group might be due to a prolongation of ventricular repolarisation. It is
easier to comprehend what is actually occurring when the QT/RR curves are plotted
for each of the three time-points in the three groups (Figure 10.5-10.7). When this is
done, it can be seen that in the healthy control group, although heart rate changes
occur that are comparable with the ICD group (no p-blockers), there is no significant
change in the overall relationship between QT and RR. When these curves are
compared with the ICD (no-pB), we can see that although QTo increases, the increase
in J is actually responsible for a shorter QT at the peak heart rate than would have
been seen at the same heart rate if the QT/RR relationship had not changed from the
relationship seen during sleep. There is therefore a shorter QT and therefore shorter
refractory period at that time of day. In the P-blocked subjects, a smaller increase in
QTo occurs, along with a substantial increase in J. If heart rate acceleration had not




Waking hour changes in the QT/RR relationship in healthy volunteers. The
large circles represent the RR interval for each of the three time points. These
curves have been generated by taking the values of QTo and J at each of the
time points (30 min pre, 120 mins post and 240 mins post waking), and using
them to calculate the values of QT at various RR intervals by using the
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Waking hour changes in the QT/RR relationship in patients with a prior history
of cardiac arrest. Curves and symbols are as in figure 10.5. In contrast to
healthy volunteers, the morning rise in heart rate is associated with a
paradoxical rise in the extrapolated value of QTo (QT at an RR interval of
1000ms). When this is viewed in the context of the curve, it can be seen that
due to the rise in slope and J, the QT interval at the higher morning heart rate
is actually shorter than it would have been at that rate on the 'sleeping curve'.
Waking Hour Changes in the QT/RR











In the ICD population receiving chronic p-blocker therapy, less separation of
the curves is seen, although there is a tendency towards shorter QT intervals
at higher heart rates. The rise in heart rate is considerably less in this group
on wakening (as shown previously in figure 10.1). No significant change in the
QT is observed, largely because heart rate has not increased as much.
Waking Hour Changes in the QT/RR
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The explanation for the observed differences between ICD patients and healthy
subjects is that the majority of these patients had ischaemic heart disease, left
ventricular impairment and/or heart failure. As in the previous chapters, we have
shown that the QT/RR relationship seems to worsen with the degree of heart failure.
In these patients, the abnormalities that we are observing may reflect an enhanced
cardiac sympathetic influence, and the fact that to increase cardiac output in the
morning, there is more reliance on increased sympathetic drive rather than
withdrawal of parasympathetic tone (which is the case in healthy volunteers).
Singh et al (Singh et al. 1998) studied a post-infarct population three to five days
following infarction and showed a similar early morning (within one hour ofwaking)
surge in the slope of the QT/RR relationship which was less marked in those patients
on p-blockers. 24h recordings were analysed using a semi-automated system for
measurement of QT and RR and QT/RR slopes were constructed using all analysable
beats for the preceding hour. As in our study, data were aligned according to the
patients hour a wakening. The QT/RR slopes measured in their study were
significantly lower than reported here, and this may be due to the methodology
employed and lack of compensation for hysteresis as discussed in chapter 4. They
hypothesised that the abnormal increase in the QT/RR slope may reflect an
instability of repolarisation and disturbances in autonomic tone.
Other investigators have studied the effective refractory period (ERP) in patients with
permanent pacemakers with no evidence of cardiac disease. In this group the
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refractory period was measured non-invasively via the permanent pacemaker. The
refractory period showed significant circadian variation, being 4% longer 4h before
waking, and reached its shortest duration one to two hours after waking (3.5% shorter
than 24h mean). This variation seemed to correlate best with epinephrine levels when
normalised for time ofwakening. The circadian variation in ERP was abolished by p-
blockade.
Another study (McLelland et al. 1990) assessed the inducibility of ventricular
arrhythmias and the refractory period in patients at electrophysiological study
according to the time of day of testing. They found no difference in the refractory
period and concluded that circadian variation in ERP may not play a role in the
morning excess of arrhythmias. However, the EP lab is a highly artificial
environment, and there are external and internal influences at work, not least patient
anxiety during the test, which might abolish any genuine differences present.
The use of beta-blockade in the post-myocardial infarction population is well
established and proven to provide mortality benefit (Beta-blocker Heart Attack Trial
Research Group 1982, Norwegian Multi-center Group 1981). A sub-study analysis of
the mortality data from the The Beta-Blocker Heart Attack Trial (Peters 1990)
specifically examined the differences in the incidence and circadian variation in SCD
in those receiving the non-specific P-blocker propranolol with the control group. The
incidence of sudden death was reduced in the treatment group. In addition, the
morning excess of SCD in the placebo group (38% of all SCD) was significantly
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reduced in the treatment arm (24%). Excluding this period, there were nearly equal
numbers of death at other times of day.
More recently, p-blockers have been proven to be beneficial in the treatment of
patients with ischaemic and dilated cardiomyopathy (Merit-HF Study Group 1999,
CIBIS-II Investigators and Committees 1997, Australia/New Zealand... 1997).
Although an improvement is seen in markers of severity of heart failure such as
ejection fraction, NYHA class, heart rate variability and biochemical markers of
neuro-humoral activation, and a corresponding reduction in the incidence of death
due to worsening of heart failure is seen, much of the mortality benefit is actually due
to a reduction in the incidence in sudden cardiac death, approaching 50% in most of
the large studies. Studies assessing the circadian variation in heart failure have
suggested that the classical morning excess of SCD is reduced or absent in this
population (Carson et al. 2000). Regardless of this, given that patients with heart
failure are known to have increased sympathetic activity throughout the day, it is
highly likely that sympathetic activity plays a role in the initiation and maintenance of
arrhythmias. However, as already discussed in the chapter on heart failure, prolonged
repolarisation and triggered activity is a postulated mechanism of initiation of
malignant ventricular arrhythmias in these patients, particularly in the absence of an
identifiable anatomical substrate for macro-reentry.
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10.5.3 Implications Of The Observed Repolarisation Abnormalities And The
Connection To Arrhythmic Death
We have shown that in this population of patients with predominantly ischaemic,
post-myocardial infarction related VT or VF, the morning excess of arrhythmias
appears to correspond with an abnormal shortening of the QT interval. In contrast, the
incidence of non-sustained arrhythmias is more evenly distributed throughout the 24h
period. This would suggest that the shorter repolarisation (and therefore refractory
period) seen at higher heart rates may be altering the properties of potential re-entrant
circuits to allow maintenance ofVT, and/or degeneration into VF. This is comparable
to the techniques employed in the EP lab by cardiologists to induce arrhythmias with
infusion of the (3-agonist isoprenaline. Our data suggests that one mechanism by
which beta-blockers are effective, at least in terms of repolarisation dynamics, is by
blunting the heart rate increase as well as preventing the rise in rate dependence of the
QT interval.
10.5.4 Implications for future research
By continuously assessing the QT/RR relationship, it is possible to see that the
changes occurring in the morning are in fact gradual and progressive over more than
an hour, as seen in figures 10.2 - 10.4. The technique employed offers greater
temporal resolution than methods which cannot compensate for hysteresis.
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The increase in QTo which can subsequently be shown to correspond with a shorter
QT interval when heart rate is taken into consideration highlights the limitations of
quoting a 'corrected QT' as a stand-alone assessment of cardiac repolarisation in the
dynamic setting. One must also describe the curves on which the points lie in order to
understand what is truly occurring.
The assessment of dynamic repolarisation characteristics in this way may be
providing a more direct insight into the action of the autonomic nervous system on
the ventricular myocardium. The ability to constantly monitor changes over short
periods may prove important in the assessment of patients with coronary artery
disease or cardiac failure in specific situations such as exertion.
Many agents, whether anti-arrhythmic drugs or drugs with an incidental tendency to
cause prolongation of repolarisation (such as anti-psychotics, macrolide antibiotics or
anti-histamines), may also cause changes in heart rate, or can be used in patients who
are tachycardic (e.g. the febrile patient with pneumonia). Measurement and
'correction' of the QT interval using standard formula is likely to give misleading
results, particularly if a generic formula is used (such as Bazett's).
The subject is even more complex for class three agents such as Sotalol. Let us
consider d-Sotalol, the dextro-isomer of racaemic sotalol, which has less than 2% of
the p-blocking activity of the laevo-isomer. This drug causes QT prolongation by
blocking inward potassium currents (IKr). It does so by binding to closed potassium
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channels. This results in greater prolongation ofQT at lower heart rates as more
molecules bind during the longer diastolic period (phase 4 of the action potential). If
we were to arbitrarily say that at a heart rate of 60bpm, a fixed dose of sotalol induces
a 40ms lengthening ofQT as measured on a resting ECG. It would be possible to
apply Bazett's correction formula and estimate the QT at a heart rate of 30 bpm or
130 bpm. However, we have made two assumptions which we know to be incorrect-
firstly that a subjects QT/RR relationship has a square-root relationship with heart
rate (or J=0.5), and secondly that the relationship will follow the same relationship at
30 or 130 bpm, which we also know to be incorrect due to the rate dependent binding
properties of the drug. It is comparable to measuring QT at a heart rate of 60 bpm
after 50mg of IV sotalol, and then giving a further dose of sotalol and expecting the
QT interval to still be the same.
Ifwe are to prevent arrhythmias in patients with re-entrant circuits that are dependent
on a short refractory period, we need to prolong action potential and/or the refractory
period, or render a cell less excitable. The SWORD (Waldo and Camm and de Ruyter
1996) and CAST (The et al. 1989) studies have highlighted the risk ofpro-arrhythmia
in the use of class I and III agents in relatively low risk subjects. The risk of pro-
arrhythmia is related to the binding characteristics of these agents and the relative
lack of effect at high heart rates. In the CAST study in particular, the excess of deaths
appeared to be at least in part due to an increase in nocturnal death, when RR and QT
intervals are at their longest (Peters et al. 1994). The advantage of defibrillators is that
they do nothing unless it is required of them. The disadvantage of drugs is that they
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act all the time, and many are less effective during tachycardias as they produce less
change in the action potential at high heart rates, and perversely are far more potent
when least needed (when heart rate is low), creating a situation where long-QT
mediated arrhythmias may occur. The Holy Grail of arrhythmologists is an
'intelligent' drug which exerts minimal effect at normal heart rates, and then binds
aggressively to receptors during tachycardias. This positive use dependent property
has not been found in any agent under development to date, but is likely to come in
the future.
Amiodarone is a special case worth mentioning. Although it exerts most of its anti¬
arrhythmic effect through class III action potential prolongation, it also has non¬
receptor mediated anti-adrenergic activity. In addition, it appears to have less reverse
use dependence than other class III agents. It may be these properties which have
rendered it arguably the most effective agent at our fingertips. If it were not for the
unfortunate side-effect profile, it would surely be more widely used.
10.6 Conclusions
The 'high-risk' early morning period when arrhythmias are more likely to occur is
associated with an abnormal increase in the rate dependence ofQT in cardiac arrest
survivors. A paradoxical increase in the estimated QTo is seen but constructed
QT/RR curves demonstrate that the QT interval is abnormally short at this time. The
shortening ofQT is abolished by (5-blockade, largely due to a modification of the
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heart rate response. This may explain the mechanism of anti-arrhythmic action of p-
blockers in these patients. These findings highlight the problems of correcting the QT
interval for heart rate, and cast further doubt over the use of rate correction formulae











The two previous chapters have been concerned with the circadian variation and the
early morning changes in repolarisation in a group of patients with implantable
defibrillator devices. Having demonstrated that there is an early morning excess of
episodes of sustained ventricular arrhythmias, we hypothesised that this was due to
the increase in sympathetic activity. On wakening, considerable changes in the
repolarisation characteristics were seen, and these were attenuated by p-blockade.
In this chapter we assess the clinical variables and the 24-hour repolarisation
characteristics in the patients who had Holter recordings of sufficiently high quality
to assess whether any of these parameters serve as predictors of events.
11.2 Hypotheses
Having demonstrated repolarisation abnormalities in heart failure and HCM, we
hypothesised that in a population known to be at risk of SCD, we might expect the
mean 24-hour characteristics of repolarisation to be abnormal. We compare the
patients who, over a one year follow up period received therapies from their ICD with
those who were event free.
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11.3 Subjects and Method
Of the 83 patients in whom Holter recordings were performed, 41 were of sufficient
quality for 24-hour assessment of the QT/RR relationship. Ejection fraction, NYHA
class, and medication were recorded. Patients taking class III agents were also
excluded for this section as they would have a significant effect on repolarisation and
possibly reduce events due to the anti-arrhythmic action. This resulted in exclusion of
three patients from the No-Therapy group, and one patient from the Therapies group.
All patients were followed up for one year and the number of episodes of non-
sustained (NSVT) and sustained VT were recorded. The patients were divided into
two groups according to whether or not they received therapies from the defibrillator.
The characteristics of the patients are laid out in table 11.1. The significance of
differences in values between groups was assessed by x testing for categorical data
and t-testing for continuous data.
11.4 Results
The characteristics of the patients with recordings suitable for analysis are given in
table 11.1. It can be seen from the table that there was no significant difference in
age, sex or ejection fraction between groups (although significantly more patients had
structurally normal hearts in the 'event' group), raising the possibility that this
skewed the ejection fraction data. Corroboration for this is provided by the fact that
70% of patients in the 'no-event' group were taking ACE-inhibitor therapy. There
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was a slightly greater incidence of episodes ofNSVT in the event grouping,
suggesting this as a possible marker of risk of further sustained events.
Table 11.1 Population and group characteristics
No
events
Events Overall p value
Number 21 16 37 N/A
Sex 4 female 4 8 female p=NS
female
Age 55 52 53 p=NS
Ejection Fraction 32 34 33 p=NS
NYHA Class 1.75 1.46 1.63 p=NS
% IHD 73% 57% 67% p<0.001
% Primary VT/VF 9% 19% 14% p<0.04
ACE Inhibitors 70% 40% 57% p<0.001
Beta-blockers 40% 40% 40% p=NS
NSVT 50% 64% 56% p<0.05
The results of the 24h QT analysis are detailed in table 11.2. It shows that the group
of subjects suffering arrhythmic events during follow up had lower values of slope
and J, although these did not attain statistical significance. QTo was also significantly
shorter in the event group at the 5% level.
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Table 11.2 Results are expressed as mean (SD). Significance is assessed by
students unpaired t-test. Significance is defined as a p value of less than
0.05.
No Events Events p value
RR (ms) 904 (118) 920 (123) p=NS
QT (ms) 428 (35) 416 (32) p=NS
QTo (ms) 458 (28) 436 (32) p<0.05
S 0.185 (0.06) 0.15 (0.05) p=NS
J 0.372 (0.10) 0.33 (0.09) p=NS
SD of J 0.18 (0.09) 0.08 (0.13) p=NS
pooled r 0.80 (0.1) 0.79 (0.11) p=NS
11.5 Discussion
11.5.1 Repolarisation and Events:
It is perhaps slightly surprising, in light of the previous chapters, that the patients with
events have repolarisation characteristics that we would consider more "normal" than
those who escaped events. We must bear in mind, however, that the population is
very different from those with heart failure or HCM. The majority of these patients
had arrhythmias secondary to ischaemic heart disease, the majority having had a
remote myocardial infarction, many with subsequent aneurysm formation. The
mechanism of arrhythmia in this group is more likely to be macro-reentry.
Prolongation of the QT interval in this situation is not necessary to sustain the
arrhythmia, although triggered beats may well cause initiation. It is more likely that in
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this situation, dispersion of repolarisation or the presence of delayed impulse
propagation through or around the aforementioned anatomical barriers are more
relevant. When this is considered, it becomes slightly less disappointing that the
repolarisation characteristics do not appear to be predictive of arrhythmic events.
Significantly more patients in the 'event' group had structurally normal hearts. The
mechanisms for their arrhythmias are often unclear. It may be that transient ischemia
or, for unknown reason, transient electrophysiological abnormalities, may be
responsible, as many subjects with witnessed out-of hospital arrhythmic events will
be non-inducible at subsequent electrophysiological testing.
This study was ambitious in that it attempted to establish whether arrhythmic risk
could be determined from a high risk population followed for one year. Although
over one-hundred subjects were recruited, the numbers of recordings available for
direct comparison of repolarisation dynamics has dwindled to less than 40. This is a
disappointment and has reduced the potential of the study.
11.5.2 Observations in Diagnostic Groups
Given that all these patients are considered to be at ongoing risk of SCD, it is valid to
consider these patients as being at higher risk than a patient with an equivalent
clinical diagnosis and symptoms who has not had a cardiac arrest. If we consider each
diagnostic group separately, some insight can be gained regarding the relevance of
the QT/RR relationship, and hopefully guide further studies. These data are
subsequently summarised in figure 11.1.
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Group 1:
Patients with Previous Cardiac Arrests and Structurally Normal Hearts
There were five subjects in this group with tapes of sufficiently high quality for
analysis. Four were female. None was taking amiodarone or (3-blockers. They had an
average RR interval of 815ms, QT of 384ms and QTo of 420ms. Slope and J were
0.17 and 0.35 respectively. In summary, the individuals with 'structurally normal
hearts' also appeared to have, at least in terms of 24h averages, entirely normal
repolarisation characteristics. Given that these patients may also be non-inducible at
the time of electrophysiological study, it may be that, at times, changes in
repolarisation occur that trigger or predispose to arrhythmias.
Group 2:
Patients with severely impaired LV function.
Out of the 37 ICD patients, seven had a primary diagnosis was of heart failure and
had an ejection fraction less than 15%. One patient had idiopathic dilated
cardiomyopathy and the others had ischaemic cardiomyopathy due either to previous
infarction or severe coronary artery disease with chronic ischemia. The mean values
in this group were far more abnormal than those with normal hearts. Mean RR
interval was 852 ms and QT 434ms. QTo was considerably elevated at 482 ms and
both slope and J were high (0.255 and 0.470 respectively). Four of the five subjects
were taking p-blockers which as we have shown, will tend to reduce both slope and J.
These values, although not statistically significant, are higher than the average for our
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heart failure population in chapter 5 (QTo = 472ms, J = 0.44). These findings tend to
suggest that repolarisation abnormalities may play a role in sudden cardiac death in
the heart failure population.
Group 3: Hypertrophic cardiomyopathy
Unfortunately there were only two patients in this population with recordings suitable
for analysis. They are however interesting and deserve special comment:
Patient 1: A 39 year-old lady was diagnosed with HCM following family screening
after the death of several family members at an early age. She was assessed at a
tertiary centre for HCM research where it was revealed that she had a troponin gene
mutation which, statistically, carries a high risk of sudden death. Despite no previous
history of arrhythmias, and the fact that she was asymptomatic, it was felt that there
was sufficient evidence to warrant defibrillator implantation for primary prevention.
She underwent 24h Holter analysis for our study, and the results were in the upper
ranges of our HCM study population (QTo = 484ms, J = 0.463), compared with
population means from chapter 6 (QTo = 457±27, J = 0.412±0.08).
Patient 2: A 43 year old gentleman was diagnosed with HCM after being
successfully resuscitated from VF at a football ground where he was spectating. An
ICD was implanted, and during follow-up he has had four further episodes requiring
therapy. His mean 24-hour repolarisation characteristics were also abnormally high,
even for an HCM patient (QTo = 478, J = 0.554).
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Figure 11.1
The repolarisation characteristics of the subgroups from the populations
studied are represented graphically by plotting the mean 24H QTo against
mean 24h J. The values for the ICD subgroups are more abnormal than the
corresponding patient population without defibrillators. The exception to this is
those subjects diagnosed with a primary arrhythmia with structurally normal
hearts (labelled primary VF). X and Y error bars represent one standard
deviation of the mean. The study population of patients with hypertrophic
cardiomyopathy are indicated by the green circle, whereas the two patients
with hypertrophic cardiomyopathy who have ICDs (ICD HCM1 and ICD
HCM2) are indicated by individual green markers. For the general heart
failure population studied, a yellow circle has been used, whereas the
subgroup of ICD patients with a primary diagnosis of heart failure are
indicated by a yellow triangle, with associated error bars.
Graphical Comparison of the Mean 24h






















It was known before embarking on this ambitious project that the interpretation of
results would be difficult. Data on dynamic QT abnormalities in different patient
groups was not available at the outset, and the heterogeneous nature of the population
meant that it was less likely that we would find that patients with events would fall on
the side ofmore abnormal repolarisation. The previous chapters which looked at the
timing of arrhythmic events and the changes in the QT/RR relationship at that time of
day suggest that the majority of the patients in this particular population have events
at a particular time and for a reason. Ischemia and increased sympathetic activity are
just two possible reasons for this.
The data presented in this and the previous chapter would seem to suggest that there
may be two distinct types of patients - those in whom the arrhythmias are mediated
by re-entry, ischemia and sympathetic activity, and those in whom abnormal
repolarisation plays a part. This will hopefully encourage further studies in the fields
of heart failure and hypertrophic cardiomyopathy. We plan to undertake both a
retrospective and prospective study ofHCM patients in collaboration with
Dr Fananapazir at the NIH. The patients with idiopathic ventricular arrhythmias had
entirely normal 24h repolarisation dynamics on the day tested, but no comment can
be made about the response to adrenergic activity. It would seem unlikely however
that prolongation of repolarisation is the culprit.
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Chapter 12




This body ofwork has been concerned with the application of a newly developed
method for the analysis of the relationship between the QT interval and the inter-beat
or RR interval. As with many new techniques there are inevitably problems
encountered along the way. In the first section, data is presented on the
reproducibility of 24-hour averages in healthy volunteers, and we also highlighted the
impact QT adaptation lag has on the QT/RR relationship when assessed over a short
time frame.
One of the points raised in this chapter was that the signal quality is paramount ifwe
are to be able to comment reliably on the underlying relationship. Although 2-channel
recorders were used, frequently only one channel would be suitable for analysis. In
healthy volunteers, this was often the apical channel CM5. In heart failure, it could be
either, although in at least fifty percent of the recordings, neither was suitable. This
was usually due to low signal amplitude and subsequent unfavourable signal to noise
ratio, or, as is often the case in patients with severe left ventricular impairment or
arrhythmias, frequent ventricular ectopy.
Patients with hypertrophic cardiomyopathy posed different although equally
challenging problems. Again, although the magnitude of the complexes was
sufficiently good for analysis, the morphology of the T wave could at times cause
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erroneous measurement of Tend- This, as stated in an earlier chapter, is due to the
algorithm for Tend detection, which offers significant advantages in other respects, but
can result in the analyser being misled into measuring Q-Tapex rather than Q-Tend •
Fortunately, due to the fact that the operator can continuously monitor the Q and Tend
markers during playback, erroneous results can be avoided, but sometimes at the
expense of excluding a subject from analyses. It is anticipated that this problem will
be largely resolved as hardware and software refinements currently in the late stages
of development become available. This would include the function of being able to
define a 'region of interest' during playback that would start after Tapex and end
shortly after Tend- By setting this, it would force the analyser to ignore any slope
changes prior to the onset of the region of interest, reducing the likelihood of
measurement of Q-Tapex.
12.2 Implications for the Assessment of the QT/RR
Relationship in HCM and Heart Failure
The main aims of this thesis were to establish whether abnormalities existed between
not just the QT interval, but also the overall relationship between QT and RR
intervals in health and disease. Considerable differences are seen in both heart failure
and hypertrophic cardiomyopathy. These illnesses share several common features, in
particular the cellular hypertrophy in response to impaired contractile function, and
also in the unpredictable episodes of sudden arrhythmic death. In both of these groups
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we have shown associations between stage of disease and abnormal repolarisation
characteristics, suggesting that the 'electrophysiological remodelling' is a progressive
phenomenon. In light of the well known relationship between prolongation of the QT
interval and polymorphic VT, it is tempting to conclude that this is likely to be
associated with an increased risk of arrhythmia. In view of this, steps are underway to
analyse prospectively collected data from a long-term follow up study in hypertrophic
cardiomyopathy to assess whether prognostic information with regards to sudden
cardiac death are present.
12.3 Short-term Assessment ofRepolarisation Dynamics
The latter sections of the thesis studied first the circadian distribution of arrhythmic
events in patients with a previous out-of-hospital cardiac arrest. A significant
circadian variation of sustained arrhythmias was seen relative to non-sustained VT
The morning excess of sustained arrhythmias was not seen in patients on beta-
blockers, implicating increased early morning sympathetic activity as the
arrhythmogenic trigger. The majority of these subjects had re-entrant monomorphic
VT secondary to ischaemic heart disease. Assessment of changes in the QT/RR
relationship at around this time in the morning showed that a significant change
occurred with an increase in the steepness of the curve as indicated by a rise in J. This
equated to an overall greater shortening of QT and refractory period, implicating an
abnormal or excessive response to autonomic changes in the morning. It is, of course,
possible that having impairment of the left ventricle, autonomic balance is towards
sympathetic preponderance with lower vagal tone. In order to increase heart rate and
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cardiac output to match metabolic demands, less can be achieved by withdrawal vagal
tone, and greater sympathetic activity is required. This would appear to be borne out
by the reduced changes seen in the group taking p-blockers. Nonetheless, it would
appear to link changes in the relationship between repolarisation and heart rate with
arrhythmic events in this group.
The short-term changes in this study have also highlighted the limitations of 'rate
correction' ofQT. The majority of formulae for correcting the QT interval for heart
rate were developed using resting ECG data. It is now recognised that these formulae
are not applicable during exercise and we have clearly demonstrated with this method
that progressive changes in the relationship occur, particularly at times of increased
sympathetic activity. This should discourage us from the arbitrary use of such
formula in dynamic situations, particularly at high heart rates.
12.4 Short-term versus 24-hour Measurements
The main body of this thesis quotes 24-hour values of repolarisation characteristics.
The latter section on the ICD subset looked at the early morning changes which
coincided with the arrhythmic episodes. The subsequent chapter looked at the 24-
hour characteristics in the same population and showed that the patients with events
actually had more 'normal' 24-hour values than those without.
While logic would dictate that if a mean 24-hour QT-RR characteristic is more
abnormal, one might expect more events. This would appear to hold true for the data
on heart failure patients and HCM, and there is limited evidence that this may be the
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case from subgroup analysis. However, it may not be appropriate for the patients with
re-entrant arrhythmias. The ICD group was composed largely of such patients, and
there was a striking circadian variation in events. The majority of these patients had
re-entrant VT which is dependent on refractory periods and conduction velocities,
factors which are determined by autonomic activity and the presence of ischaemic
areas in the ventricle.
It may be that the study of repolarisation dynamics using this method can be
employed in different ways in different conditions. In patients with previous
myocardial infarction, the assessment of short-term episodes where metabolic stress
is present, such as during exercise tolerance testing, may be more fruitful. In this
situation there is increased sympathetic activity, potentially ischemia and also
changes in acid-base balance and temperature. This may yield interesting results and
identification of 'at-risk' patients may be possible. In contrast, patients who are
thought to be more prone to the 'triggered activity' type ofVT/VF may be more
usefully stratified by measurement of longer-term repolarisation characteristics. In
these subjects, if arrhythmias mediated by prolonged repolarisation are hypothesised,
one would expect that the overall 24-hour 'burden' of repolarisation may be
predictive. Indeed, as mentioned earlier, the circadian variation in SCD is less striking
in these groups in some studies.
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12.5 Assessment of Pharmacologically Induced
Repolarisation Changes
In chapter eleven I discuss a theoretical model of what might be seen in patients given
a class III anti-arrhythmic agent with 'reverse-use-dependent' properties at varying
heart rates. The advantages of the current method of assessing repolarisation change
in the setting of drug testing are twofold. Firstly, as the QT-RR relationship is
assessed for each individual, comparisons between placebo and active agents can be
made more accurately. We have shown that in healthy volunteers, the 24h
characteristics are highly reproducible but also that there is a considerable variation,
not only in terms ofQTo but also J. The mean values of J are also considerably lower
than that used in Bazett's formula, the most widely applied correction method. The
use of Bazett's formula is therefore liable to produce errors when heart rate varies
significantly from 60 beats per minute.
The second advantage is that the overall relationship, expressed in terms ofQTo and J
can be computed continuously and independently of heart rate. This may lend itself in
particular to agents which have non-linear binding characteristics or rate modifying
effects. The search for anti-arrhythmic agents with positive-use dependence is
continuing, but can be difficult to assess. While initial work on novel agents is always
carried out on isolated cells and animal models, with ligand binding characteristics
established in the laboratory, at some stage it needs to be assessed in man. Anti¬
arrhythmic efficacy can be tested either in the electrophysiology laboratory, or by
long-term follow-up studies. These are invasive and expensive. A method that allows
210
reliable assessment of repolarisation changes at varying heart rates may prove to be a
very useful and cost effective means to test these agents.
At present, the method is being used in two diverse settings to evaluate it's potential
contribution. Firstly, we are performing a study in collaboration with the Scottish
Poisons Unit in the Royal Infirmary ofEdinburgh which aims to assess the
repolarisation changes in patients who have taken overdoses of substances known to
prolong the QT interval and provoke arrhythmias. These fall into three main groups:
1. Tricyclic Antidepressants (e.g. Amitryptyline)
2. Antipsychotic Agents (e.g. Chlorpromazine)
3. Anti-histamines. (e.g. Terfenadine)
As many of these agents will also induce tachycardia due to intrinsic
sympathomimetic activity or secondary to hypotension, the rate correction ofQT is
problematic and prone to error if Bazett's or other correction formulae are used. In
addition, the repeat measurement from 12 lead ECGs is laborious, expensive and time
consuming and therefore less likely to be done. Ifwe are able to continuously track
changes in the overall relationship, it may be possible to incorporate such a method
into monitoring facilities which will enable the medical staff to determine when a
significant risk is present and also to monitor the improvement, enabling more
accurate prediction ofwhen a patient's risk of arrhythmia has passed.
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We are also analysing recordings from a pharmaceutical company in the late stages of
phase II clinical trials where infusion of a novel pharmaceutical agent was noted to
induce prolongation of the corrected QT. Unfortunately it also causes significant
tachycardia which complicates accurate rate correction. On analysis of dynamic
recordings, it is seen that the baseline measurements of J are around 0.3, and QTo is
well within the normal range. During the infusions, continuous assessment shows that
there is in fact very little change in J or QTo. The perceived prolongation of the
corrected QT is actually due to the overestimation of J in the standard rate correction
formula. This is similar to the findings in the 'waking hour' repolarisation changes,
where we demonstrated that quoting QTo alone is misleading. It also emphasises that
using the wrong value of J and quoting QTc alone is even worse.
The disadvantage of applying a new method in these settings is that normal ranges
will need to be established, new markers of arrhythmic risk will need to be sought
and some method of assessing combinations ofQTo and J in terms of arrhythmic risk
will need to be developed. Nonetheless it would appear to be an ideal use of this
method.
12.6 Conclusions
I have been fortunate to be the first person to use this method for dynamic QT
analysis. The research contained in this thesis has yielded many interesting results,
underlining the importance of abnormal repolarisation and also changes in the QT/RR
relationship in many conditions. This method also appears to offer many of the
solutions to the problems associated with 'correcting' QT for heart rate. There are
now, however, even more interesting questions to be answered. Whenever a project is
embarked upon, the goals are often relatively well defined, but as more of the pieces
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OMPUTER COLUMN
'he Impact ofQT Lag Compensation on Dynamic
issessment ofVentricular Repolarization:
eproducibility and the Impact of Lead Selection
1RISTOPHER C.E. LANG, ANDREW D. FLAPAN, and JAMES M.M. NEILSON*
)m the Department of Cardiology, Royal Infirmary of Edinburgh and the
epartment of Medical Physics, University of Edinburgh, Edinburgh, United Kingdom
lNG, C.C.E., et al.: The Impact of QT Lag Compensation on Dynamic Assessment of Ventricular Re-
larization: Reproducibility And The Impact of Lead Selection. In cardiac disease, abnormalities exist
the rate-corrected QT interval and the relationship between QT and heart rate. The QT/RR relationship
known to be dynamic and show circadian variation. The availability of automated methods for mea-
rement ofQT and RR intervals ullows monitoring of the QT/RR relationship and may provide insights
o arrhythmia onset. Using a methodfor analyzing 24-hour recordings that incorporates beat-hy-beat QT
d RR measurement and an automuled mechanism for compensating for lag in adaptation of QT to
mges in RR, the authors evaluated the impact of lag compensation on assessment of the QT/RR rela-
nship, reproducibility, and the effect of lead selection in 15 normal subjects. The QT/RR relationship
continuously estimated from the lag compensated data over a 5-minute scrolling time frame. The rela-
nship is expressed as an exponential formula, QT = QTo ■ RRJ where QTo is the QT interval at a stan-
rdized RR interval of 1 second and J is a variable exponent. Wc found that the use of lag compensation
nificantly improves the mean 24-hour correlation between QT and RR data (r = 0.87 vs 0.65). The 24-
irmean ofQTo and J were highly reproducible (coefficients of variation 2% and 8%, respectively). The
an 24-hour QT/RR relationship for the population was QT = 0.415 ■ (RR)a32. There was a small differ-
:e between leads in QTo and ). Compensating for QT adaptation lag provides a means ofassessing the
'/RR relationship over long and short periods. This method allows investigation of the effect ofacute in¬
dentions on the dynamic QT/RR relationship, which has previously been restricted by the presence of
'
hysteresis. (PACE 2001; 24:366-373)
interval, dynamic, ambulatory, hysteresis
Introduction
Interest in the QT interval has grown ever
le the association between congenital or ac¬
red QT prolongation and malignant ventricular
lythmias was made.1 The QT interval is infill¬
ed by many factors, the most apparent of
ch is heart rate. Therefore, it is necessary to
ect for this to allow comparison among clini-
variables, individuals, or populations. Since
0 when Fridericia2 and Bazett3 first indepen-
tly proposed exponential rate correction for-
!as, many other formulas have been proposed
have included linear,4'5 exponential, 6 and
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logarithmic models.7 Controversy exists over the
true relationship between the QT interval and the
interbeat or RR interval, and much of this may be
due to the timing of measurement of the QT and
RR intervals. It is well recognized that when heart
rate changes, there is a delay in the adaptation of
the QT interval to the new heart rate (QT lag).8-12
For example, if heart rate changes quickly to a new
sustained higher rate during sudden exertion, it
may take several minutes before the QT interval
adapts to the new steady-state heart rate. The con¬
verse is also true, such that as heart rate slows, the
QT interval will require several minutes to fully
prolong to its new steady-state value. Investigators
attempt to allow for this when measuring QT at
different heart rates, but it may be that the times
allowed to reach steady state are inadequate. If
this is the case, there will be underestimation of
the QT/RR slope.
Recent advances in medical technology now
allow automated short- and long-term measure¬
ment of the QT interval on a beat-by-beat basis
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m ambulatory electrocardiographic (ECG)
ordings. This makes it possible to study the cir-
lian variation in the QT/RR relationship and
j yielded insights into the possible reasons for
increased incidence of arrhythmias early in the
irning.13 Furthermore, analyses of long-term
ordings allow the assessment of acute interven-
as such as drug administration on the changes
he QT/RR relationship. It has become clear that
QT/RR relationship is not constant but varies
ring the day, and therefore, when assessing dy-
nic long-term recordings, a more flexible
thod is needed to describe the QT/RR relation-
p and to permit more accurate rate correction.
Caution must be used in analyzing dynamic
a precisely because the heart rate is constantly
inging and the QT will always tend to lag he¬
ft changes in heart rate. Unless a method is
d that allows for this time lag, errors will oc-
. One approach to this problem has been to an-
ze periods when heart rate has been constant
hin a narrow range for several minutes.14'15
s method can result in loss of large amounts of
a when heart rate is changing and decreased
poral resolution of observations.
In 1998, Neilson16 proposed and developed a
erent approach to QT/RR analysis that incor-
ated a modeled correction for QT lag, thereby
wing accurate estimation of the underlying re-
onship over even very short intervals. Using
t-by-beat QT and RR data, the QT lag is cor¬
ed by imposing a matching lag to RR data. This
ection allowed determination of the slope of
underlying, steady-state QT/RR plot and cal-
ition of the exponent J in the general relation-
): QT = QTo- (RR/RRo)1.
For any point in time, the precise relationship
veen the QT and the RR interval is defined by
variables QTo (the extrapolated QT at RRo,
chosen reference RR interval) and J (the expo-
t of the general formula that determines the
re of the curve).
In this study we chose RRo equal to 1,000 ms
assessed the 24-hour mean values of QTo and
a population of healthy volunteers and com-
ft the results with and without the use of lag
pensation. Spatial differences in QT/RR rela-
ship were also examined by comparing the
obtained simultaneously from two different
leads. We report the reproducibility of the
our mean values of QTo and J over a 7-day
■val.
Method
Fifteen healthy male volunteers (mean age
ears) without a cardiac history and on no
ication underwent 24-hour ECG recordings
g two-channel 'Tracker 2' recorders
(Reynolds Medical Ltd., Hertford, England) on
two occasions 1 week apart. Standard bipolar tho¬
racic leads CM5 and CM1 were used. All subjects
were asked to abstain from alcohol and follow
their normal daily routines on both recording
days. One subject was excluded from further
analysis due to the presence of frequent supraven¬
tricular ectopics. Consent was obtained in all sub¬
jects in accordance with the authors' local ethics
committee requirements.
The tapes were replayed on a Pathfinder
Analyser (Reynolds Medical Limited) that ex¬
cluded ectopic complexes and those that were sig¬
nificantly distorted by artefact. The analyzer mea¬
sured each RR interval and its associated QT
interval. The Tend was measured using the slope
method whereby the end of the T wave is deter¬
mined as being the point at which the current
slope of the T wave drops below a predetermined
proportion of the maximum slope. The accuracy
of the automated QT interval measurement has
been independently validated.17
Twenty-four-hour files of RR and QT inter¬
vals are then processed on a personal computer
using a novel technique to determine the QT:RR
relationship. The three-stage process is described
below.
First, the well-known two component time
lag18'19 with which the QT interval follows
changes in RR interval is "compensated" by ap¬
plying a matching two-component time lag to the
RR data. This resynchronizes the QT and RR vari¬
ations so that when the compensation is correctly
adjusted, a screen display of QT against RR no
longer shows the characteristic loops due to "QT
Hysteresis" but retraces the corresponding part of
the underlying steady-state QT/RR curve. This is
the curve that would have been traced if RR had
changed slowly enough so the effect of the QT de¬
lay on the plot would be negligible. During analy¬
sis the operator can confirm the absence of "hys¬
teresis loops" and hence correct compensation for
the QT lag (Fig. 1).
Second, throughout the analysis, the RR and
QT signals are cross-correlated within a moving 5-
minute time window that is scrolled through the
24-hour data. As long as the correlation between
QT and RR remains high (r > 0.8), the slope (S) of
the QT/RR plot around each successive (RR, QT)
point is computed as the linear regression coeffi¬
cient in the time window currently centered on
that point. Thus, a continuously updated measure
of the slope of the QT/RR characteristic curve is
generated.
Third, it is found that this slope decreases at
longer RR intervals, providing evidence that the
steady-state QT/RR characteristic is curved. To
avoid the necessity of reporting the value of RR at
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Figure 1. An example of the QT lag compensation in action. The figure represents a 3-minute
excerpt from a 24-hour recording. The left panel is raw QT:RR data. Each QT interval is plotted
against the preceding RR interval and each point is connected to the previous one by a line. The
right panel is the same QT data, hut matching lag has been placed on the RR data and each QT
interval is then plotted against the corresponding delayed RR interval, RR'. This has resulted in
an improved correlation between QT and RR with accelerations and decelerations in heart rate
tracing out one curve. This enables the measurement of the underlying QT/RR relationship as
though it were derived from steady-state data.
:h measure of slope, the simple exponential em-
ical formula used by Fridericia2 and Bazett3 is
opted.
These investigators used QT = K • RR° 33 and
1
= K • RR0'5, respectively, from which the "Cor-
ted QT" has customarily been computed as
c (Bazett) = QT / VRR and QTc (Fridericia) =
/ 3Vrr.
These familiar formulas have given rise to
ne confusion regarding the correct units for
c. To avoid this difficulty the present method
s the most general expression: QT = QTo *
:/RRo)J.
Here QTo is the intercept of the curve with
ordinate at RRo, a chosen reference RR inter-
and J is the exponent determining the shape of
curve. (Bazett's formula assumes that J is con-
it and equal to 0.5, while the Fridericia for-
la is equivalent to adopting a fixed value of
1 for J) In the present method the value of J is
tinuously computed from J = S • (RR'/QT),
ire RR' is the compensated value of RR.
Statistical Analysis
Recordings were excluded from statistical
lysis if they did not fulfill the following crite-
data used > 90%, pooled 24-hour QT:RR cor¬
don > 0.8, recording duration > 18 hour. A
ikdown of the number of recordings available
ach channel is given in Table I. Of the 14 pairs
ecordings, 13 pairs were of sufficient quality
assessment of 24-hour reproducibility in one
oth channels. When comparing the difference
he calculated QT/RR relationship between
compensated and uncompensated data, all ana-
lyzable channels were used. This produced a to¬
tal of 35 acquired recordings that were then ana¬
lyzed with and without lag correction and
compared by paired f-test. Due to a low yield of
high quality recordings in channel 2 (CMl), only
11 tapes were available for comparison of inter-
lead differences when quality criteria were ap¬
plied. Reproducibility of the technique was as¬
sessed by calculation of the coefficient of
variation (CV) defined as the standard deviation
of the mean difference between recordings, di¬
vided by the mean of the population, and ex¬
pressed as a percentage. Interlead differences
were assessed using paired f-tests.
Results
The mean pooled 24-hour regression coeffi¬
cient was 0.86 for compensated data, implying
that throughout the 24-hour period the correlation
between QT and RR data was high. This contrasts
with the correlation for the uncompensated data (r
= 0.63). Although the mean pooled correlation for
the population is 0.86, for the duration ofmost of
the recordings it is actually much higher, as can be
seen in Figure 2, a 24-hour chart from a typical
normal subject.
Figure 1 demonstrates the lag compensation
in action during a 3-minute excerpt of the play¬
back. The left panel shows raw QT and RR data-
points and the right panel shows the lag correction
has been applied. QT is now plotted against the
delayed RR intervals (RR'). This increases the cor¬
relation between QT and RR.
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Table I.
Summary of Suitability of Recordings for Analysis
Pairs where both
Total of Tapel and Tape 2
Analyzable Analyzable in the Total Pairs
Tape 1 Tape 2 Recordings Same Channel (either channel)
Channel 1 (CM5) 12/14 12/14 24/28 11/14 13/28
Channel 2 (CM1) 7/14 4/14 11/28 2/14
Total analyzable 19/28 16/28 35/56
recordings
Pairs where channel 7/14 4/14
1 and channel 2
analyzable from
the same tape
Total pairs (either tape) 11/28
Breakdown of recordings suitable for analysis by channel and tape number. Where the same channel was
available for analysis in both recordings (tape 1 and tape 2) this is used as a pair of assessment of the
reproducibility. Where both channels were of sufficient quality in the same recording (tape 1 or tape 2), the pair
is used to assess the effect of using different leads on mean 24-hour values. All recordings of sufficient quality,
irrespective of channel or tape number, were combined to assess the effect of applying lag compensation on
the estimated QT/RR relationship.
Figure 2. A 24-hour printout of compensated QT and RR (RR'), along with the parameters S and
J used to describe the QT/RR relationship. Recording was commenced at 1100 hours. It can be
seen that while the patient is sleeping (approximately 2330-0700 hours), there is a slight
lengthening ofQTo with reduction in the variation seen during waking hours. Slope is also seen
to decrease slightly, secondary to a longer RR interval, meaning the QT intervals are on the flatter
portion of the QT/RR curve. There is a slight reduction in J during sleep relative to waking hours.
On waking, there is a sharp rise in QTo, slope and J that coincides with the rapid shortening of
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Table II.
Comparison of Lag Compensated Versus Uncompensated Data
RR QT QTo 24-hour 24-hour




901.4 396 408 0.06 0.127 0.009 0.650
(86.65) (23.6) (19) (0.01) (0.019) (0.0028) (0.08)
901.4 396 415.74 0.146 0.320 0.018 0.87
(86.65) (23.6) (17) (0.02) (0.04) (0.014) (0.06)
N/A N/A < 0.001 < 0.001 < 0.001 < 0.001 < 0.00001
All results are 24-hour mean (standard deviation). Correlation between QT and RR is less good when data is
uncompensated. There are significant differences in the estimated mean 24-hour QTo, S, and J.
The mean 24-hour results for compensated
id uncompensated values are given in Table II.
To is significantly shorter when data is uncom-
msated. Lack of compensation also results in a
duction in the mean 24-hour slope which, in
rn, reduces the observed 24-hour mean J. Con-
ructed QT/RR plots using mean 24-hour com-
msated and uncompensated results are shown in
gure 3.
The reproducibility of the method was as-
ssed by comparing mean 24-hour values. Where
u channels were of sufficient quality in both
wordings, both channels were included in analy-
;. Table III gives the mean differences and CV for
ch of the parameters. The standardized QT at an
I interval of 1,000 ms (QTo) is highly repro-
cible despite a 7% variation in mean 24-hour
L Slope and J also had a low CV (11% and 7%,
ipectively).
In 11 recordings, both channels were of suffi-
intly high quality to allow assessment of the im-
ct of lead selection on the value of the parame-
s. Table IV details the differences between
mnel 1 (CM5) and channel 2 (CM1). The slight
ference in mean 24-hour RR is due to automatic
ling of noisy segments that differ according to
i channel analyzed. There was a 15-ms differ-
:e in QT and a 13-ms difference in QTo be-
3en channel 1 and channel 2 with the CM5 lead
dng a longer mean 24-hour QT and QTo. The
15 lead also tended to have a steeper slope and
her J.
Discussion
Compensating for QT lag by delaying RR data
rroves the correlation between QT and RR, as
denced by the high pooled 24-hour correlation
fficient. This demonstrates the ability of the
thod to compensate for hysteresis and enable
mation of the underlying QT/RR relationship
ng short-term nonsteady-state data. QT lag
ipensation also corrects for the underestima-
i of slope that occurs with beat-by-heat assess¬
ment of QT dynamics. Other researchers have
shown that when nonsteady-state data is used, the
QT/RR slope is less steep.15






Figure 3. Demonstration of the different curves derived
by analyzing QT/RR data over a scrolling short time
frame. The uncompensated data gives a lower value of
QTo. Mean slope and the exponent describing the curve
(f) are also lower for the uncompensated data, giving the
light grey curve.
March 2001 PACE, Vol. 24
IMPACT OF QT LAG COMPENSATION
Table III.
Reproducibility of Parameters for Paired Recordings 1-Week Apart
RR QT QTo 24-Hour
n = 13 (ms) (ms) (ms) S J Pooled r
Mean (SD) 895.65 396.11 415.9 0.152 0.33 0.893
(89.61) (21.63) (17.33) 0.022 (0.03) (0.044)
Mean difference 15 5.1 5.0 0.0041 0.00829 -0.012
(SD) (66.63) (12.1) (8.11) (0.017) (0.025) (0.046)
CV 7.44% 3.04% 1.95% 11.1% 7.42% 5.2%
The coefficient of variation (CV) is calculated as the standard deviation (SD) of the differences between
recordings, divided by the mean value for the population.
The use of a short (5-minute) time window of-
3 high temporal resolution for assessment of the
ierlying QT/RR characteristic.
We found that J varies constantly throughout
day, usually within a fairly narrow range, as
licated by the small average 24-hour SD of J
ble II). However, occasional peaks and troughs
l occur. An example of circadian changes in J
[ be seen in Figure 2. Whether the degree of
iation in J, which can be described by the 24-
lr mean SD of J for the recording, reflects the
;ree and frequency of alteration in factors such
:he autonomic nervous system remains to be
n.
In contrast, QTo seems to vary little with this
:hod, showing a trend to be longer at night,
ler than varying constantly. For consistency, in
are 1, the same scale is used for QT and QTo.
in, occasional peaks and troughs are seen in
3, most commonly on waking in the morning
jrtly after 0700 hours in this subject). These
nges may reflect the interaction of numerous
ors that are known to affect QT independently
ate, namely posture, autonomic tone, and cir-
iting factors like corticosteroids and cate¬
cholamines. The peaks on waking may be linked
to the increased incidence of arrhythmias seen in
the early hours of the day. Acute arousal events
have been shown to be important triggers in the
initiation of ventricular arrhythmias in some pa¬
tients with the congenital long QT syndromes.20,21
Even in this small study, there was a consid¬
erable spread of 24-hour mean values of QTo and
) across the population. The range of mean 24-
hour QTo was from 384 ms to 448 ms, although
this has been accentuated by analyzing channels 1
and 2 together. Equally, there was a spread of val¬
ues for J (0.28-0.382).
Despite the constantly changing nature of J,
and the range of values seen in QTo and J across
the population, the intrasubject mean 24-hour val¬
ues of both are reproducible. The 2% CV in QTo
corresponding to an 8-ms difference between
recordings is small when compared with the ob¬
served 17-ms SD of QTo across our population. A
similarly small difference is seen in J. This sug¬
gests that genuine differences exist between indi¬
viduals, and that the 24-hour mean QT/RR curve
is reproducible under stable conditions. The high
reproducibility of this new method suggests that
Table IV.
Interlead Differences in 24-Hour Parameters
RR QT QTo 24-Hour
n = 11 (ms) (ms) (ms) S J Pooled r
Channel 1 902 (107) 405 (21.2) 424 (14.9) 0.151 0.324 0.89012
(CM5) (0.03) (0.01) (0.03)
Mean (SD)
Channel 2 894 (97) 389 (31.3) 409 (19.7) 0.142 0.313 0.83
(CM1) (0.026) (0.021) (0.05)
Mean (SD)
Mean 9.5 (18.02) 15.1 (16.2) 13.2 (16.4) 0.0094 0.0132 0.0663
difference (0.010) (0.019) (0.060)
P Value NS < 0.05 < 0.05 < 0.05 0.06 < 0.05
Paired f-test used to assess the significance of difference between leads.
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;ure 4. The effects of varying values ofQTo and f on
• overall QT/RR relationship. Abnormal values ofQT
7 occur despite a "normal" QTo. At long RFl intervals,
J is greater than normal, QT will he prolonged,
aversely, at higher heart rates, ifJ is low, QT intervals
1 be prolonged relative to mean values.
sn small intrasubject changes in the QT/RR re-
onship could be detected.
The variation of J with time and among sub-
is highlights the problems associated with the
rch for a universally applicable rate correction
inula, as discussed by others.22 Figure 4 is a
istructed plot of families of curves created by
ying QTo or J. It can be seen that as QTo or J
ies, significant differences in QT occur over a
ge of heart rates. It can be seen that under cer-
i circumstances, a "normal" QTo at a standard-
1 heart rate of 60 beats/min can be associated
h abnormal QT intervals at fast or slow heart
s if J is significantly different from normal. By
cribing the QT/RR relationship in terms ofQTo
J, a more informed judgement can be made as
/hether the QT/RR relationship is abnormal.
Lead selection has been shown in this study
roduce a small but significant difference in ob¬
served QT and QTo. There is also a small differ¬
ence in the estimated values of S (0.01) and J
(0.01). Estimation of the spatial dispersion of re¬
polarization by measurement of the QT dispersion
has generated a huge number of publications over
the years. Controversy exists over whether the
measured dispersion in QT intervals is truly a re¬
flection of spatial differences in repolarization or
due the geometrical projection of the T wave on
the ECG23,24 and there have been numerous edito¬
rials on the use and significance of QT disper¬
sion.25-27 Whether QT dispersion is real or not,
the significance of lead differences in the context
of analysis of the QT/RR relationship is unknown.
From a technical standpoint, the use of a stan¬
dardized lead with a low amplitude T wave and
an unfavorable signal to noise ratio (S:N) is more
likely to provide erroneous results than selecting
the lead with the most accurately determinable
Tend, albeit on a different axis.
Limitations
This study was relatively small and exam¬
ined only normal subjects. Further work will be
required to assess normal ranges and the influ¬
ence of the patient's sex. As with all methods for
the analysis of QT dynamics from ambulatory
recordings, the quality of acquired ECG wave¬
forms, in terms of signal quality and the accurate
editing out of frequent premature or aberrant
beats, is essential. T wavemorphology may be ab¬
normal or of low amplitude in many patients
with heart disease and ectopy more frequent.
This will affect the yield of recordings of suffi¬
ciently high quality where accurate Tend mea¬
surement is possible. In this study, mean 24-hour
values are quoted and an average of 72,000 beats
was analyzed per recording. A few nonedited ab¬
normal beats are unlikely to influence results.
The yield of high quality recordings in this popu¬
lation was good, particularly for the CM5 chan¬
nel. Individuals were young, slim, and had nor¬
mal hearts with normal T wave morphology. This
is often not the case in clinical practice. It can
readily be seen that when analyzing CM1, T
waves were of lower amplitude, degrading the
S:N ratio so that when this study's selection cri¬
teria are applied, the yield drops from > 90% to
< 50% of recordings suitable for analysis. This
finding reinforces the importance of ranking a
good T wave morphology over lead position
when selecting electrode sites for ECG recordings
intended for QT analysis.
Conclusions
This method shows potential for the assess¬
ment of the short- and long-term characteristics
of the QT/RR relationship in healthy volunteers.
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represents a significant change from previous
>proaches to the analysis of dynamic recordings
that it is the first to use a method for compen-
ting for QT lag. As the QT/RR relationship fol-
ws a curve over a broad range of heart rates in
abulatory data, describing the QT/RR charac-
ristic in terms of two variables, QTo and J, it re¬
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Abnormalities of the Repolarization Characteristics
of Patients with Heart Failure Progress with
Symptom Severity
Christopher C. E. Lang, B.Sc. (Hons), M.B., Ch.B.,* James M. M. Ncilson, Ph.D.,f
and Andrew D. Flapan, M.B., Ch.B., M.D.*
From the *Department ofCardiology, Royal Infirmary of Edinburgh and the ^Department of Medical Physics,
University of Edinburgh United Kingdom
Background: Congestive heart failure is a common condition with high mortality. Many of these
deaths are sudden and unexpected. Ventricular action potential, surface repolarization (QT interval),
and dispersion of repolarization are prolonged in the failing heart, contributing to arrhythmogenesis
and sudden death. We studied the relationship between QT and heart rate (RR interval) from ambu¬
latory recordings using a novel method in patients with ischemic heart disease and varying degrees
of left-ventricular impairment (IHD) and compared them to healthy subjects (HS). We compare the
degree of abnormality with the functional impairment and ejection fraction.
Methods: Using a previously described automated method for continuous estimation of the QT/RR
characteristic that incorporates a correction formula for compensation of QT adaptation lag (VERDA,
Del Mar Reynolds Medical Ltd., Hertford, UK), we compared recordings from 41 IHD patients with
age-matched HS.
Results: IHD Patients have prolonged 24-hour mean QTo (461 ms vs 426 ms, P < 0.01), and
abnormal rate dependence relative to controls (24-hour mean slope: 0.20 vs 0.14, P < 0.001; J: 0.38
vs 0.28, P < 0.001). There is increased temporal variation in J with respect to HS. These abnormalities
of repolarization increase with worsening NYHA class, but do not correlate with ejection fraction.
Conclusions: The use of a universal correction formula to compare dynamic QT data in IHD
patients is inappropriate. The observed progressive abnormalities may be responsible for the high
incidence of sudden death through promotion of arrhythmias. A.N.E. 2004;9(3):257-264
QT; cardiomyopathy; repolarization; Holter
Congestive heart failure (CHF) is a common condi¬
tion with high mortality. Many of these patients die
suddenly,1 and often tachyarrhythmias are respon¬
sible for this.2,1 The failing ventricle exhibits pro¬
longation of action potential duration (APD),4 and
prolongation of the surface QT interval is linked to
malignant arrhythmias.5-8
To allow comparisons of QT interval data be¬
tween individuals and populations, it is necessary
to correct the QT duration for heart rate, as this
is the greatest single influence upon QT. However,
QT duration is also influenced by autonomic tone
and the effects of many cardiac drugs. Correcting
QT for rate is problematic and has led to the devel¬
opment of numerous linear, logarithmic, and expo¬
nential formulae, although researchers have ques¬
tioned whether any single formula can be univer¬
sally applicable.9
More recently, due to the developments in the
field of electronics, it has become possible to an¬
alyze large quantities of data at high speed, with
automated measurement of both the RR and QT
intervals. This has enabled the study of long-term
ECG recordings and assessment of the relation¬
ship between QT and RR. This has the advan¬
tage that large quantities of data can be processed
quickly and removes some of the problems of in-
terobserver errors in manual QT measurement.10
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re is also the advantage that assessment of repo-
ation over long recordings allows a more com-
; assessment of the relationship between QT
heart rate throughout the day, as considerable
idian variation in repolarization characteristics
ought to occur.11-13 Unfortunately the analysis
ynamic recordings, where heart rate is varying
tantly, prompts special care when attempting
aw conclusions regarding short-term changes
e QT/RR relationship. QT does not adapt im-
iately to changes in RR but tends to lag behind,
time lag has been shown in cellular and pac-
itudies to have two components14-16 with an
ediate rapid phase with a very short time con-
that acts over the first or second inter-beat in-
il. The second delayed component has a much
:r time constant, estimated at 1 min or more,
h means that several minutes are required be-
full adaptation of QT to the new heart rate
ached. Estimation of the QT/RR relationship
short time periods will, therefore, be influ-
1 by incomplete QT adaptation and errors in
lation of the QT/RR slope or rate-corrected QT
) will occur.17 Automated methods for analysis
2 QT/RR relationship have circumvented this
em by only analyzing steady-state data when
rate has been constant within a narrow range
period of time. This permits assessment of
eady-state QT:RR characteristic, but removes
ta when heart rate is changing. Our primary
tive was to describe the QT/RR relationship
continuous 24-hour data in patients with left
icular impairment, and to establish whether
was a correlation between abnormalities in
dationship and the severity of the condition.
sessed by a clinician blinded to the results of the
ambulatory ECG data. For the purposes of subanal-
yses, patients were divided into four broad groups
according to ejection fraction (<15%, 16-25%, 26-
40%, >40%). The characteristics of patients and
controls are shown in Table 1. Twenty-four-hour
ambulatory ECG recordings were acquired with
two-channel ambulatory ECG recorders using stan¬
dard bipolar thoracic leads CM1 and CM5.
Dynamic QT/RR Measurements
The tapes were replayed on a Pathfinder Ana¬
lyzer (Del Mar Reynolds Medical Ltd., Hertford
England), which excluded ectopic complexes and
those that were significantly distorted by artefact.
The analyzer measured each QT interval and the
preceding RR interval. Tend was measured using the
slope method, whereby, the end of the T wave is
determined as being the point at which the current
slope of the T wave drops below a predetermined
proportion of the maximum slope. The accuracy of
QT interval measurement has been validated inde¬
pendently.18 Twenty-four-hour files of RR and QT
intervals were then processed on a personal com¬
puter using VERDA software (Del Mar Reynolds
Medical Ltd.). The three-stage process has been de¬
scribed elsewhere17,19 but is outlined below.
For any given change in RR, the change in QT is
related to the slope of the QT/RR plot at that heart
rate. If changes in RR were infinitely slow, the plot
would describe the steady-state characteristic and
the change in QT (AQT) due to a change in RR
(ARR) would be given by the formula
AOT = S.ARR.
METHODS
ent Population and Data Acquisition
ents with ischemic heart disease and ei-
iymptoms of heart failure or left ventricu-
pairment (or both) who had been stable on
c medications for at least 1 month were suit-
)r inclusion in the study. Left ventricular ejec-
action was estimated by standard echocardio-
c, angiographic, or radionuclide methods,
ts on agents known to prolong the QT in-
were excluded. Patients with bundle branch
(BBB) or atrial fibrillation were excluded,
rom recordings in 41 patients from NYHA
> I-IV were compared with 15 age-matched
y volunteers. NYHA functional class was as-
Table 1. Characteristics of Subjects
Healthy
Volunteers IHD
Age 53 (6) 57 (14)
Sex 10 male, 35 male,
5 female 6 female
EF NA 25% (14)
Mean heart rate (SD) 71 (6) 70 (11)
Beta blockers NA 50%
ACE Inhibitors/All antagonists NA 90%
Diuretics NA 90%
Digoxin NA 5%
Class III agents NA 0%
Data are expressed as means (SD). or as percentages; NA =
not assessed.
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However, for more physiological changes in
RR, one must incorporate a model for the lag
phenomenon. The change in QT comprises an im¬
mediate undelayed fraction described as
a(S • ARR)
and the remainder as the fraction
(1 - a) ■ (S • ARR),
which has suffered a single-pole lag with a time
constant of r seconds. In Laplace transform nota¬
tion the lag function is thus
AQT(s) = [a + (1 - or)/(1 + sr)]-S-ARR(s).
This model was refined electronically by adjust¬
ing the time constants and applying this lag func¬
tion to the RR signal to create RR', an iden¬
tically lagging version of the RR signal. From
analysis of recordings from normal individuals,
it was found that a remains relatively constant
throughout the 24-hour period, with a popula¬
tion range of 0.22 to 0.31 (mean 0.26 ± 0.02).
When the proportion of the fast and slow com¬
ponents of the lag function are correctly adjusted,
the QT/RR plot no longer has hysteresis loops
but traces out a curve which is presumed to be
the underlying steady-state characteristic (Fig. 1).
During analysis the operator can monitor the re¬
moval of "hysteresis loops" and manually adjust the
lag-compensation algorithm if necessary by adjust¬
ing the proportion of a.
Technically, however, this is now a QT/RR' plot
as the QT data are the same, but the RR data
have been delayed by applying the lag function. As
these "pseudo-steady-state" plots are not linear but
curved, the relationship is estimated by fitting the
data against a general exponential formula with an
X/Y intercept at zero. The curve can be described
in terms of two variables—the exponent J and QTo,
which is the QT interval at RRo, a reference RR
interval (chosen as 1000 ms for reasons of conven¬
tion).
Secondly, throughout the analysis, the RR' and
QT signals are cross-correlated within a moving 5-
min time window that is scrolled through the 24-
hour data. As long as the correlation between QT
and RR' remains high (correlation coefficient r >
0.8), the slope (S) of the QT/RR plot around each
successive (RR', QT) point is computed as the lin¬
ear regression coefficient in the 5-min time window
currently centered on that point. Thus a continu¬
ously updated measure of the slope of the QT/RR'
characteristic curve is generated. If the mean 5-min
correlation coefficient drops below 0.8, these data
are automatically edited out and not used for the





Figure 1. A 3-min excerpt of data as would be seen during analysis of a Holter recording.
The panel on the left is a plot of raw QT values against the preceding RR intervals (QT/RR).
Hysteresis loops are seen as heart rate accelerates and decelerates. The right-hand panel
shows the same QT intervals plotted against the lag-compensated (RR') intervals. The re¬
sultant effect is seen as removal of the hysteresis loops, enabling the fitting of data to the
exponential formula.
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nlike some methods for QT/RR analysis, the
are not divided into epochs, but rather, values
ontinuously calculated from the mean of a con-
>usly scrolling 5-min window of data. Thus, if
:orrelation coefficient transiently drops below
tnly data from this period are edited out, rather
larger blocks of data. In this study, an average
I ± 4% and 93 ± 2% of 24-hour data was in-
;d for analysis in the heart failure and healthy
iteer groups, respectively,
irdly, it is found that the slope of the curve
rases at longer RR intervals, providing evi-
e that the steady-state QT/RR characteristic
rved. To avoid the necessity of reporting the
: of RR at each measure of slope, a simple
"ic exponential formula, as adopted by both
ricia20 and Bazett21 is used. These familiar for-
e have given rise to some confusion regard-
le correct units for "QTc." To avoid this dif-
y the present method uses the most general
ssion:
= QT/(RR/RRo)J.
QTo is the intercept of the curve with the or-
5 at RRo, a chosen reference RR interval (e.g.,
ms), and J is the exponent determining the
of the curve (using Bazett's formula J = 0.5;
idericia's, J = 0.33). The value of J is contin-
y computed from J = S (RR'/QT), where RR'
compensated value of RR.
: overall 24-hour variation of J is expressed
mean 24-hour standard deviation (SD) of J,
: derived from the mean of the continuously
ated mean SD of J from the 5-min scrolling
/indow.
Statistical Analysis
minimize the impact of noisy recordings on
;, only tapes where the percentage of data an-
was greater than 80% and the mean 24-hour
Jtion between OT and RR' was greater than
:re included. Mean 24-hour parameters from
recordings were compared between popula-
>y unpaired f-test.
RESULTS
re was no significant difference in mean 24-
R or QT between the two groups. The mean
r QTo was significantly prolonged in the
roup (461 vs 426 ms, P < 0.005). The mean
24-hour slope (S) was also steeper in IHD (0.195 vs
0.140, P < 0.01). The mean 24-hour J (the exponent
of the general formula that determines the form of
the QT/RR curve) was significantly elevated in HF
(0.38 vs 0.28). Constructed QT/RR curves created
by using the mean population values of QTo and
J are shown in Figure 2 to illustrate the different
characteristics over a range of heart rates. In addi¬
tion, the spread of values of J throughout the 24-
hour period indicated by the mean 24-hour SD of J
is much greater in the IHD group (0.181 vs 0.059,
P < 0.01), reflecting an increased variation in the
relationship between QT and heart rate. These data
are summarized in Table 2. The increased variation
in J cannot be explained by differences in the lag
compensation as the overall correlation between
QT and RR for compensated data is comparable
Constructed QT/RR Plot Using Grouped
Population Values of QTo and J
RR interval (ms)
Figure 2. Curves generated from the mean population
data in heart failure and healthy subjects. This illustrates
how, at higher heart rates, little difference is observed
between HF subjects and HV subjects. However, at lower
heart rates, the combination of a higher J and longerQTo
leads to a wider separation of the two curves. Error bars
indicate standard errors of the means.
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Table 2. Characteristics of 24-Hour Recordings
RR QT QTo 24-Hour Pooled 24-Hour
(ms) (ms) (ms) S J SD of J Value
HV (n = 15) 845 (105) 402 (24) 426 (20) 0.14 (0.02) 0.28 (0.05) 0.05 (0.05) 0.742 (0.08)
IHD (n = 41) 859 (152) 420 (45) 461 (37) 0.20 (0.07) 0.38 (0.1 1) 0.181 (0.25) 0.77 (0.10)
P-value 0.76 0.18 <0.01 <0.01 <0.01 <0.01 0.25
Data are expressed as mean 24-hour values (SD).
between the two groups, as indicated by the
similar-pooled mean 24-hour correlation (r).
When patients were subdivided according to
NYHA class, the values of S, QTo and J increase
with worsening functional class (Fig. 3). Analysis
of variance (ANOVA) confirmed statistical signif¬
icance (Table 3). In contrast, when patients were
subgrouped according to ejection fraction (0-15%,
16-25%, 25-40%, and >40%), no significant differ¬
ence is seen between the subgroups (Fig. 4).
CONCLUSIONS
The most appropriate method for assessment of
ventricular repolarization is debatable. The sim¬
plest approach would be to take a resting 12-lead
ECG and use one of the available correction formu¬
lae to correct for differences in heart rate. Unfortu¬
nately, the use of formulas to correct for heart rate
are limited by the fact that most are only accurate
at rest when heart rate is relatively low. In addition,
they impose the same underlying QT/RR relation¬
ship on both populations, and can only be applied
when heart rate has been stable for several minutes
due to the significant time delay in reaching steady
state. Investigators have shown that different sub¬
jects have different overall QT/RR relationships,
and patient groups tend to have steeper QT/RR
slopes and longer QT intervals, making direct com¬
parison between populations using the same cor¬
rection formula inappropriate. This is particularly
true when using Holter data, which by nature are
largely non-steady-state. The use of this method
permits continuous assessment of the 24-hour rela¬
tionship in patients with heart failure. Several dif¬
ferences come to light as a result.
Differences in the QT/RR Relationship
between Heart Failure Subjects and
Controls
When the overall QT/RR characteristic is ex¬
amined, a marked difference emerges between
patients and controls. The extrapolated QTo is sig¬
nificantly prolonged, and the exponent, J, is greater.
The resultant effect of these two abnormalities is
that the curves are separated over a broad range
of heart rates, with the differences most marked at
low heart rates.
The ability to detect prolongation of QT is de¬
pendent on the method used for correction of rate-
related changes. Previous studies have shown that
survivors of out-of-hospital cardiac arrests can have
a normal QTc when traditional rate correction for¬
mulae are applied, but abnormal rate dependence
when QT/RR plots are constructed with raw data.22
This is an important point, because if one consid¬
ers that in this study QTo is chosen arbitrarily as
1 s for no reason other than convention, it can be
seen from Figure 3 that if QTo was set at, for exam¬
ple, 500 ms, little difference would be observed be¬
tween the groups. QTo as a stand-alone measure of
repolarization may show differences between pop¬
ulations, but when combined with the exponent J
it takes on a much more useful role, as it allows
description of the entire QT/RR characteristic, re¬
gardless of heart rate. Knowing both of these vari¬
ables gives more precise information about repolar¬
ization at any point in time.
Increased Variability in the QT/RR
Relationship
By calculating the mean 24-hour SD of J, informa¬
tion is obtained about the frequency and magnitude
of changes occurring in the QT/RR characteristic
throughout the day. In both healthy volunteers and
HF variation is seen although the magnitude of this
variation is greater in heart failure. This increased
variation in the QT/RR relationship bears similari¬
ties with the work of Atiga et al.22,24 They used a
novel approach for the assessment of repolarization
dynamics that assesses changes in QT with respect
to changes in RR over relatively short time periods
(256 s). When they compared healthy volunteers
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Figure 3. Comparison of the correlation between functional class, ejection fraction, and
repolarization characteristics. Error bars indicate standard errors of the means.
latients, they found that there was decreased
rate variance but an increase in QT variance
patient groups. When these two parameters
mbined to produce the QT variability index
) they found that it discriminated between
ntrol and patient groups. This increased vari-
• in the QT/RR relationship may reflect an in-
of the myocardium to regulate repolarization
anges in heart rate.
elation with NYHA Functional Class
ough this study was small, subjects were dis-
:d across all four NYHA classes. When sub-
; were analyzed, it became apparent that the
nalities of the QT/RR relationship show a
ling trend with functional class. NYHA func-
class correlates with the degree of neuro-
al activation in heart failure. The maladap-
echanisms of increased sympathetic tone,
sed parasympathetic activity, and activation
of the renin-angiotensin-aldosterone system have
been shown to, either directly or indirectly, influ¬
ence cardiac repolarization, with downregulation of
ion currents and abnormal expression of adrener¬
gic receptors. These factors may be partly respon¬
sible for the progressive changes in repolarization
Table 3. Statistical Analysis of NYHA and EF








In this table, P values are shown for each parameter mea¬
sured, according to whether patients were subgrouped by
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Figure 4. Comparison of the correlation between ejection fraction and repolarization
characteristics. Error bars indicate standard errors of the means.
dynamics that we have described. Other investi¬
gators25-27 have shown that beta-blockade reduces
the slope of the QT/RR relationship in both healthy
subjects and patients, and this implies that in¬
creased sympathetic drive is at least one of the fac¬
tors responsible for the increases seen in J and QTo
relative to controls.
Previous studies28 have shown that sudden death
is disproportionately common in relatively asymp¬
tomatic patients and our findings would seem to
be discordant. However, arrhythmic death is fre¬
quently hard to determine as it is often unwitnessed
and rhythms are not documented in the commu¬
nity. Certainly, patients with NYHA IV failure pro¬
portionately more likely to die from pump failure
compared to NYHA I patients, but studies suggest
that they are also very likely to die of arrhythmias.3
In summary, as both the "corrected" QT, and the
exponent describing the curve (J) are different be¬
tween controls and patients with LV impairment,
the use of "off the shelf" rate correction formulas
to correct QT for heart rate will lead to errors in
measurement, particularly if used on dynamic data.
The observed progression in QT prolongation, in¬
creased rate dependence, and increased variation
in the relationship may promote ventricular ar¬
rhythmias and sudden death. Further studies will
demonstrate whether prognostic information can
be obtained using this method.
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